
<html lang="en"     class="pb-page"  data-request-id="632778db-8ebd-41ef-a1e6-12cecbdf4d36"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2019.62.issue-17;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00861;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease" /></meta><meta name="dc.Creator" content="Masayoshi  Miyagawa" /></meta><meta name="dc.Creator" content="Toshiyuki  Akiyama" /></meta><meta name="dc.Creator" content="Yoshiyuki  Taoda" /></meta><meta name="dc.Creator" content="Kenji  Takaya" /></meta><meta name="dc.Creator" content="Chika  Takahashi-Kageyama" /></meta><meta name="dc.Creator" content="Kenji  Tomita" /></meta><meta name="dc.Creator" content="Kazuya  Yasuo" /></meta><meta name="dc.Creator" content="Kazunari  Hattori" /></meta><meta name="dc.Creator" content="Shinya  Shano" /></meta><meta name="dc.Creator" content="Ryu  Yoshida" /></meta><meta name="dc.Creator" content="Takao  Shishido" /></meta><meta name="dc.Creator" content="Tomokazu  Yoshinaga" /></meta><meta name="dc.Creator" content="Akihiko  Sato" /></meta><meta name="dc.Creator" content="Makoto  Kawai" /></meta><meta name="dc.Description" content="The medicinal chemistry and structure–activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disc..." /></meta><meta name="Description" content="The medicinal chemistry and structure–activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disc..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 6, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00861" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00861" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00861" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00861" /></link>
        
    
    

<title>Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00861" /></meta><meta property="og:title" content="Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0013.jpeg" /></meta><meta property="og:description" content="The medicinal chemistry and structure–activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disclosed. Substituent effects were evaluated at the C (N)-1, N-3, and C-7 positions of the CAB ring system using a docking study. Submicromolar EC50 values were achieved in the cellular assay with C-7-unsubstituted CAB which possessed a benzhydryl group on either the C-1 or the N-1 position. An N-3 substituent was found to be critical for the plasma protein binding effect in vitro, and the CAB-N analogue 2v exhibited reasonable total clearance (CLtot). More importantly,  compound 2v displayed significant efficacy in a mouse model infected with influenza viruses." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00861"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00861">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00861&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00861&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00861&amp;href=/doi/10.1021/acs.jmedchem.9b00861" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 8101-8114</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00858" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00912" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Masayoshi Miyagawa</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Masayoshi Miyagawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +81-6-6331-6306. Fax: +81-6-6332-6385. E-mail: <a href="/cdn-cgi/l/email-protection#9df0fceefce4f2eef5f4b3f0f4e4fcfafceafcddeef5f4f2f3f2faf4b3fef2b3f7ed"><span class="__cf_email__" data-cfemail="eb868a988a9284988382c58682928a8c8a9c8aab9883828485848c82c58884c5819b">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Masayoshi++Miyagawa">Masayoshi Miyagawa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8940-5407" title="Orcid link">http://orcid.org/0000-0001-8940-5407</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Toshiyuki Akiyama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Toshiyuki Akiyama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Toshiyuki++Akiyama">Toshiyuki Akiyama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yoshiyuki Taoda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yoshiyuki Taoda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yoshiyuki++Taoda">Yoshiyuki Taoda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenji Takaya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenji Takaya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Takaya">Kenji Takaya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chika Takahashi-Kageyama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chika Takahashi-Kageyama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chika++Takahashi-Kageyama">Chika Takahashi-Kageyama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenji Tomita</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenji Tomita</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Tomita">Kenji Tomita</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazuya Yasuo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazuya Yasuo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazuya++Yasuo">Kazuya Yasuo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazunari Hattori</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazunari Hattori</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazunari++Hattori">Kazunari Hattori</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shinya Shano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shinya Shano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shinya++Shano">Shinya Shano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryu Yoshida</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryu Yoshida</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryu++Yoshida">Ryu Yoshida</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takao Shishido</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takao Shishido</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takao++Shishido">Takao Shishido</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomokazu Yoshinaga</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomokazu Yoshinaga</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomokazu++Yoshinaga">Tomokazu Yoshinaga</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akihiko Sato</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akihiko Sato</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akihiko++Sato">Akihiko Sato</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Makoto Kawai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Makoto Kawai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Makoto++Kawai">Makoto Kawai</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00861&amp;href=/doi/10.1021%2Facs.jmedchem.9b00861" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 8101–8114</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 6, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 May 2019</li><li><span class="item_label"><b>Published</b> online</span>6 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00861" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00861</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8101%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMasayoshi%2BMiyagawa%252C%2BToshiyuki%2BAkiyama%252C%2BYoshiyuki%2BTaoda%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D17%26contentID%3Dacs.jmedchem.9b00861%26title%3DSynthesis%2Band%2BSAR%2BStudy%2Bof%2BCarbamoyl%2BPyridone%2BBicycle%2BDerivatives%2Bas%2BPotent%2BInhibitors%2Bof%2BInfluenza%2BCap-dependent%2BEndonuclease%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8114%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00861"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1678</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00861" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and SAR Study of Carbamoyl Pyridone Bicycle Derivatives as Potent Inhibitors of Influenza Cap-dependent Endonuclease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Masayoshi&quot;,&quot;last_name&quot;:&quot;Miyagawa&quot;},{&quot;first_name&quot;:&quot;Toshiyuki&quot;,&quot;last_name&quot;:&quot;Akiyama&quot;},{&quot;first_name&quot;:&quot;Yoshiyuki&quot;,&quot;last_name&quot;:&quot;Taoda&quot;},{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Takaya&quot;},{&quot;first_name&quot;:&quot;Chika&quot;,&quot;last_name&quot;:&quot;Takahashi-Kageyama&quot;},{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Tomita&quot;},{&quot;first_name&quot;:&quot;Kazuya&quot;,&quot;last_name&quot;:&quot;Yasuo&quot;},{&quot;first_name&quot;:&quot;Kazunari&quot;,&quot;last_name&quot;:&quot;Hattori&quot;},{&quot;first_name&quot;:&quot;Shinya&quot;,&quot;last_name&quot;:&quot;Shano&quot;},{&quot;first_name&quot;:&quot;Ryu&quot;,&quot;last_name&quot;:&quot;Yoshida&quot;},{&quot;first_name&quot;:&quot;Takao&quot;,&quot;last_name&quot;:&quot;Shishido&quot;},{&quot;first_name&quot;:&quot;Tomokazu&quot;,&quot;last_name&quot;:&quot;Yoshinaga&quot;},{&quot;first_name&quot;:&quot;Akihiko&quot;,&quot;last_name&quot;:&quot;Sato&quot;},{&quot;first_name&quot;:&quot;Makoto&quot;,&quot;last_name&quot;:&quot;Kawai&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8101-8114&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00861&quot;},&quot;abstract&quot;:&quot;The medicinal chemistry and structure–activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disclosed. Substituent effects were evaluated at the C (N)-1, N-3, and C-7 positions of the CAB ring system using a docking study. Submicromolar EC50 values were achieved in the cellular assay with C-7-unsubstituted CAB which possessed a benzhydryl group on either the C-1 or the N-1 position. An N-3 substituent was found to be critical for the plasma protein binding effect in vitro, and the CAB-N analogue 2v exhibited reasonable total clearance (CLtot). More importantly, compound 2v displayed significant efficacy in a mouse model infected with influenza viruses.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00861&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00861" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00861&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00861" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00861&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00861" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00861&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00861&amp;href=/doi/10.1021/acs.jmedchem.9b00861" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00861" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00861" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00861%26sid%3Dliteratum%253Aachs%26pmid%3D31386363%26genre%3Darticle%26aulast%3DMiyagawa%26date%3D2019%26atitle%3DSynthesis%2Band%2BSAR%2BStudy%2Bof%2BCarbamoyl%2BPyridone%2BBicycle%2BDerivatives%2Bas%2BPotent%2BInhibitors%2Bof%2BInfluenza%2BCap-dependent%2BEndonuclease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D17%26spage%3D8101%26epage%3D8114%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=290860" title="Solution chemistry">Solution chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/jmcmar.2019.62.issue-17/20190912/jmcmar.2019.62.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The medicinal chemistry and structure–activity relationships (SAR) for a novel series of carbamoyl pyridone bicycle (CAB) compounds as influenza Cap-dependent endonuclease (CEN) inhibitors are disclosed. Substituent effects were evaluated at the C (N)-1, N-3, and C-7 positions of the CAB ring system using a docking study. Submicromolar EC<sub>50</sub> values were achieved in the cellular assay with C-7-unsubstituted CAB which possessed a benzhydryl group on either the C-1 or the N-1 position. An N-3 substituent was found to be critical for the plasma protein binding effect in vitro, and the CAB-N analogue <b>2v</b> exhibited reasonable total clearance (CL<sub>tot</sub>). More importantly,  compound <b>2v</b> displayed significant efficacy in a mouse model infected with influenza viruses.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Influenza is an acute respiratory infectious disease that affects 5–10% of the world population every winter, resulting in 3–5 million severe cases with 250 000–50 000 deaths.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the past century, four influenza pandemics have occurred, each causing the death of millions.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> While vaccination is a reasonable preventive, its efficacy is heavily dependent on accurate prediction of the predominant infectious strains for each season.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Major antiviral drugs, such as zanamivir, oseltamivir, and peramivir, target viral neuraminidase and can be useful for treatment but must be administered within 48 h of infection.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> These therapeutics also can cause undesirable side effects, including unusual neurologic or psychiatric events such as delirium, hallucinations, confusion, and abnormal behavior, primarily in children.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Moreover, problems such as the appearance of resistant strains as well as worldwide epidemics caused by new strains of influenza viruses possessing high pathogenicity and mortality<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> have raised the need for the development of novel anti-influenza drugs that function via different mechanisms.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The influenza virus is a lipid-enveloped virus with a negative-sense single-strand RNA with the viral genome having eight genomic segments: PB2, PB1, PA, HA, NP, NA, M, and NS. PB2, PB1, and PA compose the polymerase complex and are responsible for both transcription and replication of the viral genome.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The viral replication starts with “cap-snatching” and occurs in three steps. First, the PB2 subunit binds the 5′-mRNA cap of a host cell, and in the second step the PA subunit cleaves 10–13 nucleotides downstream to yield 5′-capped RNA fragments. These fragmenst serve as primers for viral mRNA elongation catalyzed by the PB1 subunit in the third step.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Those three subunits are essential for proliferation of the influenza virus, in particular, Cap-dependent endonuclease (CEN) in the N-terminal domain of the PA subunit is highly conserved across various influenza types and subtypes.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Therefore, CEN inhibitors are expected to have broad efficacy against multiple influenza viruses. However, there are no currently approved drugs.</div><div class="NLM_p">Biochemical and crystallographic studies have revealed CEN to contain a dinuclear metal in the active site, employing two Mn<sup>2+</sup> or Mg<sup>2+</sup> ions.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In previous research, several potent inhibitors which bind the CEN active site have been reported (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Almost all of them (<b>1a</b>–<b>g</b>) belong to 1 metal, 2 metal, or water-mediated 2 metal chelator which has a hydrophobic region behind the chelate side to enhance CEN inhibitory potency.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22">(15−22)</a> However, their antiviral activities are very weak compared to their enzyme inhibitory potencies. This may be due to low cell membrane permeability caused by the high polarity of their chelate motifs. Recently, the nonchelate compound <b>1h</b> was reported<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> to have low dissociation of enzyme and virus inhibition activity, but its in vitro activity was not sufficient for clinical applications.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported potent CEN inhibitors. Results of compound <b>1a</b> tested in our conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our research effort focused on a new type of scaffold, a 2-metals chelator, namely, carbamoyl pyridone bicycle (CAB), shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. First, we identified the hit compound <b>2a</b>, which binds two metals, as a CEN inhibitor from our compound library. As described below, the evolution from <b>2a</b> to the promising lead CAB compounds was accompanied by a marked increase in enzyme inhibitory and antiviral activity. In addition, one CAB congener which had acceptable in vivo clearance in rat showed significant efficacy in a mouse model infected with influenza viruses.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening hit compound <b>2a</b>, and  chemical structure of the CAB scaffold and each substituent positions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> shows the synthetic routes to the carbamoyl pyridone bicycle (CAB) moiety. Cyclization of <b>3</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with cinnamoyl chloride and LHMDS yielded pyrone <b>4</b>. Ruthenium-catalyzed oxidative cleavage of olefin provided aldehyde <b>5</b>. This compound <b>5</b> was oxidized with sodium sulfite to produce the corresponding carboxylic acid <b>6</b>. Condensation of <b>6</b> with 2-methoxyethylamine afforded compound <b>7</b>. Insertion of various amino–alcohols yielded pyridone derivatives <b>8</b>. Cyclization of <b>8</b> under Mitsunobu conditions gave CAB-C moiety <b>11</b>. Insertion of <i>N</i>-Boc hydrazine to compound <b>7</b> yielded <i>N</i>-amino pyridone <b>9</b>. Compound <b>9</b> was deprotected with TFA followed by cyclization to provide CAB-N moiety <b>10</b>. Alkylation of <b>10</b> with various alkyl bromides gave <b>11</b><b>d</b>,<b>j</b>. Compound <b>11k</b> was deprotected with TFA to produce <b>2k</b>. Hydrolysis of ethyl ester and deprotection of benzyl ether furnished compounds <b>2</b><b>b–j</b>. 1-Benzhydryl-7-carboxylic acid <b>12i</b> was converted to its <i>N</i>-methyl amide <b>13</b> and Weinreb amide <b>14</b> derivatives by condensation with the corresponding amines. Compound <b>13</b> was deprotected with TFA to produce <b>2l</b>. Treatment of <b>14</b> with MeMgBr in THF afforded 7-acetyl compound <b>15</b>. Baeyer–Villiger oxidation of <b>15</b> with <i>m</i>-CPBA and hydrolysis of acetyl group gave 7-hydroxy pyridone <b>17</b>. Compound <b>17</b> was alkylated with MeI in the presence of NaH to afford 7-methoxy-pyridone <b>18</b>. Compound <b>18</b> was treated with TFA to yield <b>2n</b>. On the other hand, Curtius rearrangement of <b>12i</b> by a stepwise method provided 7-methoxycarbonylaminopyridone <b>19</b>. Hydrolysis of <b>19</b> and deprotection of the benzyl group gave <b>2m</b>. Decarboxylation of <b>12i</b> at high temperature (245 °C) in a sealed tube under microwave condition produced 7-nonsubstituted pyridone <b>21</b>. Deprotection of the benzyl group gave compound <b>2q</b>. In the same way, compound <b>2t</b> was synthesized from compound <b>12j</b> via compound <b>24</b>. Compound <b>21</b> was treated with NBS to convert 7-bromo-pyridone <b>22</b>. Treatment of <b>22</b> with CuCl in DMSO afforded 7-chloro derivative <b>2p</b> in which benzyl ether was deprotected under the reaction conditions. Palladium-catalyzed methylation of compound <b>22</b> at the C-7 position was performed to give compound <b>23</b>. Deprotection of benzyl ether furnished compound <b>2o</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2b</b>–<b>q</b> and <b>2t</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) cinnamoyl chloride, LHMDS, THF, −78 °C; (ii) RuCl<sub>3</sub>, NaIO<sub>4</sub>, conc. H<sub>2</sub>SO<sub>4</sub>, MeCN, rt; (iii) conc. H<sub>2</sub>SO<sub>4</sub>, amidosulfuric acid, sodium sulfite, MeCN, rt; (iv) (1) WSC-HCl, HOBt, DMF, rt; (2) 2-methoxyethanamine, rt; (v) amino-alcohol, xylene, 120 °C; (vi) PPh<sub>3</sub>, DEAD, THF, rt; (vii) <i>N</i>-Boc hydrazine, AcOH, toluene, reflux; (viii) (1) TFA, DCM, rt; (2) formaldehyde, EtOH, microwave, 100 °C; (ix) R-Br, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (x) TFA, rt; (xi) 2N NaOH aq., EtOH, rt; (xii) (1) ethyl chloroformate, TEA, DMF, rt; (2) amine, DMAP, rt; (xiii) MeMgBr, THF, −50 °C; (xiv) m-CPBA, DCM, rt; (xv) EtOH, reflux; (xvi) MeI, NaH, DMF, rt; (xvii) (1) ethyl chloroformate, TEA, DMF, rt; (2) NaN<sub>3</sub>, rt; (3) MeOH, 50 °C; (xviii) 2N NaOH aq., EtOH, 60 °C; (xix) microwave, Ph<sub>2</sub>O, 245 °C; (xx) NBS, DCM, reflux; (xxi) CuCl, DMSO, 120 °C; (xxii) hexamethyldistannane, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, reflux; BH means benzhydryl.</p></p></figure><div class="NLM_p">The synthetic routes to 7-decarboxylated CAB-C and CAB-N analogues are shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The commercially available pyrone <b>25</b> was converted to pyridone <b>26</b> via amination with <i>N</i>-Boc-ethylene diamine derivatives. Deprotection of the Boc group and neutralization led <b>26</b> to CAB-C ring <b>27</b>. Hydrolysis of methyl ester followed by decarboxylation yielded compound <b>29</b>. Alkylation of <b>29</b> with the corresponding alkyl bromides gave <b>30r</b> and <b>30s</b>. Deprotection of the benzyl ether furnished compounds <b>2r</b> and <b>2s</b>. On the other hand, amination of the commercially available pyrone <b>31</b> with ammonia gave pyridone <b>32</b>. After condensation of carboxylic acid with the corresponding amine, <i>N</i>-amination was performed to give intermediates <b>34u</b>–<b>w</b>. Cyclization of <b>34</b>  followed by alkylation provided CAB-N ring <b>35u</b>–<b>w</b>. Deprotection of the benzyl group gave compounds <b>2u</b>–<b>w</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2r</b>, <b>2s</b>, and <b>2u</b>–<b>w</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine, toluene, reflux; (ii) (1) 4 N HCl EtOAc, rt; (2) NaHCO<sub>3</sub> aq., rt; (iii) 2N NaOH aq., THF–MeOH, rt; (iv) microwave, Ph<sub>2</sub>O, 240 °C; (v) R-Br, Cs<sub>2</sub>CO<sub>3</sub>, rt; (vi) TFA, rt; (vii) 28% NH<sub>3</sub> aq., rt; (viii) (1) WSC-HCl, HOBt, DMF, rt, (2) amine, rt; (ix) <i>O</i>-(2,4-dinitrophenyl)hydroxylamine, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (x) (1) paraformaldehyde, AcOH, toluene, 100 °C, then concentration, (2) bromodiphenylmethane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, (xi) TFA, rt.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.1.  In Vitro SAR</h3><div class="NLM_p">We identified several hit compounds in our library. One of them was compound <b>2a</b>, which was a CEN inhibitor without a hydrophobic region, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. From our previous research,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> introduction of the hydrophobic domain to the chelator moiety led to enhanced inhibitory activity of CEN. A compound substituted by a benzyl group at the C-1 position, <b>2b</b> showed remarkable activity compared to <b>2a</b>, whereas its enantiomer <b>2c</b> had very low activity. In addition, replacement of the nitrogen atom at the 1 position (CAB-N) maintained activity against CEN. On the other hand, either a shorter or a longer linker, <b>2e</b> or <b>2f</b>, was clearly associated with a dramatic loss of potency compared to <b>2b</b>. In the same way, conversion to an alkyl group, <b>2g</b> and <b>2h</b>, reduced in the potency. A branched structure closer to the CAB ring was found to be favorable for the enzyme inhibition. From these findings we hypothesized that substitution at the benzylic position of compounds <b>2b</b> and <b>2d</b> would be effective. Benzhydryl-substituted compounds <b>2i</b> and <b>2j</b> were found to show 4–5-fold higher inhibition potency than <b>2b</b> and <b>2d</b>, respectively (corresponding benzyl analogues).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of 1-Substitited CAB Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Reported values are the means of three or more experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Enzyme inhibitory activity of CEN was measured by a fluorescence recovery assay of the enzyme reaction.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">MDBK cells were incubated with test compounds and influenza A virus (A/WSN/33) for 72 h, and the concentration of test compound resulting in 50% cell protection was reported as the EC<sub>50</sub>. N.D., not determined.</p></div></div><div></div></div><div class="NLM_p">We attempted to validate the chelating mode of our inhibitors to the active site in CEN. We hypothesized that chelation by the CAB scaffold could be done by the four modes shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. In order to estimate the chelate binding mode, constrained docking and minimization studies were performed for a reported CEN crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W69">2W69</a>)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> with Glide and MacroModel (Schrödinger Inc. U.S.A.). Metal binding oxygen atoms of <b>2i</b> were fixed in each optimal geometry to bind the two metals in the active site. The ligand molecule <b>2i</b> and the receptor protein were minimized in the flexible mode. The coordinating phenolic oxygen atom of inhibitor <b>2i</b> was deprotonated, and the charge on each metal center was assigned as 2+ in the simulation.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conceivable chelate modes of the CEN active site with CAB-C analogue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a result, docking analysis showed that the CAB derivative <b>2i</b> could chelate to the active site metals in the most stabilized mode (c). C-7 carboxylic acid on <b>2i</b> did not chelate to metals but interacted with the side chains of Lys134 and Tyr130 mediated by the hydrogen bond. More interestingly, the two benzenes on <b>2i</b> nicely filled two hydrophobic pockets (Pockets 1 and 2 in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In addition, the methoxyethyl moiety binding pocket neighboring the N-3 position (Pocket 3) could tolerate a variety of substitutions, which suggests that this region of the binding site is not spatially constrained.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking simulation of <b>2i</b> (green) binding to the active site of CEN. Two metals and lipophilic sites are shown in light blue and yellow, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the light of these findings, we considered the conversion of carboxylic acid at C-7 to be acceptable for the CEN active pocket, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Ethyl ester <b>2k</b> and <i>N</i>-methyl amide <b>2l</b> were less potent in both the CEN and the CPE assays, but the activities did not disappear. When sterically restricted and nonchelatable substituents, such as an amino, methoxy, methyl, or chloro group, were evaluated, the potency decreased by 2–8-fold. By removing the carboxylic acid at the C-7 position, we obtained a new type of inhibitor <b>2q</b> that was 2-fold less potent than <b>2i</b> in the CEN assay. This may have been due to the absence of the hydrogen bond. However, compound <b>2q</b> showed the same range of activity in the CPE assay. Consequently, it is reasonable to assume that nonsubstitution at the C-7 position increases membrane permeability to result in enhancing cell activity, because decarboxylation reduces  the molecular weight and increases the lipophilicity (calculated LogP of <b>2i</b> and <b>2q</b> were 1.29 and 2.06, respectively).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of 7-Substitited CAB Inhibitors<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0010.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">CEN IC<sub>50</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">CPE EC<sub>50</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b></td><td class="colsep0 rowsep0" align="left">COOH</td><td class="colsep0 rowsep0" align="char" char=".">0.0478</td><td class="colsep0 rowsep0" align="char" char=".">0.293</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>Et</td><td class="colsep0 rowsep0" align="char" char=".">0.298</td><td class="colsep0 rowsep0" align="char" char=".">2.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2l</b></td><td class="colsep0 rowsep0" align="left">CONHMe</td><td class="colsep0 rowsep0" align="char" char=".">1.59</td><td class="colsep0 rowsep0" align="char" char=".">7.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2m</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.358</td><td class="colsep0 rowsep0" align="char" char=".">3.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2n</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.110</td><td class="colsep0 rowsep0" align="char" char=".">1.68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2o</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.281</td><td class="colsep0 rowsep0" align="char" char=".">2.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2p</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.114</td><td class="colsep0 rowsep0" align="char" char=".">0.541</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2q</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.115</td><td class="colsep0 rowsep0" align="char" char=".">0.134</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Reported values are the mean of three or more experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Enzyme inhibitory activity of CEN was measured by a fluorescence recovery assay of the enzyme reaction.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">MDBK cells were incubated with test compounds and influenza A virus (A/WSN/33) for 72 h, and the concentration of test compound resulting in 50% cell protection was reported as the EC<sub>50</sub>.</p></div></div></div><div class="NLM_p">Next, we explored the N-3 position of the CAB scaffold. We thought conversion of the N-3 position could adjust the physicochemical property of molecules without loss of potency, because the docking study indicated that this region was not spatially constrained in the CEN active site. The presence of an N-3 methyl or isopropyl substituent in CAB-C series (<b>2r</b>, <b>2s</b>) appeared to lead to  retention of antiviral potency. The CAB-N series (<b>2t</b>, <b>2u</b>, <b>2v</b>) was similarly found to be equipotent to CAB-C analogues in the CPE assay except for the 2-methyl-furan-substituted <b>2w</b>, which showed reduced potency in both assays. In silico docking study using <b>2v</b> demonstrated the isopropyl group at the N-3 position did not interact with any residues in CEN, because it was located in the solvent exposure resion (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_002.pdf" class="ext-link">Figure S3</a>). Interestingly, PK study with rat showed that more hydrophobic substituent groups improved rat iv clearance in each series. This was caused by the decreasing fu value in plasma in a group with high metabolic stability (<b>2q</b>–<b>v</b>), <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. On the other hand, <b>2w</b> was lower than the clearance value in spite of having the lowest fu value. It may be due to low stability in the rat microsome. As a result, we obtained the promising inhibitor <b>2v</b> which exhibited good antiviral potency with 81.6 nM and reasonable in vivo clearance with 10.9 mL/min/kg.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of 3-Substitited CAB Inhibitors<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> and Rat PK Parameters<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0011.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0012.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Reported values are the means of three or more experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Values are the means of duplicate experiments.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Enzyme inhibitory activity of CEN was measured by a fluorescence recovery assay of the enzyme reaction.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">MDBK cells were incubated with test compounds and influenza A virus (A/WSN/33) for 72 h, and the concentration of test compound resulting in 50% cell protection was reported as the EC<sub>50</sub>.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Metabolic stability in the presence of rat liver microsomes was represented as the % compound remaining at a concentration of 2 μM after 30 min, incubated at 37 °C.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Rat clearance was measured by LC/MS/MS after a single intravenous administration.</p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">Free fraction ratio in the presence of rat serum.</p></div></div><div></div></div><div class="NLM_p">As the active site of CEN is highly conserved among all influenza virus families, we confirmed the broad antiviral spectrum using compounds <b>2s</b> and <b>2v</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. They showed similar antiviral behavior in the CPE assay. The atom at the 1 position (C or N) may not have affected the antiviral activity as described previously. They displayed equivalent antiviral activities against the H1N1 type, including the reverse genetic strain (rgA/WSN/33), oseltamivir-resistant strain (rgA/WSN/33–NA/H274Y), and  clinically isolated strain (A/PR/8/34). Although their antiviral activities against H3N2 (A/Victoria/3/75, A/HongKong/8/68) were slightly reduced, those of influenza B exhibited the same range as that against H1N1.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiviral Potency of Compound <b>2s</b> and <b>2v</b> against Various Influenza Viruses</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">mean CPE EC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">virus</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"><b>2s</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>2v</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A/H1N1</td><td class="colsep0 rowsep0" align="left">A/PR/8/34</td><td class="colsep0 rowsep0" align="char" char="±">194.4 ± 6.0</td><td class="colsep0 rowsep0" align="char" char="±">183.0 ± 11.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rgA/WSN/33<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">154.8 ± 45.9</td><td class="colsep0 rowsep0" align="char" char="±">165.1 ± 15.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rgA/WSN/33–NA/H274Y<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">89.2 ± 67.7</td><td class="colsep0 rowsep0" align="char" char="±">80.4 ± 50.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A/H3N2</td><td class="colsep0 rowsep0" align="left">A/Victoria/3/75</td><td class="colsep0 rowsep0" align="char" char="±">487.6 ± 185.5</td><td class="colsep0 rowsep0" align="char" char="±">828.8 ± 94.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">A/HongKong/8/68</td><td class="colsep0 rowsep0" align="char" char="±">232.4 ± 17.4</td><td class="colsep0 rowsep0" align="char" char="±">301.5 ± 77.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">B/Hong Kong/5/72</td><td class="colsep0 rowsep0" align="char" char="±">100.1 ± 19.0</td><td class="colsep0 rowsep0" align="char" char="±">124.3 ± 39.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">B/Maryland/1/59</td><td class="colsep0 rowsep0" align="char" char="±">177.0 ± 11.6</td><td class="colsep0 rowsep0" align="char" char="±">176.0 ± 6.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">MDCK cells were incubated with test compounds and influenza viruses for 72 h, and the concentration of test compound resulting in 50% cell protection was reported as the EC<sub>50</sub>.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">rg; means reverse genetics.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.2.  In Vivo Efficacy</h3><div class="NLM_p">Finally, compound <b>2v</b> was advanced to a mouse influenza B (B/Maryland/1/59) model (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), where it showed dose-dependent efficacy in an immediate treatment model after infection at 0.08–10 mg/kg(q.d., 1 day) by intravenous administration (ED<sub>50</sub> = 0.89 mg/kg/day). Moreover, we confirmed a 100% survival rate at 10 mg/kg. This demonstrated that CEN is an attractive target for influenza treatment and its efficacy against influenza B is superior to another target of influenza virus (PB2).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, we confirmed that <b>2v</b> was deficient with respect to antiviralpotency because a low dose (0.08, 0.4, and 2 mg/kg) of <b>2v</b> was not able to protect all mice infected with influenza virus. Furthermore, the oral bioavailability of <b>2v</b> was not sufficient to confirm its in vivo activity with the same model.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo activity of <b>2v</b> in mouse influenza B model when administered immediately after infection: survival curve of female BALB/C mice (5 mice/group) inoculated with influenza viruses B/Maryland/1/59 (100 TCID<sub>50</sub>/mouse) by intranasal instillation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we established the synthesis of two carbamoyl pyridone bicycle analogues (CAB-C, N) focused on the 1-, 3-, and 7-positions, which were identified asCEN inhibitors of the influenza virus starting from our library compounds. Our research on the substituent effects of 1- and 7-positions of the core templates, led to improved enzyme inhibition and antiviral activity with corroboration by docking analysis. Additionally, more hydrophobic substituents at the 3-position, in particular of thtet CAB-N moiety, presenteda reasonable pharmacokinetic profile in rat coupled with increased protein binding. Further testing showed that compound <b>2s</b> and <b>2v</b> were potent against all influenza A and B strains tested, including pandemic H1N1 flu strains. Moreover, <b>2v</b> was effective in the mouse model infected with influenza B virus in a dose-dependent manner. Additional SAR studies in the title series leading to the discovery and development of clinical candidate S-033188 will be reported in future publications.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Compound Purity and Identity</h3><div class="NLM_p"><sup>1</sup>H NMR (400 MHz) spectra were measured on a Varian MERCURY or Bruker instrument in a solution of either CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> using tetramethylsilane as the internal standard. Chemical shifts are expressed as δ (ppm) values for protons relative to the internal standard. The purity of the test compounds was confirmed by UPLC-MS with UV diode array detection to determine purity and by MS to confirm molecular weight. A Waters Acquity UPLC system comprising Binary Solvent manager, Sample Manager, PDA Detector, Waters ZQ or SQD mass spectrometer, and Waters Acquity evaporative light scattering detector were employed.  Column: ACQUITY UPLC BEH C18 (1.7 μm, i.d. 2.1 × 50 mm) (Waters). Flow rate: 0.8 mL/min. UV detection wavelength: 254 nm. Mobile phase: [A] is 0.1% formic acid-containing aqueous solution, and [B] is 0.1% formic acid-containing acetonitrile solution. Gradient: linear gradient of 5–100% solvent [B] for 3.5 min was performed, and 100% solvent [B] was maintained for 0.5 min. The purity of all tested compounds was ≥95%. Analytical HPLC was also used in some cases to monitor reactions and establish final compound purity using a C-18 column (5.0 μm, 0 → 100% CH<sub>3</sub>CN/water with 0.1% TFA and UV detection with mass spectrometer detection. Preparative HPLC conditions were as follows: C-18 column, 5 μm, 21.2 mm × 150 mm; flow rate = 4 mL/min; mobile phase = 10 → 100% CH<sub>3</sub>CN/H<sub>2</sub>O/0.1%HCOOH (10 min run).</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Ethyl-(<i>E</i>)-5-(benzyloxy)-4-oxo-6-styryl-4<i>H</i>-pyran-3-carboxylate (<b>4</b>)</h4><div class="NLM_p last">A 1 N lithiumhexamethyldisilazane THF solution (4.29 mL, 4.29 mmol) was cooled to −78 °C, and a THF solution (4 mL) of compound <b>3</b> (500 mg, 1.72 mmol) and cinnamoyl chloride (343.2 mg, 2.06 mmol) was added dropwise  over 3 min while the same temperature was retained. After the reaction solution was stirred at the same temperature for 25 min, 2 N hydrochloric acid (10 mL) was added and the mixture was further stirred at room temperature for 10 min. To the reaction solution was added ethyl acetate, the organic layer was separated, and the aqueous layer was extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. From the fraction eluted with <i>n</i>-hexane-ethyl acetate (1:1, v/v), 364.3 mg (yield 56%) of compound <b>4</b> was obtained as a white solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 1.40 (3H, t, <i>J</i> = 7.2 Hz), 4.39 (2H, q, <i>J</i> = 7.2 Hz), 5.27 (2H, s), 6.99 (1H, d, <i>J</i> = 16.2 Hz), 7.23 (1H, d, <i>J</i> = 16.2), 7.26–7.48 (10H, m), 8.45 (1H, s).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Ethyl-5-(benzyloxy)-6-formyl-4-oxo-4<i>H</i>-pyran-3-carboxylate (<b>5</b>)</h4><div class="NLM_p last">To a MeCN (5 mL) solution of compound <b>4</b> and ruthenium chloride (2.76 mg, 0.0133 mmol) was added dropwise an aqueous solution (8 mL) of sodium periodate (625.8 mg, 2.93 mmol) and 96% sulfuric acid (287.4 mg, 2.93 mmol) over 10 min at room temperature under nitrogen stream. After the reaction solution was stirred at the same temperature for 5 min, ethyl acetate was added, the organic layer was separated, and the aqueous layer was extracted with ethyl acetate two times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. From fraction eluted with <i>n</i>-hexane-ethyl acetate (1:1, v/v), 303.2 mg (yield 75%) of compound <b>5</b> was obtained as a colorless oil. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 1.39 (3H, t, <i>J</i> = 6.9 Hz), 4.40 (2H, q, <i>J</i> = 6.9 Hz), 5.54 (2H, s), 7.37 (5H, s), 8.48 (1H, s), 9.85 (1H, s).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 3-(Benzyloxy)-5-(ethoxycarbonyl)-4-oxo-4<i>H</i>-pyran-2-carboxylic Acid (<b>6</b>)</h4><div class="NLM_p last">To a MeCN (15 mL) solution of compound <b>5</b> (1.00 g, 3.31 mmol) was added an aqueous solution (10 mL) of 96% sulfuric acid (421.7 mg, 4.30 mmol) and amidosulfuric acid (642.7 mg, 6.62 mmol) at room temperature, the mixture was stirred, and an aqueous solution (10 mL) of sodium chlorite (388.9 mg, 4.30 mmol) was added dropwise over 5 min while the same temperature was retained. After the reaction solution was stirred at the same temperature for 5 min, an aqueous saturated sodium chloride solution was added, and the mixture was extracted with ethyl acetate three times. The combined extracts were dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel column chromatography. The materials were eluted first with chloroform and then with chloroform–MeOH (7:3, v/v). Concentration of the objective fraction afforded 748.8 mg (yield 71%) of compound <b>6</b> as a colorless oil. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 1.40 (3H, t, <i>J</i> = 7.2 Hz), 3.93 (1H, br s), 4.40 (2H, q, <i>J</i> = 7.2 Hz), 5.61 (2H, s), 7.38–7.44 (10H, m), 8.52 (1H, s).</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Ethyl-5-(benzyloxy)-6-((2-methoxyethyl)carbamoyl)-4-oxo-4<i>H</i>-pyran-3-carboxylate (<b>7</b>)</h4><div class="NLM_p last">To a DMF (10 mL) solution of compound <b>6</b> (1.00 g, 3.14 mmol) were added WSC·HC1 (1.20 g, 6.28 mmol) and HOBt (551.6 mg, 4.08 mmol) at room temperature, and the mixture was stirred at the same temperature for 90 min. The reaction solution was cooled to 0 °C, and a DMF (2 mL) solution of 2-methoxyethanamine (236.0 mg, 3.14 mmol) was added dropwise over 3 min. The reaction solution was stirred at the same temperature for 1 h, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted first with <i>n</i>-hexane–ethyl acetate (1:1, v/v) and then with <i>n</i>-hexane–ethyl acetate (1:9, v/v). Concentration of the objective fraction afforded 928.5 mg (yield 79%) of compound <b>7</b> as a brown oil. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 1.39 (3H, t, <i>J</i> = 7.2 Hz), 3.29 (3H, s), 3.41 (2H, t, <i>J</i> = 5.4 Hz), 3.47–3.53 (2H, m), 4.39 (2H, q, <i>J</i> = 7.2 Hz), 5.44 (2H, s), 7.36 (3H, m), 7.44–7.47 (2H, m), 8.07 (1H, br s), 8.54 (1H, s).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Ethyl-(<i>S</i>)-5-(benzyloxy)-1-(1-hydroxy-3-phenylpropan-2-yl)-6-((2-methoxyethyl) carbamoyl)-4-oxo-1,4-dihydropyridine-3-carboxylate (<b>8b</b>)</h4><div class="NLM_p">A xylene (2 mL) solution of compound <b>7</b> (500 mg, 1.33 mmol) and (<i>S</i>)-2-amino-3-phenylpropan-l-ol (604.2 mg, 4.0 mmol) was heated to 120 °C and stirred for 30 min. After the reaction solution was cooled to room temperature, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. The materials were eluted first with chloroform and then with chloroform–MeOH (9:1, v/v). Concentration of the objective fraction afforded 487 mg (yield 72%) of compound <b>8b</b> as a colorless oil. <sup>1</sup>H NMR (CDC1<sub>3</sub>) 8:1.41 (3H, t, <i>J</i> = 6.9 Hz), 2.24–2.34 (1H, m), 2.24–3.00 (1H, m), 3.03–3.16 (1H, m), 3.05 (3H, m), 3.25–3.32 (2H, m), 4.13–4.19 (1H, m), 4.17–4.30 (1H, m), 4.36–4.47 (1H, m), 4.51–4.54 (1H, m), 4.55 (1H, d, <i>J</i> = 10.5 Hz), 5.78 (1 H, t, <i>J</i> = 6.9 Hz), 7.17–7.26 (4H, m), 7.28–7.35 (5H, m), 7.49 (1H, t, <i>J</i> = 5.4 Hz), 6.32 (1H, s).</div><div class="NLM_p last">Compound <b>8i</b> was prepared by the procedure used for compound <b>11b</b>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Ethyl-(<i>S</i>)-5-(benzyloxy)-1-(3-hydroxy-1,1-diphenylpropan-2-yl)-6-((2-methoxyethyl)carbamoyl)-4-oxo-1,4-dihydropyridine-3-carboxylate (<b>8i</b>)</h4><div class="NLM_p">Brown oil, 52% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.15 (1H, s), 7.58–7.27 (12H, m), 7.20 (1H, d, <i>J</i> = 7.1 Hz), 7.09 (2H, t, <i>J</i> = 7.3 Hz), 7.00 (1H, d, <i>J</i> = 7.2 Hz), 5.02–4.92 (2H, m), 4.74 (1H, d, <i>J</i> = 11.4 Hz), 4.58 (1H, d, <i>J</i> = 10.4 Hz), 4.46–4.32 (1H, m), 4.12 (2H, q, <i>J</i> = 7.2 Hz), 3.65 (1H, t, <i>J</i> = 9.5 Hz), 3.45–3.34 (2H, m), 3.17–2.97 (5H, m), 1.35 (3H, t, <i>J</i> = 7.1 Hz).</div><div class="NLM_p last">Compounds <b>8c</b>, <b>8e</b>, <b>8f</b>, <b>8g</b>, and <b>8h</b> were not identified because of the parallel synthesis. Used reagents were same as the synthesis of <b>8b</b>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Ethyl-5-(benzyloxy)-1-((<i>tert</i>-butoxycarbonyl)amino)-6-((2-methoxyethyl)carbamoyl)-4-oxo-1,4-dihydropyridine-3-carboxylate (<b>9</b>)</h4><div class="NLM_p last">To a solution of compound <b>7</b> (3.5 g, 9.32 mmol) in toluene (30 mL) was added <i>tert</i>-butyl hydrazinecarboxylate (2.465 g, 18.65 mmol) and acetic acid (0.213 mL, 3.73 mmol) at rt under N<sub>2</sub> atmosphere. The mixture was stirred at reflux for 3 h. After evaporation, the crude product was purified by silica gel chromatography. The material was eluted with chloroform–MeOH (20:1, v/v). Collected fractions were evaporated to afford compound <b>9</b> (3.8 g, 7.76 mmol, 83%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.12 (1H, br s), 7.41–7.29 (5H, m), 5.20 (2H, s), 4.35 (2H, q, <i>J</i> = 7.2 Hz), 3.39–3.24 (7H, m), 1.46 (9H, s), 1.38 (3H, t, <i>J</i> = 7.2 Hz).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Ethyl-5-(benzyloxy)-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylate (<b>10</b>)</h4><div class="NLM_p last">To a solution of compound <b>9</b> (500 mg, 1.021 mmol) in DCM (10 mL) was added TFA (2 mL) at room temperature. The mixture was stirred at room temperature for 3 h. After toluene (10 mL) was added, the mixture was concentrated under reduced pressure. The resulting residue was diluted with satd NaHCO<sub>3</sub> and then extracted with CH<sub>2</sub>Cl<sub>2</sub> to afford the deprotected crude product. The crude compound was taken to the next step without purification. To a dried sealed tube were added crude product in EtOH (10 mL) and paraformaldehyde (92 mg, 3.06 mmol) at room temperature. After the mixture was stirred at 140 °C for 10 min, the reaction mixture was concentrated under reduced pressure. The crude product was subjected to silica gel chromatography and eluted with CHCl<sub>3</sub>/MeOH. Collected fractions were evaporated to afford compound <b>10</b> (352 mg, 85.9% yield) as a pale yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.16 (1H, s), 7.37–7.28 (5H, m), 6.18 (1H, t, <i>J</i> = 7.8 Hz), 5.27 (2H, s), 4.46 (2H, d, <i>J</i> = 7.8 Hz), 4.33 (2H, q, <i>J</i> = 7.2 Hz), 3.57–3.51 (2H, m), 3.51–3.46 (2H, m), 3.31 (3H, s), 1.35 (3H, t, <i>J</i> = 7.2 Hz).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Ethyl-(<i>S</i>)-4-benzyl-9-(benzyloxy)-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylate (<b>11b</b>)</h4><div class="NLM_p last">To a THF (6 mL) solution of compound <b>8b</b> (2.86 g, 5.63 mmol) and triphenylphosphine (2.21 g, 8.45 mmol) was added dropwise a DEAD 40 wt % toluene solution (3.68 g, 8.45 mmol) at room temperature over 3 min. The reaction solution was stirred at the same temperature for 30 min, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate–MeOH (9:1, v/v), 1.37 g (yield 50%) of compound <b>11b</b> was obtained as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.31 (3H, t, <i>J</i> = 7.2 Hz), 3.07 (2H, d, <i>J</i> = 6.9 Hz), 3.33 (3H, s), 3.57–3.80 (4H, m), 3.95 (1H, dd, <i>J</i> = 3.0 Hz, 6.6 Hz), 4.01–4.14 (1H, m), 4.16–4.34 (2H, m), 5.24 (1H, d, <i>J</i> = 9.9 Hz), 5.51 (1H, d, <i>J</i> = 9.9 Hz), 7.01–7.03 (2H, m), 7.21–7.37 (5H, m), 7.41–7.58 (1H, m), 7.64–7.69 (2H, m).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Ethyl-5-(benzyloxy)-1-(4-fluorobenzyl)-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylate (<b>11d</b>)</h4><div class="NLM_p">****To a solution of compound <b>10</b> (50 mg, 0.125 mmol) in DMF (0.5 mL) was added 1-(bromomethyl)-4-fluorobenzene (0.023 mL, 0.187 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (101 mg, 0.311 mmol) at room temperature. After the mixture had been stirred at r.t. for 18 h, the reaction mixture was diluted with H<sub>2</sub>O, then extracted with CHCl<sub>3</sub> (2 × 20 mL). The organic layers were combined and washed with H<sub>2</sub>O, and brine. The organic layer was dried over MgSO<sub>4</sub>, filtered and concentrated under reduced pressure. The crude product was purified by silica gel chromatography. From a fraction eluted with CHCl<sub>3</sub>/MeOH, collected fractions were evaporated to afford compound <b>11d</b> (45.8 mg, 72% yield) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.70 (1H, s), 7.64 (2H, d, J = 7.3 Hz), 7.38–7.28 (3H, m), 7.18 (2H, t, J = 6.5 Hz), 7.05 (2H, t, J = 8.2 Hz), 5.44 (2H, br s), 4.29 (2H, q, J = 6.9 Hz), 4.10 (2H, s), 3.68–3.50 (4H, m), 3.31 (3H, s), 1.31 (3H, t, J = 7.2 Hz).</div><div class="NLM_p last">Compound <b>11i</b> was prepared by the procedure used for compound <b>11b</b>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Ethyl-(<i>S</i>)-4-benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylate (<b>11i</b>)</h4><div class="NLM_p">Yellow solid; 33% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.18 (3H, m), 3.11 (3H, s), 3.16 (1H, m), 3.28 (1H, m), 3.76 (1H, m), 3.97–4.13 (3H, m), 4.31(1H, d, J = 11.3 Hz),5.08(2H, s), 5.52 (1H, d, J = 12.0 Hz), 7.18–7.25 (6H, m), 7.25–7.45 (6H, m), 7.55–7.66 (6H, m). MS: <i>m</i>/<i>z</i> 567.7 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>11j</b> was prepared by the procedure used for compound <b>11d</b>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Ethyl-1-benzhydryl-5-(benzyloxy)-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylate (<b>11j</b>)</h4><div class="NLM_p">White solid; 71% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.66 (2H, d, J = 7.3 Hz), 7.59 (1H, s), 7.53 (2H, d, J = 7.2 Hz), 7.44 (2H, t, J = 7.1 Hz), 7.40–7.27 (5H, m), 7.15 (4H, d, J = 13.1 Hz), 5.44 (2H, q, J = 10.2 Hz), 5.23 (1H, s), 4.88 (1H, d, J = 13.7 Hz), 4.46 (1H, d, J = 13.6 Hz), 4.28–4.15 (2H, m), 4.08 (1H, d, J = 14.1 Hz), 3.49–3.36 (2H, m), 3.17 (3H, s), 3.03–2.90 (1H, m), 1.28 (3H, t, J = 7.1 Hz).</div><div class="NLM_p last">Compound <b>11c, 11e, 11f, 11g</b>, and <b>11h</b> were not identified because of the parallel synthesis. Used reagents were same as the synthesis of <b>11b</b>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-4-Benzyl-9-(benzyloxy)-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>12b</b>)</h4><div class="NLM_p">To an EtOH (6 mL) solution of compound <b>11b</b> (1.0 g, 2.04 mmol) was added a 2N aqueous sodium hydroxide solution (6 mL), and the mixture was stirred at room temperature for 30 min. The reaction solution was neutralized with 2N hydrochloric acid, and the precipitated solid was filtered, and dried to obtain 754 mg (yield 80%) of compound <b>12b</b> as a white solid. <sup>1</sup>H NMR (CDCI<sub>3</sub>) δ 3.10 (2H, d, J = 7.8 Hz), 3.33 (3H, s), 3.57–3.69 (4H, m), 3.82–3.90 (1H, m), 3.95 (1H, dd, J = 3.3 Hz, 13.8 Hz),4.36(1H, dd, J = 6.3 Hz, 7.5 Hz),5.36(1H, d, J = 10.2 Hz), 5.45 (1H, d, J = 10.2 Hz), 6.98–7.01 (2H, m), 7.28–7.39 (6H, m), 7.59 (2H, dd, J 1.8 Hz, 8.1 Hz), 7.87 (1H, s).</div><div class="NLM_p last">Compound <b>12d, 12i</b>, and <b>12j</b> were prepared by the procedure used for compound <b>12b</b>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-(Benzyloxy)-1-(4-fluorobenzyl)-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylic Acid (<b>12d</b>)</h4><div class="NLM_p last">White solid; 80% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.11 (1H, s), 7.58 (2H, dd, J = 7.5, 1.8 Hz), 7.41–7.31 (3H, m), 7.21–7.14 (2H, m), 7.07 (2H, t, J = 8.5 Hz), 5.47 (2H, br s), 4.14 (3H, br s), 3.68–3.50 (4H, m), 3.33–3.25 (4H, m).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>12i</b>)</h4><div class="NLM_p last">White solid; 94% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.11 (3H, s), 3.16 (1H, m), 3.25(1H, m), 3.75 (1H, m),4.11 (1H, m), 4.36 (1H, d, J = 11.6 Hz), 5.18 (2H, dd, J = 15.7 Hz, 10.4 Hz), 5.71 (1H, d, J = 11.6 Hz), 7.08–7.20 (5H, m), 7.29–7.45 (6H, m), 7.55 (2H, d, J = 6.7 Hz), 7.61 (2H, d, J = 7.5 Hz), 7.98 (1H, s). MS: <i>m</i>/<i>z</i> 539.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-Benzhydryl-5-(benzyloxy)-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylic Acid (<b>12j</b>)</h4><div class="NLM_p">White solid; 83% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.13 (3H, s), 3.25–3.34 (3H, m), 3.79 (1H, d, J = 13.73 Hz), 4.42 (1H, d, J = 14.03 Hz), 5.11–5.27 (3H, m), 5.48 (1H, s), 7.18–7.21 (5H, m), 7.33–7.49 (6H, m), 7.56–7.58 (2H, m), 7.74 (2H, d, J = 7.32 Hz), 8.01 (1H, s).</div><div class="NLM_p">Compounds <b>12c, 12e, 12f, 12g</b>, and <b>12h</b> were not identified because of the parallel synthesis. Used reagents were same as the synthesis of <b>12b</b>.</div><div class="NLM_p last">Compound <b>13</b> was prepared by the procedure used for compound <b>14</b>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-<i>N</i>-methyl-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxamide (<b>13</b>)</h4><div class="NLM_p last">99% yield, white solid <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.72 (1H, d, J = 4.1 Hz), 7.63 (2H, d, J = 7.3 Hz), 7.59 (1H, s), 7.46–7.28 (8H, m), 7.23–7.14 (3H, m), 7.02 (2H, d, J = 6.8 Hz), 5.36 (2H, s), 4.67 (1H, d, J = 11.2 Hz), 4.30 (1H, d, J = 11.3 Hz), 4.04 (1H, d, J = 14.3 Hz), 3.95 (1H, d, J = 12.0 Hz), 3.56–3.35 (3H, m), 3.17 (3H, s), 3.12–3.01 (1H, m), 2.87 (3H, d, J = 4.8 Hz).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-<i>N</i>-methoxy-2-(2-methoxyethyl)-<i>N</i>-methyl-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxamide (<b>14</b>)</h4><div class="NLM_p last">Compound <b>12i</b> (112 mg, 0.208 mmol) was dissolved in DMF (2 mL), triethylamine (0.144 mL, 1.04 mmol) and, subsequently, ethyl chloroformate (0.040 mL, 0.42 mmol) was added under ice-cooling, the mixture was stirred at room temperature for 10 min. Next, N,O-dimethylhydroxyamine hydrochloride (41 mg, 0.42 mmol) and then DMAP (3 mg, 0.02 mmol) were added, and the mixture was stirred at room temperature for 1 h. To the reaction solution was added water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. From a fraction eluted with EtOAc/MeOH, collected fractions were evaporated to afford 127 mg (quant yield) of compound <b>14</b> as a yellow oil including DMF. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.61 (2H, d, J = 6.9 Hz), 7.47–7.27 (8H, m), 7.16–7.10 (3H, m), 7.01–6.94 (2H, m), 6.71 (1H, s), 5.45 (2H, d, J = 9.9 Hz), 4.50 (1H, d, J = 11.5 Hz), 4.28 (1H, d, J = 11.5 Hz), 3.90 (1H, dd, J = 13.8, 2.9 Hz), 3.44 (2H, t, J = 13.2 Hz), 3.17 (3H, s), 3.07–2.99 (2H, m), 2.96 (3H, s), 2.88 (3H, s). MS: <i>m</i>/<i>z</i> 582.20 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-7-Acetyl-4-benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>15</b>)</h4><div class="NLM_p last">Compound <b>14</b> (137 mg, 0.236 mmol) was dissolved in THF (8 mL), a 2 M THF solution of methyl magnesium bromide (0.444 mL, 0.471 mmol) was added at −78 °C. under nitrogen stream, and the mixture was stirred for 30 min while temperature was raised to −50 °C. To the reaction solution was added 1 M hydrochloric acid (4 mL), the mixture was stirred at 0 °C for 20 min, ethyl acetate was added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined extracts were neutralized with an aqueous saturated sodium bicarbonate solution, sodium sulfate was added to the organic layer, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. From a fraction eluted with EtOAc/MeOH, collected fractions were evaporated to afford 67 mg (53% yield) of compound <b>15</b> as a yellow oil. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.55 (3H, s), 3.01–3.14 (1H, m), 3.16 (3H, s), 3.37–3.54 (3H, m), 3.91–4.07 (2H, m), 4.28 (1H, d, J = 11.3 Hz), 4.50–4.60 (1H, m), 5.42 (2H, d, J = 1.2 Hz), 6.97–6.99 (2H, m), 7.14–7.17 (4H, m), 7.31–7.45 (8H, m), 7.65 (2H, d, J 6.5 Hz). MS: <i>m</i>/<i>z</i> 537.20 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-7-hydroxy-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>17</b>)</h4><div class="NLM_p last">Compound <b>15</b> (67 mg, 0.13 mmol) was dissolved in dichloromethane (4 mL), mCPBA (32 mg, 0.19 mmol) was added at 0 °C under nitrogen stream, and the mixture was stirred at room temperature for 3 h. The reaction solution was ice-cooled, then an aqueous sodium thiosulfate solution, and ethyl acetate were added, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. The combined extracts were neutralized with an aqueous saturated sodium bicarbonate solution, sodium sulfate was added to the organic layer, the mixture was filtered, and the solvent was distilled off to obtain 64 mg (89% yield) of compound <b>16</b> as a white solid. The crude product was directly used for the next step. Compound <b>16</b> (64 mg, 0.12 mmol) was dissolved in ethanol (8 mL), and the solution was heated to reflux for 4 h. The reaction solution was concentrated, and the resulting residue was purified by silica gel column chromatography. From a fraction eluted with EtOAc/MeOH, collected fractions were evaporated to afford 42 mg (69% yield) of compound <b>17</b> as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.93–3.09 (1H, m), 3.16 (3H, s), 3.33–3.53 (4H, m), 3.90–4.07 (2H, m), 4.29–4.47 (2H, m), 5.41 (2H, q, J = 10.4 Hz), 6.34 (1H, s), 6.95–6.99 (2H, m), 7.12–7.21 (4H, m), 7.33–7.42 (8H, m), 7.64 (2H, d, J = 6.9 Hz). MS: <i>m</i>/<i>z</i> 511.21 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-7-methoxy-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>18</b>)</h4><div class="NLM_p last">Compound <b>17</b> (41 mg, 0.080 mmol) was dissolved in DMF (1 mL), sodium hydride (6.4 mg, 0.16 mmol) was added under ice-cooling, the mixture was stirred for 10 min, methyl iodide (0.010 mL, 0.16 mmol) was added, and the mixture was stirred at room temperature for 1.5 h. To the reaction solution were added ice water and ethyl acetate, the ethyl acetate layer was separated, and the aqueous layer was extracted with ethyl acetate. To the combined extracts was added sodium sulfate, the mixture was filtered, and the solvent was distilled off. The resulting residue was purified by silica gel column chromatography. From a fraction eluted with EtOAc/MeOH, collected fractions were evaporated to afford 41 mg (98% yield) of compound <b>18</b> as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.99–3.09 (1H, m), 3.16 (3H, s), 3.25 (3H, s), 3.32–3.38 (1H, m), 3.42–3.50 (2H, m), 3.94–4.03 (2H, m), 4.28 (1H, d, J = 11.3 Hz), 4.43 (1H, br s), 5.40 (2H, dd, J = 28.3 Hz, 10.2 Hz), 6.01 (1H, s), 6.90–7.19 (5H, m), 7.28–7.44 (8H, m), 7.66 (2H, d, J = 6.4 Hz). MS: <i>m</i>/<i>z</i> 525.21 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl-(<i>S</i>)-(4-benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazin-7-yl)carbamate (<b>19</b>)</h4><div class="NLM_p last">A DMF (5 mL) solution of compound <b>12i</b> (424 mg, 0.787 mmol) was ice-cooled,then triethylamine (327 ul, 2.36 mmol) and, subsequently, ethyl chloroformate (150 ul, 1.57 mmol) were added. After the reaction solution was stirred at room temperature for 10 min, it was ice-cooled again, sodium azido (154 mg, 2.36 retool) was added, and the mixture was stirred for 1 h. To the reaction solution were added dichloromethane, water and a small amount of methanol, the dichloromethane layer was separated, and the aqueous layer was extracted once with dichloromethane. The combined extracts were concentrated, methanol (8 mL) was added to the resulting residue, the mixture was stirred at 50 °C for 3 h, and the solvent was distilled off. The resulting oil was purified by silica gel column chromatography. The materials were eluted first with <i>n</i>-hexane-ethyl acetate (1:1, v/v) and, then, with only ethyl acetate. Concentration of objective fraction afforded 160 mg (36% yield) of compound <b>19</b> as a white solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.08–3.18 (4H, m), 3.35–3.49 (3H, m), 3.68 (3H, s), 3.98 (2H, dt, J = 23.1, 5.6 Hz), 4.32 (1H, d, J = 11.3 Hz), 4.59 (1H, d, J= 11.3 Hz), 5.37 (2H, dd, J = 12.0, 10.4 Hz), 6.98–7.70 (15H, m). MS: <i>m</i>/<i>z</i> 568.25 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-7-Amino-4-benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>20</b>)</h4><div class="NLM_p last">Compound <b>19</b> (160 mg, 0.102 mmol) was dissolved in EtOH (10 mL), a 2N aqueous sodium hydroxide solution (14 mL) was added, and the mixture was stirred at 60 °C for 2 h. After the reaction solution was concentrated under reduced pressure, the residue was distributed between dichloromethane and water. The dichloromethane layer was separated, and the aqueous layer was extracted with dichloromethane three times. The solvent was distilled off to obtain 143 mg (quant yield) of compound <b>20</b> as a pale yellow solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.97–3.06 (1H, m), 3.15 (3H, s), 3.38–3.44 (3H, m), 3.71 (2H, s), 3.93–3.99 (2H, m), 4.35 (2H, dd, J = 19.3, 11.1 Hz), 5.37 (2H, dd, J = 31.6, 10.1 Hz), 6.04 (1H, s), 6.98 (2H, dd, J = 6.4, 2.9 Hz), 7.17 (4H, t, J = 3.3 Hz), 7.28–7.69 (12H, m). MS: <i>m</i>/<i>z</i> 509.23 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>21</b>)</h4><div class="NLM_p last">Compound <b>12i</b> (164 mg, 0.304 mmol) was dissolved in diphenyl ether (1 mL), the mixture was stirred at 245 °C for 1 h using a microwave apparatus and, thereafter, the reaction solution was purified by silica gel column chromatography. Concentration of the objective fraction afforded 72 mg (48% yield) of compound <b>21</b> as a brown solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.92–3.01 (1H, m), 3.16 (3H, s), 3.32–3.50 (3H, m), 3.90–4.46 (4H, m), 5.42 (2H, dd, J = 26.1, 10.3 Hz), 5.94 (1H, d, J = 7.4 Hz), 6.28 (1H, d, J = 7.5 Hz), 6.96–6.99 (2H, m), 7.15–7.19 (3H, m), 7.28–7.44 (8H, m), 7.62–7.65 (2H, m). MS: <i>m</i>/<i>z</i> 495.21 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-7-bromo-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>22</b>)</h4><div class="NLM_p">To a dichloromethane (4 mL) solution of compound <b>21</b> (21 mg, 0.042 mmol) was added NBS (11 mg, 0.062 mmol), and the mixture was heated to reflux for 1 h. The reaction solution was allowed to cool and then purified by silica gel column chromatography. Concentration of the objective fraction afforded 26 mg (quant yield) of compound <b>22</b> as a white solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.01–3.09 (1H, m), 3.16 (3H, s), 3.35–3.53 (3H, m), 3.92–4.47 (4H, m), 5.41 (2H, dd, J = 32.6 Hz, 10.0 Hz), 6.72 (1H, s), 6.97–7.00 (2H, brm), 7.20–7.22 (3H, m), 7.30–7.46 (8H, m), 7.66–7.70 (2H, m). MS: <i>m</i>/<i>z</i> 573.20 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Compound <b>24</b> was prepared by the procedure used for compound <b>21</b>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-Benzhydryl-5-(benzyloxy)-3-(2-methoxyethyl)-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>24</b>)</h4><div class="NLM_p last">White solid; 48% yield <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.92–3.01 (1H, m), 3.16 (3H, s), 3.32–3.50 (3H, m), 3.90–4.46 (4H, m), 5.42 (2H, dd, J = 26.1, 10.3 Hz), 5.94 (1H, d, J = 7.4 Hz), 6.28 (1H, d, J = 7.5 Hz), 6.96–6.99 (2H, m), 7.15–7.19 (3H, m), 7.28–7.44 (8H, m), 7.62–7.65 (2H, m). MS: <i>m</i>/<i>z</i> 495.21 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Dimethyl-(<i>S</i>)-3-(benzyloxy)-1-(3-((tert-butoxycarbonyl)amino)-1,1-diphenylpropan-2-yl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate (<b>26</b>)</h4><div class="NLM_p last">Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate (974 mg, 3.06 mmol), and <i>tert</i>-butyl (S)-(2-amino-3,3-diphenylpropyl)carbamate (999 mg, 3.06 mmol) were added to toluene (10 mL), and the mixture was stirred at 110 °C for 5 h. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform–methanol, 98:2, v/v) to obtain 1.51 g of compound <b>26</b> as a pale yellow solid (79% yield). <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 1.36 (9H, s), 3.40 (1H, m), 3.53 (1H, m), 3.82 (3H, s), 3.91 (3H, s), 4.29 (1H, d, J = 11.3 Hz), 4.78 (1H, m), 4.82 (1H, m), 5.11 (1.9H, d, J = 7.5 Hz), 7.10–7.38 (10H, m), 8.27 (1H, s).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl-(<i>S</i>)-4-benzhydryl-9-(benzyloxy)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylate (<b>27</b>)</h4><div class="NLM_p last">To compound <b>26</b> (1.45 g, 2.31 mmol) was added 4 N HCl (ethyl acetate solution, 20 mL), and the mixture was stirred at room temperature for 1.5 h. After the solvent was distilled off under reduced pressure, sodium bicarbonate water was added, and the mixture was stirred at room temperature for 1.5 h. This was extracted with chloroform, and dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform–methanol, 95:5, v/v) to obtain 1.01 g of compound <b>27</b> as a colorless solid (89% yield). <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.40 (1H, dd, J = 13.6, 6.6 Hz), 3.78 (3H, s), 3.80 (1H, m), 4.37 (1H, d, J = 11.6 Hz), 4.59 (1H, d, J = 11.0 Hz), 5.43 (2H, d, J = 10.2 Hz), 5.93 (1H, d, J = 5.8 Hz), 7.03–7.21 (5H, m), 7.37 (9H, m), 7.63 (2H, m).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic acid (<b>28</b>)</h4><div class="NLM_p last">Compound <b>27</b> (460 mg, 0.930 mmol) was dissolved in THF (2.5 mL) and methanol (2.5 mL), a 2N aqueous sodium hydroxide solution (2.33 mL, 4.65 mmol) was added at room temperature, and the mixture was stirred for 1.5 h. After 1N hydrochloric acid was added, the mixture was extracted with ethyl acetate, and the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, 405 mg (91% yield) of compound <b>28</b> was obtained as a colorless solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.45 (1H, ddd, J = 13.8, 6.9, 1.3 Hz), 3.80 (1H, dd, J = 13.5, 2.1 Hz), 4.35 (1H, d, J = 11.6 Hz), 4.77 (1H, d, J = 11.3 Hz),5.46 (1H, d, J = 10.5 Hz),5.52 (1H, d, J = 10.5 Hz), 6.11 (1H, d, J = 5.8 Hz), 6.94–6.98 (2H, m), 7.17 (3H, m), 7.31–7.46 (8H, m), 7.58 (3H, m).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>29</b>)</h4><div class="NLM_p last">Compound <b>27</b> (402 mg, 0.837 mmol) was added to diphenyl ether (5 mL), and the mixture was stirred at 245 °C for 1 h under microwave irradiation. The reaction solution was poured into <i>n</i>-hexane, and the precipitated solid was filtered. The resulting crude product was purified by amino column chromatography (chloroform–methanol, 99:1, v/v) to obtain 164 mg of compound <b>28</b> as a colorless solid (45% yield). <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.36 (1H, dd, J = 13.0, 7.0 Hz), 3.72 (1H, d, J = 11.1 Hz), 4.35 (1H, d, J = 11.4 Hz), 4.49 (1H, d, J = 10.2 Hz), 5.38 (1H, d, J = 10.5 Hz), 5.43 (1H, d, J = 10.4 Hz), 5.94 (1H, d, J = 7.2 Hz), 6.29 (1H, d, J = 6.6 Hz), 6.38 (1H, d, J = 7.5 Hz), 6.99 (2H, m), 7.17 (3H, m), 7.36 (8H, m), 7.60 (2H, m).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-2-methyl-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>30r</b>)</h4><div class="NLM_p">Compound <b>29</b> (33 mg, 0.076 mmol) was dissolved in DMF (0.7 mL), and cesium carbonate (123 mg, 0.38 mmol) was added. After stirring at room temperature for 30 min, iodomethane (0.024 mL, 0.38 mmol) was added, and the mixture was stirred at room temperature for 3 h. After the reaction solution was poured into water, and the mixture was extracted with ethyl acetate, the extract was dried with sodium sulfate. After the solvent was distilled off under reduced pressure, the resulting crude product was purified by silica gel column chromatography (chloroform–methanol, 95:5, v/v) to obtain 18 mg of compound <b>30r</b> as a white solid (53% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.65 (2H, d, J = 7.3 Hz), 7.43 (2H, t, J = 7.5 Hz), 7.37–7.29 (6H, m), 7.19 (3H, t, J = 3.0 Hz), 7.06–7.00 (2H, m), 6.31 (1H, d, J = 7.6 Hz), 5.96 (1H, d, J = 7.6 Hz), 5.41 (2H, dd, J = 36.4, 10.1 Hz), 4.43 (1H, d, J = 11.1 Hz), 4.22 (1H, d, J = 11.1 Hz), 3.86 (1H, dd, J = 13.6, 3.0 Hz), 3.25 (1H, d, J = 14.4 Hz), 2.91 (3H, s).</div><div class="NLM_p last">Compound <b>30s</b> was prepared by the procedure used for compound <b>29r</b>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>S</i>)-4-Benzhydryl-9-(benzyloxy)-2-isopropyl-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>30s</b>)</h4><div class="NLM_p last">White solid; 93% yield. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 0.76 (3H, d, <i>J</i> = 6.7 Hz), 0.98 (3H, d, <i>J</i> = 6.9 Hz), 3.43–3.52 (2H, m), 3.62 (1H, dd, <i>J</i> = 13.6, 3.5 Hz), 4.22 (1H, d, <i>J</i> = 11.6 Hz), 4.52 (1H, d, <i>J</i> = 11.6 Hz), 4.86–4.95 (1H, m), 5.37 (1H, d, <i>J</i> = 10.2 Hz), 5.45 (1H, d, <i>J</i> = 10.2 Hz), 5.90 (1H, d, <i>J</i> = 7.5 Hz), 6.22 (1H, d, <i>J</i> = 7.5 Hz), 6.89 (2H, m), 7.15 (3H, m), 7.36 (8H, m), 7.67 (2H, m).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(Benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylic Acid Hydrochloride (<b>32</b>)</h4><div class="NLM_p last">Compound <b>31</b> (1.0 g, 4.06 mmol) was dissolved in 28% aqueous ammonia, and the solution was stirred at room temperature for 12 h. After concentration of the reaction solution, the resulting residue was neutralized with 2 N hydrochloric acid, and the precipitated solid was suspended in ethyl acetate, filtered, and dried to obtain 1.14 g (yield 100%) of compound <b>32</b> as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 5.14 (2H, s), 7.31 (1H, d, <i>J</i> = 6.6 Hz), 7.34–7.41 (3H, m), 7.45–7.51 (2H, m), 8.17 (1H, d, <i>J</i> = 6.6 Hz).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-(Benzyloxy)-<i>N</i>-methyl-4-oxo-1,4-dihydropyridine-2-carboxamide (<b>33u</b>)</h4><div class="NLM_p">To a DMF (10 mL) solution of compound <b>32</b> (3.00 g, 10.65 mmol) were added WSC HC1 (3.06 g, 15.98 mmol) and HOBt (1.58 g, 11.7 mmol) at room temperature, the mixture was stirred for 10 min, and a methylamine 33 wt % ethanol solution (1.50 g, 15.98 mmol) was added dropwise. After the reaction solution was stirred at the same temperature for 2 h water was added, and the mixture was extracted with chloroform five times. The extract was dried with sodium sulfate, the solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate–MeOH (6:4, v/v), 2.62 g (yield 95%) of compound <b>33u</b> was obtained as a pale brown solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.77 (3H, d, <i>J</i> = 4.8 Hz), 5.49 (2H, s), 6.57 (1H, d, <i>J</i> = 6.9 Hz), 7.25–7.43 (5H, m), 7.48 (1H, t, <i>J</i> = 6.0 Hz), 8.23 (1H, br s), 9.77 (1H, br s).</div><div class="NLM_p last">Compounds <b>33v</b> and <b>33w</b> were prepared by the procedure used for compound <b>33u</b>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-(Benzyloxy)-<i>N</i>-isopropyl-4-oxo-1,4-dihydropyridine-2-carboxamide (<b>33v</b>)</h4><div class="NLM_p last">Yellow solid; 80% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.71 (1H, s), 8.22 (1H, s), 7.53–7.41 (6H, m), 6.59 (1H, dd, <i>J</i> = 7.2, 2.2 Hz), 5.57 (2H, s), 4.14–3.99 (1H, m), 0.99 (6H, d, <i>J</i> = 6.5 Hz).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-(Benzyloxy)-<i>N</i>-(furan-2-ylmethyl)-4-oxo-1,4-dihydropyridine-2-carboxamide (<b>33w</b>)</h4><div class="NLM_p last">Yellow solid; 70% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 9.65 (1H, br s), 8.66 (1H, br s), 7.46 (1H, t, <i>J</i> = 6.6 Hz), 7.38–7.28 (6H, m), 6.54 (1H, dd, <i>J</i> = 7.2, 2.0 Hz), 6.33 (1H, t, <i>J</i> = 2.5 Hz), 6.16 (1H, d, <i>J</i> = 3.2 Hz), 5.50 (2H, s), 4.45 (2H, d, <i>J</i> = 5.6 Hz).</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-Amino-3-(benzyloxy)-<i>N</i>-methyl-4-oxo-1,4-dihydropyridine-2-carboxamide (<b>34u</b>)</h4><div class="NLM_p">Into a DMF (10 mL) solution of compound <b>33u</b> (2.62 g, 10.14 mmol) was suspended potassium carbonate (4.20 g, 30.42 mmol) at room temperature, the suspension was stirred for 5 min, <i>O</i>-(2,4-dinitrophenyl)hydroxylamine (3.03 g, 15.21 mmol) was added, and the mixture was stirred at the same temperature for 3 h. To the reaction solution was added water, then the mixture was extracted with chloroform five times, and the extract was dried with sodium sulfate. After the solvent was distilled off, the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate–MeOH (6:4, v/v), 1.41 g (yield 51%) of compound <b>34u</b> was obtained as a brown solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.62 (3H, d, <i>J</i> = 5.1 Hz), 5.06 (2H, s), 5.22 (2H, s), 6.18 (1H, d, <i>J</i> = 7.8 Hz), 7.25–7.36 (5H, m), 5.89 (1H, d, <i>J</i> = 7.8 Hz), 7.57 (1H, q, <i>J</i> = 5.1 Hz).</div><div class="NLM_p last">Compounds <b>34v</b> and <b>34w</b> were prepared by the procedure used for compound <b>34u</b>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-Amino-3-(benzyloxy)-<i>N</i>-isopropyl-4-oxo-1,4-dihydropyridine-2-carboxamide (<b>34v</b>)</h4><div class="NLM_p last">Brown solid; 25% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.44–7.30 (6H, m), 6.26 (1H, d, <i>J</i> = 7.8 Hz), 5.59 (2H, s), 5.21 (2H, s), 4.06 (1H, dq, <i>J</i> = 14.3, 6.6 Hz), 1.07 (6H, d, <i>J</i> = 6.6 Hz).</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1-Amino-3-(benzyloxy)-N-(furan-2-ylmethyl)-4-oxo-1,4-dihydropyridine-2-carboxamide (<b>34w</b>)</h4><div class="NLM_p last">Brown solid; 50% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.73 (1H, br s), 7.42 (1H, d, <i>J</i> = 7.8 Hz), 7.34–7.23 (6H, m), 6.32 (1H, t, <i>J</i> = 2.4 Hz), 6.27–6.22 (2H, m), 5.55 (2H, s), 5.14 (2H, s), 4.33 (2H, d, <i>J</i> = 5.8 Hz).</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 1-Benzhydryl-5-(benzyloxy)-3-methyl-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>35u</b>)</h4><div class="NLM_p">To a toluene (10 mL) solution of compound <b>34u</b> (1.0 g, 3.66 mmol) were added paraformaldehyde (109.9 mg, 3.66 mmol) and acetic acid (22 mg, 0.37 mmol), and the mixture was heated with stirring at 100 °C for 40 min. After cooling, the solvent was distilled off, the residue was dissolved in DMF (10 mL) without purification, cesium carbonate (3.58 g, 10.98 mmol) was added under ice cooling, and the mixture was stirred for 10 min. To the reaction solution was added bromodiphenylmethane (1.36 g, 5.49 mmol), then the mixture was stirred at room temperature for 3 h, water was added, and the mixture was extracted with ethyl acetate three times. The extract was washed with water three times and dried with sodium sulfate. The solvent was distilled off, and the resulting oil was purified by silica gel chromatography. From a fraction eluted with ethyl acetate–MeOH (9:1, v/v), 1.26 g (yield 71%) of compound <b>35u</b> was obtained as a white solid. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.91 (3H, s), 4.26 (1H, d, <i>J</i> = 13.2 Hz), 4.77 (1H, d, <i>J</i> = 13.2 Hz), 5.12 (1H, s), 5.42 (1H, <i>J</i> = 13.2 Hz), 5.45 (1H, d, <i>J</i> = 13.2 Hz), 5.82 (1H, <i>J</i> = 7.5 Hz), 6.71 (1H, d, <i>J</i> = 7.5 Hz), 7.10–7.23 (5H, m), 7.27–7.46 (6H, m), 7.52 (2H, d, <i>J</i> = 6.9 Hz), 7.60–7.64 (2H, m).</div><div class="NLM_p last">Compounds <b>35v</b> and <b>35w</b> were prepared by the procedure used for compound <b>35u</b>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-Benzhydryl-5-(benzyloxy)-3-isopropyl-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>35v</b>)</h4><div class="NLM_p last">White solid; 46% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.70–7.60 (2H, m), 7.55–7.28 (8H, m), 7.20–7.07 (3H, m), 6.99 (2H, d, <i>J</i> = 6.7 Hz), 6.65 (1H, d, <i>J</i> = 7.8 Hz), 5.76 (1H, d, <i>J</i> = 7.8 Hz), 5.43 (2H, dd, <i>J</i> = 14.0, 10.4 Hz), 5.18 (1H, s), 4.90–4.80 (1H, m), 4.64 (1H, d, <i>J</i> = 13.3 Hz), 4.44 (1H, d, <i>J</i> = 13.3 Hz), 1.00 (3H, d, <i>J</i> = 6.7 Hz), 0.93 (3H, d, <i>J</i> = 6.7 Hz).</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-Benzhydryl-5-(benzyloxy)-3-(furan-2-ylmethyl)-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>35w</b>)</h4><div class="NLM_p last">White solid; 63% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.60 (2H, dd, <i>J</i> = 7.7, 1.8 Hz), 7.40–7.26 (8H, m), 7.22 (1H, dd, <i>J</i> = 1.8, 0.8 Hz), 7.16–7.09 (3H, m), 7.02 (2H, dd, <i>J</i> = 7.8, 1.5 Hz), 6.69 (1H, d, <i>J</i> = 7.8 Hz), 6.25 (1H, dd, <i>J</i> = 3.2, 1.8 Hz), 6.14 (1H, d, <i>J</i> = 3.2 Hz), 5.77 (1H, d, <i>J</i> = 7.8 Hz), 5.43 (2H, dd, <i>J</i> = 13.3, 10.6 Hz), 5.05 (1H, s), 4.79–4.60 (2H, m), 4.45–4.34 (2H, m).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for <i>O</i>-Benzyl Deprotection</h3><div class="NLM_p">The indicated starting material (<b>12b–j</b>, <b>13</b>, <b>18</b>, <b>20</b>, <b>21</b>, <b>24</b>, <b>30r</b>, <b>30s</b>, and <b>35u</b>–<b>w</b>) was dissolved in trifluoroacetic acid (2 mL), and the mixture was stirred at room temperature for 1 h. The solvent was distilled off, the residue was dissolved in dichloromethane, and the solution was neutralized with a saturated aqueous sodium bicarbonate solution. The resulting solution was made acidic with an aqueous citric acid solution, and the organic layer was separated. The aqueous layer was extracted with dichloromethane, and the combined organic layers were washed with brine and dried with anhydrous sodium sulfate. After the solvent was distilled off, the resulting solid was recrystallized from diisopropyl ether/dichloromethane or purified by preparative HPLC to obtain the desired compounds.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>S</i>)-4-Benzyl-9-hydroxy-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2b</b>)</h4><div class="NLM_p last">White solid; 64% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.14 (2H, d, <i>J</i> = 6.3 Hz), 3.36 (3H, s), 3.60–3.86 (5H, m), 4.14 (1H, d, <i>J</i> = 12.9 Hz), 4.47 (1H, s), 7.03–7.05 (2H, m), 7.30–7.35 (3H, m), 7.88 (1H, s), 12.68 (1H, s), 14.83 (1H, s).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>R</i>)-4-Benzyl-9-hydroxy-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2c</b>)</h4><div class="NLM_p last">White solid; 58% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 14.74 (1H, br s), 12.64 (1H, br s), 7.81 (1H, s), 7.38–7.29 (3H, m), 7.02 (2H, d, <i>J</i> = 5.9 Hz), 4.37 (1H, s), 4.13 (1H, d, <i>J</i> = 13.3 Hz), 3.89–3.64 (5H, m), 3.36 (3H, s), 3.18–3.06 (2H, m).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-(4-Fluorobenzyl)-5-hydroxy-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylic Acid (<b>2d</b>)</h4><div class="NLM_p last">White solid; 75% yield. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.34 (3H, s), 3.57–3.68 (2H, m), 3.73 (2H, br s), 4.18 (2H, s), 4.75 (2H, br s), 7.06–7.12 (2H, m), 7.21–7.24 (2H, m), 8.10 (1H, s), 11.96 (1H, br s), 14.52 (1H, br s).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-9-Hydroxy-2-(2-methoxyethyl)-1,8-dioxo-4-phenyl-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2e</b>)</h4><div class="NLM_p last">White solid; 72% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 14.82 (1H, s), 12.76 (1H, s), 8.19 (1H, s), 7.48–7.42 (3H, m), 7.12–7.05 (2H, m), 5.40 (1H, t, <i>J</i> = 4.2 Hz), 4.24 (1H, dd, <i>J</i> = 13.8, 3.9 Hz), 4.11 (1H, dd, <i>J</i> = 13.6, 4.8 Hz), 3.79–3.70 (1H, m), 3.66–3.57 (1H, m), 3.55–3.50 (1H, m), 3.40–3.35 (1H, m).</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-9-Hydroxy-2-(2-methoxyethyl)-1,8-dioxo-4-phenethyl-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2f</b>)</h4><div class="NLM_p last">White solid; 46% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 2.07 (2H, m), 2.55 (1H, m), 2.74 (1H, m), 3.17 (1H, s), 3.23 (3H, s), 3.48–3.65 (4H, m), 3.79 (1H, d, <i>J</i> = 13.6 Hz), 3.87 (1H, m), 4.09 (1H, d, <i>J</i> = 13.6 Hz), 4.80 (1H, s), 7.10–7.29 (5H, m), 8.59 (1H, s), 12.77 (1H, s), 15.49 (1H, s). MS: <i>m</i>/<i>z</i> = 387.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-9-Hydroxy-4-isopropyl-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2g</b>)</h4><div class="NLM_p last">White solid; 50% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 14.88 (1H, br s), 12.56 (1H, br s), 8.24 (1H, s), 4.07 (1H, d, <i>J</i> = 13.8 Hz), 3.97–3.84 (2H, m), 3.78 (1H, d, <i>J</i> = 9.3 Hz), 3.69–3.58 (3H, m), 3.37 (3H, s), 2.27–2.14 (1H, m), 1.12 (3H, d, <i>J</i> = 6.4 Hz), 0.83 (3H, d, <i>J</i> = 6.8 Hz).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>S</i>)-9-Hydroxy-4-isobutyl-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2h</b>)</h4><div class="NLM_p last">White solid; 55% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 14.91 (1H, br s), 12.59 (1H, br s), 8.25 (1H, s), 4.27 (1H, s), 4.11 (1H, d, <i>J</i> = 13.2 Hz), 3.96–3.85 (1H, m), 3.74–3.60 (4H, m), 3.37 (3H, s), 1.90–1.78 (1H, m), 1.03 (3H, d, <i>J</i> = 5.6 Hz), 0.97 (3H, d, <i>J</i> = 5.5 Hz).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylic Acid (<b>2i</b>)</h4><div class="NLM_p last">White solid; 92% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.15 (3H, s), 3.50–3.70 (5H, m),4.19 (1H, dd, <i>J</i> = 13.8 Hz, 3.1 Hz), 4.49 (1H, d, <i>J</i> = 11.6 Hz), 5.78 (1H, d, <i>J</i> = 9.6 Hz), 7.10–7.27 (6H, m), 7.34 (1H, m), 7.46 (2H, t, <i>J</i> = 7.5 Hz), 7.63 (2H, t, <i>J</i> = 7.7 Hz), 7.94 (1H, s), 12.94 (1H, s), 15.08 (1H, s). MS: <i>m</i>/<i>z</i> 449.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-Benzhydryl-5-hydroxy-3-(2-methoxyethyl)-4,6-dioxo-2,3,4,6-tetrahydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-7-carboxylic Acid (<b>2j</b>)</h4><div class="NLM_p last">White solid; 56% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.13 (3H, s), 3.41–3.56 (4H, m), 4.50 (1H, d, <i>J</i> = 13.57 Hz), 5.21 (1H, d, <i>J</i> = 13.42 Hz), 5.58 (1H, s), 7.16–7.50 (8H, m), 7.72 (2H, d, <i>J</i> = 7.32 Hz), 7.93 (1H, s), 12.12 (1H, s).</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Ethyl-(<i>S</i>)-4-benzhydryl-9-hydroxy-2-(2-methoxyethyl)-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxylate (<b>2k</b>)</h4><div class="NLM_p last">White solid; 82% yield. <sup>1</sup>H NMR(DMSO-<i>d</i><sub>6</sub>) δ 1.17 (3H, t, <i>J</i> = 6.9 Hz), 3.11 (3H, s), 3.48–3.58 (2H, m), 3.95–4.12 (3H, m), 4.40 (1H, d, <i>J</i> = 11.4 Hz), 5.59 (1H, d, <i>J</i> = 11.4 Hz),7.11 (1H, d, <i>J</i> = 7.3 Hz), 7.17 (2H, t, <i>J</i> = 7.2 Hz), 7.26 (2H, d, <i>J</i> = 7.1 Hz), 7.30 (1H, t, <i>J</i> = 7.3 Hz), 7.42 (2H, t, <i>J</i> = 7.2 Hz), 7.60 (3H, m), 12.55 (1H, br s). MS: <i>m</i>/<i>z</i> 477.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-2-(2-methoxyethyl)-<i>N</i>-methyl-1,8-dioxo-1,3,4,8-tetrahydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-7-carboxamide (<b>2l</b>)</h4><div class="NLM_p last">White solid; 4.5% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.56 (1H, br s), 9.56 (1H, d, <i>J</i> = 5.0 Hz), 7.87 (1H, s), 7.61 (3H, d, <i>J</i> = 7.9 Hz), 7.31–7.07 (7H, m), 5.72 (1H, d, <i>J</i> = 12.2 Hz), 4.41 (1H, d, <i>J</i> = 11.4 Hz), 4.10 (1H, dd, <i>J</i> = 13.7, 3.8 Hz), 3.53 (2H, t, <i>J</i> = 5.2 Hz), 3.40–3.30 (5H, m), 2.70 (3H, d, <i>J</i> = 4.7 Hz).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>S</i>)-7-Amino-4-benzhydryl-9-hydroxy-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2m</b>)</h4><div class="NLM_p last">White solid; 15% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.57 (2H, d, <i>J</i> = 8.3 Hz), 7.40 (2H, t, <i>J</i> = 8.5 Hz), 7.33–7.25 (1H, m), 7.23–7.08 (5H, m), 6.65 (1H, s), 5.31 (1H, d, <i>J</i> = 12.5 Hz), 4.45 (1H, br s), 4.36 (1H, d, <i>J</i> = 11.4 Hz), 3.99 (2H, d, <i>J</i> = 13.0 Hz), 3.40–3.30 (m, 2H), 3.12 (3H, s).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-7-methoxy-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2n</b>)</h4><div class="NLM_p last">Pink solid; 21% yield. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 3.17 (3H, s), 3.22 (3H, s), 3.40–3.53 (4H, m), 3.63–3.71 (1H, m), 4.24 (1H, d, <i>J</i> = 11.5 Hz), 4.45 (1H, d, <i>J</i> = 13.3 Hz), 4.60 (1H, d, <i>J</i> = 11.2 Hz), 6.08 (1H, d, <i>J</i> = 11.7 Hz), 6.96–6.99 (2H, br m), 7.13–7.17 (3H, m), 7.30–7.43 (5H, m). MS: <i>m</i>/<i>z</i> 435.15 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-2-(2-methoxyethyl)-7-methyl-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2o</b>)</h4><div class="NLM_p last">To a toluene (2 mL) solution of compound <b>22</b> (58 mg, 0.101 mmol) were added tetrakistriphenylphosphinepalladium (10 mg, 8.65 μmol) and hexamethylditin (80.4 mg, 0.242 mmol) at room temperature, and the mixture was heated with stirring at reflux for 10 h. After the solvent was distilled off, the resulting oil was purified by silica gel column chromatography (ethyl acetate/methanol, 70:30, v/v) to obtain 18.4 mg of crude compound <b>23</b> as a colorless oil (included compound <b>21</b>). This crude compound (18.4 mg) was dissolved in DCM (2 mL), TFA (2 mL) was added, and the mixture was stirred at room temperature for 2 h. After the solvent was distilled off, the resulting oil was purified by prep HPLC to obtain 3.6 mg (yield 8.5% for 2 steps) of compound <b>2o</b> as a pale red solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.47–7.29 (5H, m), 7.20–7.13 (3H, m), 7.03–6.97 (2H, m), 6.27 (1H, s), 4.51 (1H, d, <i>J</i> = 11.2 Hz), 4.30 (1H, d, <i>J</i> = 11.3 Hz), 4.09 (1H, d, <i>J</i> = 11.7 Hz), 3.78 (1H, d, <i>J</i> = 14.2 Hz), 3.61–3.31 (4H, m), 3.19 (3H, s), 1.65 (3H, s).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>S</i>)-4-Benzhydryl-7-chloro-9-hydroxy-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2p</b>)</h4><div class="NLM_p last">To a DMSO (2 mL) solution of compound <b>22</b> (69 mg, 0.120 mmol) was added copper(I) chloride (39 mg, 0.396 mmol) at room temperature, and the mixture was heated with stirring at 120 °C for 2 h. To that mixture was added copper(I) chloride (50 mg, 0.505 mmol) with stirring at reflux temperature for 1 h. After the reaction solution was cooled to room temperature, the solvent was distilled off, and the resulting oil was purified by preparative HPLC to obtain 20.9 mg (yield 40%) of compound <b>2p</b> as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.43 (2H, t, <i>J</i> = 7.2 Hz), 7.37–7.30 (3H, m), 7.23–7.19 (3H, m), 7.00 (2H, dd, <i>J</i> = 6.7, 2.7 Hz), 6.59 (1H, s), 4.56 (1H, d, <i>J</i> = 11.6 Hz), 4.29 (1H, d, <i>J</i> = 11.4 Hz), 4.17 (1H, dd, <i>J</i> = 13.7, 3.5 Hz), 3.82–3.72 (1H, m), 3.58 (1H, d, <i>J</i> = 13.4 Hz), 3.50–3.34 (3H, m), 3.20 (3H, s).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-2-(2-methoxyethyl)-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2q</b>)</h4><div class="NLM_p last">White solid; 35% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 3.12 (3H, s), 3.51 (5H, m), 4.05 (1H, dd, <i>J</i> = 13.9, 3.5 Hz), 4.37 (1H, d, <i>J</i> = 11.4 Hz), 5.38 (1H, d, <i>J</i> = 11.6 Hz), 5.60 (1H, d, <i>J</i> = 7.3 Hz), 6.90 (1H, d, <i>J</i> = 7.5 Hz), 7.22 (6H, m), 7.40 (2H, t, <i>J</i> = 7.5 Hz), 7.56 (2H, d, <i>J</i> = 7.2 Hz). MS: <i>m</i>/<i>z</i> 405 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-2-methyl-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2r</b>)</h4><div class="NLM_p last">White solid; 73% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 2.93 (3H, s), 3.17 (1H, d, J = 13.0 Hz),4.13(1H, dd, <i>J</i> = 13.6, 3.4 Hz), 4.47 (1H, d, <i>J</i> = 11.4 Hz),5.52(1H, dd, <i>J</i> = 9.3, 3.4 Hz), 5.99 (1H, d, <i>J</i> = 7.3 Hz), 7.18 (4H, m), 7.30 (3H, m), 7.41 (2H, t, <i>J</i> = 7.5 Hz), 7.60 (2H, d, <i>J</i> = 7.2 Hz). MS: <i>m</i>/<i>z</i> 361 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>S</i>)-4-Benzhydryl-9-hydroxy-2-isopropyl-3,4-dihydro-2<i>H</i>-pyrido[1,2-<i>a</i>]pyrazine-1,8-dione (<b>2s</b>)</h4><div class="NLM_p last">White solid; 65% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.82 (3H, d, <i>J</i> = 6.7 Hz), 1.05 (3H, d, <i>J</i> = 6.7 Hz), 3.90 (1H, dd, <i>J</i> = 13.6, 3.4 Hz), 4.39 (1H, d, <i>J</i> = 11.9 Hz), 4.77–4.86 (1H, m), 5.50 (1H, d, <i>J</i> = 8.6 Hz), 5.69 (1H, d, <i>J</i> = 7.4 Hz), 6.92 (1H, d, <i>J</i> = 7.4 Hz), 7.15–7.48 (8H, m), 7.63 (2H, d, <i>J</i> = 7.7 Hz) 12.51 (1H, br s). MS: <i>m</i>/<i>z</i> 389 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-Benzhydryl-5-hydroxy-3-(2-methoxyethyl)-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>2t</b>)</h4><div class="NLM_p last">White solid; 44% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.62–7.34 (6H, m), 7.28–7.16 (4H, m), 6.79 (1H, d, <i>J</i> = 7.7 Hz), 5.75 (1H, d, <i>J</i> = 7.7 Hz), 5.32 (1H, s), 5.04 (1H, d, <i>J</i> = 13.3 Hz), 4.56 (1H, d, <i>J</i> = 13.4 Hz), 4.00–3.89 (1H, m), 3.59–3.44 (2H, m), 3.26–3.15 (2H, m), 3.25 (3H, s).</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 1-Benzhydryl-5-hydroxy-3-methyl-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>2u</b>)</h4><div class="NLM_p last">White solid; 64% yield. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 2.95 (3H, s), 4.36 (1H, d, <i>J</i> = 13.2 Hz), 4.95 (1H, d, <i>J</i> = 13.2 Hz), 5.22 (1H, s), 5.71 (1H, d, <i>J</i> = 7.8 Hz), 6.75 (1H, d, <i>J</i> = 7.8 Hz), 7.21 (5H, br s), 7.33–7.47 (4H, m), 7.55 (2H, d, <i>J</i> = 6.6 Hz).</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-Benzhydryl-5-hydroxy-3-isopropyl-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>2v</b>)</h4><div class="NLM_p last">White solid; 68% yield. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 0.93 (3H, d, <i>J</i> = 6.9 Hz), 1.09 (3H, d, <i>J</i> = 6.9 Hz), 4.58 (1H, d, <i>J</i> = 12.6 Hz), 4.79 (1H, d, <i>J</i> = 12.6 Hz), 4.83–4.90 (1H, m), 5.20 (1H, s), 5.67 (1H, d, <i>J</i> = 7.5 Hz), 6.66 (1H, d, <i>J</i> = 7.5 Hz), 7.07–7.09 (2H, m), 7.13–7.19 (3H, m), 7.34–7.46 (3H, m), 7.52 (1H, d, <i>J</i> = 7.5 Hz).</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-Benzhydryl-3-(furan-2-ylmethyl)-5-hydroxy-2,3-dihydro-1<i>H</i>-pyrido[2,1-<i>f</i>][1,2,4]triazine-4,6-dione (<b>2w</b>)</h4><div class="NLM_p last">White solid; 61% yield. <sup>1</sup>H NMR (CDC1<sub>3</sub>) δ 4.54 (1H, d, <i>J</i> = 12.9 Hz), 4.56 (2H, s), 4.94 (1H, d, <i>J</i> = 12.9 Hz), 5.14 (1H, s), 5.68 (1H, d, <i>J</i> = 7.8 Hz), 6.20 (1H, d, <i>J</i> = 3.0 Hz), 6.25–6.27 (1H, m), 6.72 (1H, d, <i>J</i> = 7.8 Hz), 7.10–7.37 (11H, m).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00861" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00861" class="ext-link">10.1021/acs.jmedchem.9b00861</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular modeling with CEN (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Compound purity information; measurement of cap-dependent endonuclease (CEN) inhibitory activity; CPE inhibitory effect confirming assay; docking analysis of compound <b>2i</b>; docking analysis of compound <b>2v</b>; rat PK study; LC/MS/MS analysis; plasma protein binding assay; microsomal stability assay; animal care and use (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_001.pdf">jm9b00861_si_001.pdf (394.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_002.pdf">jm9b00861_si_002.pdf (586.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_003.csv">jm9b00861_si_003.csv (2.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00861" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masayoshi Miyagawa</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8940-5407" title="Orcid link">http://orcid.org/0000-0001-8940-5407</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#81ece0f2e0f8eef2e9e8afece8f8e0e6e0f6e0c1f2e9e8eeefeee6e8afe2eeafebf1"><span class="__cf_email__" data-cfemail="2845495b4951475b404106454151494f495f49685b40414746474f41064b47064258">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toshiyuki Akiyama</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoshiyuki Taoda</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Takaya</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chika Takahashi-Kageyama</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Tomita</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuya Yasuo</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazunari Hattori</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinya Shano</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryu Yoshida</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takao Shishido</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomokazu Yoshinaga</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akihiko Sato</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Makoto Kawai</span> - <span class="hlFld-Affiliation affiliation">Shionogi Pharmaceutical
Research Center, Shionogi & Company, Limited, 1-1, Futabacho, 3-chome, Toyonaka 561-0825, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3992-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Robert Webster (St. Jude Children’s Research Hospital, Memphis) generously provided materials for reverse genetics.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CEN</td><td class="NLM_def"><p class="first last">cap-dependent endonuclease</p></td></tr><tr><td class="NLM_term">BH</td><td class="NLM_def"><p class="first last">benzhydryl</p></td></tr><tr><td class="NLM_term">LHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">RuCl<sub>3</sub></td><td class="NLM_def"><p class="first last">ruthenium(III) chloride</p></td></tr><tr><td class="NLM_term">NaIO<sub>4</sub></td><td class="NLM_def"><p class="first last">sodium periodate</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>SO<sub>4</sub></td><td class="NLM_def"><p class="first last">sulfuric acid</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">WSC-HCl</td><td class="NLM_def"><p class="first last">1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">PPh<sub>3</sub></td><td class="NLM_def"><p class="first last">triphenylphosphine</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarboxylate</p></td></tr><tr><td class="NLM_term"><i>N</i>-Boc hydrazine</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonylhydrazine</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">Cs<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">cesium carbonate</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethyl-4-aminopyridine</p></td></tr><tr><td class="NLM_term">MeMgBr</td><td class="NLM_def"><p class="first last">methylmagnesium bromide</p></td></tr><tr><td class="NLM_term"><i>m</i>-CPBA</td><td class="NLM_def"><p class="first last"><i>m</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">MeI</td><td class="NLM_def"><p class="first last">iodomethane</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">NaN<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium azide</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">Ph<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diphenyl ether</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">CuCl</td><td class="NLM_def"><p class="first last">copper(I) chloride</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">Pd(PPh<sub>3</sub>)<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrakis(triphenylphosphine)palladium(0)</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">NaHCO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium hydrogen carbonate</p></td></tr><tr><td class="NLM_term">aq.</td><td class="NLM_def"><p class="first last">aqueous solution</p></td></tr><tr><td class="NLM_term">NH<sub>3</sub></td><td class="NLM_def"><p class="first last">ammonia</p></td></tr><tr><td class="NLM_term">K<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">potassium carbonate</p></td></tr><tr><td class="NLM_term">CPE</td><td class="NLM_def"><p class="first last">cytopathogenic effect</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">DMSO-<i>d</i><sub>6</sub></td><td class="NLM_def"><p class="first last">deuterated dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">UPLC-MS</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography-mass spectrometer</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array</p></td></tr><tr><td class="NLM_term">N<sub>2</sub></td><td class="NLM_def"><p class="first last">nitrogen</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, J K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G</span></span> <span> </span><span class="NLM_article-title">Antiviral Combinations for Severe Influenza</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(14)70821-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1016%2FS1473-3099%2814%2970821-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=25213733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFerur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1259-1270&author=J.+Dunningauthor=J+K.+Baillieauthor=B.+Caoauthor=F.+G+Hayden&title=Antiviral+Combinations+for+Severe+Influenza&doi=10.1016%2FS1473-3099%2814%2970821-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral combinations for severe influenza</span></div><div class="casAuthors">Dunning, Jake; Baillie, J. Kenneth; Cao, Bin; Hayden, Frederick G.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1259-1270</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Observational data suggest that the treatment of influenza infection with neuraminidase inhibitors decreases progression to more severe illness, esp. when treatment is started soon after symptom onset.  However, even early treatment might fail to prevent complications in some patients, particularly those infected with novel viruses such as the 2009 pandemic influenza A H1N1, avian influenza A H5N1 virus subtype, or the avian influenza A H7N9 virus subtype.  Furthermore, treatment with one antiviral drug might promote the development of antiviral resistance, esp. in immunocompromised hosts and critically ill patients.  An obvious strategy to optimize antiviral therapy is to combine drugs with different modes of action.  Because host immune responses to infection might also contribute to illness pathogenesis, improved outcomes might be gained from the combination of antiviral therapy with drugs that modulate the immune response in an infected individual.  We review available data from preclin. and clin. studies of combination antiviral therapy and of combined antiviral-immunomodulator therapy for influenza.  Early-stage data draw attention to several promising antiviral combinations with therapeutic potential in severe infections, but there remains a need to substantiate clin. benefit.  Combination therapies with favorable exptl. data need to be tested in carefully designed aclin. trials to assess their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKnDnW6zLM6bVg90H21EOLACvtfcHk0lhKoY_-_34BvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFerur3O&md5=cf91cd12316255bf46c75a652abbcf02</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2814%2970821-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252814%252970821-7%26sid%3Dliteratum%253Aachs%26aulast%3DDunning%26aufirst%3DJ.%26aulast%3DBaillie%26aufirst%3DJ%2BK.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DHayden%26aufirst%3DF.%2BG%26atitle%3DAntiviral%2520Combinations%2520for%2520Severe%2520Influenza%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D1259%26epage%3D1270%26doi%3D10.1016%2FS1473-3099%2814%2970821-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipsitch, M.</span></span> <span> </span><span class="NLM_article-title">Transmissibility of 1918 Pandemic Influenza</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1038/nature03063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fnature03063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=15602562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=904-906&author=C.+E.+Millsauthor=J.+M.+Robinsauthor=M.+Lipsitch&title=Transmissibility+of+1918+Pandemic+Influenza&doi=10.1038%2Fnature03063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Transmissibility of 1918 pandemic influenza</span></div><div class="casAuthors">Mills, Christina E.; Robins, James M.; Lipsitch, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7019</span>),
    <span class="NLM_cas:pages">904-906</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The 1918 influenza pandemic killed 20-40 million people worldwide, and is seen as a worst-case scenario for pandemic planning.  Like other pandemic influenza strains, the 1918 A/H1N1 strain spread extremely rapidly.  A measure of transmissibility and of the stringency of control measures required to stop an epidemic is the reproductive no., which is the no. of secondary cases produced by each primary case.  Here we obtained an est. of the reproductive no. for 1918 influenza by fitting a deterministic SEIR (susceptible-exposed-infectious-recovered) model to pneumonia and influenza death epidemic curves from 45 US cities: the median value is less than three.  The estd. proportion of the population with A/H1N1 immunity before Sept. 1918 implies a median basic reproductive no. of less than four.  These results strongly suggest that the reproductive no. for 1918 pandemic influenza is not large relative to many other infectious diseases.  In theory, a similar novel influenza subtype could be controlled.  But because influenza is frequently transmitted before a specific diagnosis is possible and there is a dearth of global antiviral and vaccine stores, aggressive transmission reducing measures will probably be required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmKijrUKQb-rVg90H21EOLACvtfcHk0lgCvCHGbX6NRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7rK&md5=3944ac7552c031753731d18ffa453882</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature03063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03063%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DC.%2BE.%26aulast%3DRobins%26aufirst%3DJ.%2BM.%26aulast%3DLipsitch%26aufirst%3DM.%26atitle%3DTransmissibility%2520of%25201918%2520Pandemic%2520Influenza%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D904%26epage%3D906%26doi%3D10.1038%2Fnature03063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span> </span><span class="NLM_article-title">Adjusted Vaccine Effectiveness Estimates
for Influenza Seasons from
2005 to 2015</span>; <a href="http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm" class="extLink">http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm</a> (accessed Sep 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Adjusted+Vaccine+Effectiveness+Estimates%0Afor+Influenza+Seasons+from%0A2005+to+2015%3B+http%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fvaccination%2Feffectiveness-studies.htm+%28accessed+Sep+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAdjusted%2520Vaccine%2520Effectiveness%2520Estimates%250Afor%2520Influenza%2520Seasons%2520from%250A2005%2520to%25202015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscona, A.</span></span> <span> </span><span class="NLM_article-title">Neuraminidase Inhibitors for Influenza</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1056/NEJMra050740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1056%2FNEJMra050740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=16192481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGmtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=1363-1373&author=A.+Moscona&title=Neuraminidase+Inhibitors+for+Influenza&doi=10.1056%2FNEJMra050740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neuraminidase inhibitors for influenza</span></div><div class="casAuthors">Moscona, Anne</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1363-1373</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The article discusses neuraminidase inhibitors for influenza virus, in particular zanamivir and oseltamivir.  It covers the development, pharmacokinetics, clin. trials, safety, resistance, and strategies for treatment of various neuraminidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTdUZ73EM37Vg90H21EOLACvtfcHk0lgCvCHGbX6NRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGmtL3L&md5=a8252ccbcc0a796e9206cfb4b3a4d29a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra050740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra050740%26sid%3Dliteratum%253Aachs%26aulast%3DMoscona%26aufirst%3DA.%26atitle%3DNeuraminidase%2520Inhibitors%2520for%2520Influenza%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D1363%26epage%3D1373%26doi%3D10.1056%2FNEJMra050740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiver, G.</span></span> <span> </span><span class="NLM_article-title">The Treatment of Influenza with Antiviral Drugs</span>. <i>Can. Med. Assoc. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=12515786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FgvFCmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2003&pages=49-57&author=G.+Stiver&title=The+Treatment+of+Influenza+with+Antiviral+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The treatment of influenza with antiviral drugs</span></div><div class="casAuthors">Stiver Grant</div><div class="citationInfo"><span class="NLM_cas:title">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>
        ISSN:<span class="NLM_cas:issn">0820-3946</span>.
    </div><div class="casAbstract">Influenza vaccination with current inactivated vaccines homologous to the prevalent wild-type virus can reduce influenza illness in 75%-80% of healthy adults.  Vaccine is recommended for all individuals with chronic underlying diseases and for those aged 65 years or older.  Although influenza vaccination is still advocated for patients with blunted immunity, protection rates are not as high, running at 40% for frail institutionalized elderly people.  The influenza antiviral agents amantadine or rimantadine, zanamivir and oseltamivir can modify the severity of illness and reduce the duration of illness by about 1.5-2.5 days.  Amantadine inhibits only influenza A.  Resistant virus may emerge in up to 33% of amantadine-treated patients in the first 5 days of treatment and be transmitted to susceptible close contacts.  Side effects are usually mild in short courses of treatment.  The neuraminidase inhibitor drugs zanamivir and oseltamivir act on both influenza A and B.  Treatment is most effective when given within 30-36 hours after the onset of illness, and the earlier the better.  Influenza should be treated with antiviral drugs in unvaccinated and vaccinated high-risk patients, as well as immunosuppressed patients with influenza-like illness, in periods of confirmed influenza prevalence.  These drugs may be of great value in the event of a major viral antigenic shift that causes pandemic influenza, if an adequate supply can be sustained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8Urfbou99qTEwO064Z95rfW6udTcc2eZkk5nz6jwZKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FgvFCmtQ%253D%253D&md5=8343e074c01f0ffdcfeed864852cff50</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStiver%26aufirst%3DG.%26atitle%3DThe%2520Treatment%2520of%2520Influenza%2520with%2520Antiviral%2520Drugs%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D2003%26volume%3D168%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Administration,
U. S. Food and Drug Tamiflu Pediatric Adverse
Events: Questions and Answers</span>; <a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107840.htm" class="extLink">http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107840.htm</a> (accessed Sep 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Administration%2C%0AU.+S.+Food+and+Drug+Tamiflu+Pediatric+Adverse%0AEvents%3A+Questions+and+Answers%3B+http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2FPostmarketDrugSafetyInformationforPatientsandProviders%2Fucm107840.htm+%28accessed+Sep+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmolke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva-Grado, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thangavel, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margine, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krammer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sastre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, N. M.</span></span> <span> </span><span class="NLM_article-title">Influenza A(H7N9) Virus Gains Neuraminidase Inhibitor Resistance Without Loss of in Vivo Virulence or Transmissibility</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2854</span>, <span class="refDoi"> DOI: 10.1038/ncomms3854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fncomms3854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=24326875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A280%3ADC%252BC2c3lsVyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2854&author=R.+Haiauthor=M.+Schmolkeauthor=V.+H.+Leyva-Gradoauthor=R.+R.+Thangavelauthor=I.+Margineauthor=E.+L.+Jaffeauthor=F.+Krammerauthor=A.+Solorzanoauthor=A.+Garcia-Sastreauthor=P.+Paleseauthor=N.+M.+Bouvier&title=Influenza+A%28H7N9%29+Virus+Gains+Neuraminidase+Inhibitor+Resistance+Without+Loss+of+in+Vivo+Virulence+or+Transmissibility&doi=10.1038%2Fncomms3854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility</span></div><div class="casAuthors">Hai Rong; Schmolke Mirco; Leyva-Grado Victor H; Thangavel Rajagowthamee R; Margine Irina; Jaffe Eric L; Krammer Florian; Solorzano Alicia; Garcia-Sastre Adolfo; Palese Peter; Bouvier Nicole M</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2854</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Without baseline human immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for controlling viral replication in severe infections.  An amino acid change in the viral neuraminidase associated with drug resistance, NA-R292K (N2 numbering), has been found in some H7N9 clinical isolates.  Here we assess the impact of the NA-R292K substitution on antiviral sensitivity and viral replication, pathogenicity and transmissibility of H7N9 viruses.  Our data indicate that an H7N9 isolate encoding the NA-R292K substitution is highly resistant to oseltamivir and peramivir and partially resistant to zanamivir.  Furthermore, H7N9 reassortants with and without the resistance mutation demonstrate comparable viral replication in primary human respiratory cells, virulence in mice and transmissibility in guinea pigs.  Thus, in stark contrast to oseltamivir-resistant seasonal influenza A(H3N2) viruses, H7N9 virus replication and pathogenicity in these models are not substantially altered by the acquisition of high-level oseltamivir resistance due to the NA-R292K mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAaLrTIVfN4IHWj6b1v8uTfW6udTcc2eZR8HYrt5CvA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3lsVyitA%253D%253D&md5=09537186462d536d4cc65fa967b00f40</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncomms3854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3854%26sid%3Dliteratum%253Aachs%26aulast%3DHai%26aufirst%3DR.%26aulast%3DSchmolke%26aufirst%3DM.%26aulast%3DLeyva-Grado%26aufirst%3DV.%2BH.%26aulast%3DThangavel%26aufirst%3DR.%2BR.%26aulast%3DMargine%26aufirst%3DI.%26aulast%3DJaffe%26aufirst%3DE.%2BL.%26aulast%3DKrammer%26aufirst%3DF.%26aulast%3DSolorzano%26aufirst%3DA.%26aulast%3DGarcia-Sastre%26aufirst%3DA.%26aulast%3DPalese%26aufirst%3DP.%26aulast%3DBouvier%26aufirst%3DN.%2BM.%26atitle%3DInfluenza%2520A%2528H7N9%2529%2520Virus%2520Gains%2520Neuraminidase%2520Inhibitor%2520Resistance%2520Without%2520Loss%2520of%2520in%2520Vivo%2520Virulence%2520or%2520Transmissibility%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2854%26doi%3D10.1038%2Fncomms3854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorlund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thabane, L.</span></span> <span> </span><span class="NLM_article-title">Systematic Review of Influenza Resistance to the Neuraminidase Inhibitors</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">134</span>, <span class="refDoi"> DOI: 10.1186/1471-2334-11-134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1186%2F1471-2334-11-134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=21592407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1Knu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=134&author=K.+Thorlundauthor=T.+Awadauthor=G.+Boivinauthor=L.+Thabane&title=Systematic+Review+of+Influenza+Resistance+to+the+Neuraminidase+Inhibitors&doi=10.1186%2F1471-2334-11-134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review of influenza resistance to the neuraminidase inhibitors</span></div><div class="casAuthors">Thorlund, Kristian; Awad, Tahany; Boivin, Guy; Thabane, Lehana</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: Antivirals play a crit. role in the prevention and the management of influenza.  One class of antivirals, neuraminidase inhibitors (NAIs), is effective against all human influenza viruses.  Currently there are two NAI drugs which are licensed worldwide: oseltamivir (Tamiflu) and zanamivir (Relenza); and two drugs which have received recent approval in Japan: peramivir and laninamivir.  Until recently, the prevalence of antiviral resistance has been relatively low.  However, almost all seasonal H1N1 strains that circulated in 2008-09 were resistant to oseltamivir whereas about 1% of tested 2009 pandemic H1N1 viruses were found to be resistant to oseltamivir.  To date, no studies have demonstrated widespread resistance to zanamivir.  It seems likely that the literature on antiviral resistance assocd. with oseltamivir as well as zanamivir is now sufficiently comprehensive to warrant a systematic review.  The primary objectives were to systematically review the literature to det. the incidence of resistance to oseltamivir, zanamivir, and peramivir in different population groups as well as assess the clin. consequences of antiviral resistance.  Methods: We searched MEDLINE and EMBASE without language restrictions in Sept. 2010 to identify studies reporting incidence of resistance to oseltamivir, zanamivir, and peramivir.  We used forest plots and meta-anal. of incidence of antiviral resistance assocd. with the three NAIs.  Subgroup analyses were done across a no. of population groups.  Meta-anal. was also performed to evaluate assocns. between antiviral resistance and clin. complications and symptoms.  Results: We identified 19 studies reporting incidence of antiviral resistance.  Meta-anal. of 15 studies yielded a pooled incidence rate for oseltamivir resistance of 2.6% (95%CI 0.7% to 5.5%).  The incidence rate for all five zanamivir resistance studies was 0%.  Only one study measured incidence of antiviral resistance among subjects given peramivir and was reported to be 0%.  Subgroup analyses detected higher incidence rates among influenza A patients, esp. for H1N1 subtype influenza.  Considerable heterogeneity between studies precluded definite inferences about subgroup results for immunocompromised patients, in-patients, and children.  A meta-anal. of 4 studies reporting assocn. between oseltamivir-resistance and pneumonia yielded a statistically significant risk ratio of 4.2 (95% CI 1.3 to 13.1, p = 0.02).  Oseltamivir resistance was not statistically significantly assocd. with other clin. complications and symptoms.  Conclusion: Our results demonstrate that a substantial no. of patients may become oseltamivir resistant as a result of oseltamivir use, and that oseltamivir resistance may be significantly assocd. with pneumonia.  In contrast, zanamivir resistance has been rarely reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRRg_pLOlP3rVg90H21EOLACvtfcHk0ljmVNYblt8EvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1Knu78%253D&md5=19171a1f09a59032ff68426138cfa851</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2F1471-2334-11-134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2334-11-134%26sid%3Dliteratum%253Aachs%26aulast%3DThorlund%26aufirst%3DK.%26aulast%3DAwad%26aufirst%3DT.%26aulast%3DBoivin%26aufirst%3DG.%26aulast%3DThabane%26aufirst%3DL.%26atitle%3DSystematic%2520Review%2520of%2520Influenza%2520Resistance%2520to%2520the%2520Neuraminidase%2520Inhibitors%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2011%26volume%3D11%26spage%3D134%26doi%3D10.1186%2F1471-2334-11-134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Someya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngyen, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaoka, Y.</span></span> <span> </span><span class="NLM_article-title">Avian Flu: Isolation of Drug-Resistant H5N1 Virus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>437</i></span>,  <span class="NLM_fpage">1108</span>, <span class="refDoi"> DOI: 10.1038/4371108a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2F4371108a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=16228009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=1108&author=Q.+M.+Leauthor=M.+Kisoauthor=K.+Someyaauthor=Y.+T.+Sakaiauthor=T.+H.+Nguyenauthor=K.+H.+L.+Nguyenauthor=N.+D.+Phamauthor=H.+H.+Ngyenauthor=S.+Yamadaauthor=Y.+Muramotoauthor=T.+Horimotoauthor=A.+Takadaauthor=H.+Gotoauthor=T.+Suzukiauthor=Y.+Suzukiauthor=Y.+Kawaoka&title=Avian+Flu%3A+Isolation+of+Drug-Resistant+H5N1+Virus&doi=10.1038%2F4371108a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Avian flu: Isolation of drug-resistant H5N1 virus</span></div><div class="casAuthors">Le, Q. Mai; Kiso, Maki; Someya, Kazuhiko; Sakai, Yuko T.; Nguyen, T. Hien; Nguyen, Khan H. L.; Pham, N. Dinh; Ngyen, Ha H.; Yamada, Shinya; Muramoto, Yukiko; Horimoto, Taisuke; Takada, Ayato; Goto, Hideo; Suzuki, Takashi; Suzuki, Yasuo; Kawaoka, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">7062</span>),
    <span class="NLM_cas:pages">1108</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An H5N1 influenza A virus was isolated on 27 Feb 2005 from a 14-yr-old Vietnamese girl.  Direct sequencing of the virus indicated that some of the population had a histidine-to-tyrosine substitution at position 274 in its neuraminidase protein, a mutation that confers resistance to oseltamivir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmQSejiypu7Vg90H21EOLACvtfcHk0ljmVNYblt8EvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaht7fF&md5=4bf9a5f6771def1987c73c2183e6ff3a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F4371108a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4371108a%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DQ.%2BM.%26aulast%3DKiso%26aufirst%3DM.%26aulast%3DSomeya%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DY.%2BT.%26aulast%3DNguyen%26aufirst%3DT.%2BH.%26aulast%3DNguyen%26aufirst%3DK.%2BH.%2BL.%26aulast%3DPham%26aufirst%3DN.%2BD.%26aulast%3DNgyen%26aufirst%3DH.%2BH.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DMuramoto%26aufirst%3DY.%26aulast%3DHorimoto%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DGoto%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKawaoka%26aufirst%3DY.%26atitle%3DAvian%2520Flu%253A%2520Isolation%2520of%2520Drug-Resistant%2520H5N1%2520Virus%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D1108%26doi%3D10.1038%2F4371108a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monod, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tissot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruigrok, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slama-Schwok, A.</span></span> <span> </span><span class="NLM_article-title">Learning from Structure-Based Drug Design and New Antivirals Targeting the Ribonucleoprotein Complex for the Treatment of Influenza</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1517/17460441.2015.1019859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1517%2F17460441.2015.1019859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=25792362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFehsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=345-371&author=A.+Monodauthor=C.+Swaleauthor=B.+Tarusauthor=A.+Tissotauthor=B.+Delmasauthor=R.+W.+Ruigrokauthor=T.+Crepinauthor=A.+Slama-Schwok&title=Learning+from+Structure-Based+Drug+Design+and+New+Antivirals+Targeting+the+Ribonucleoprotein+Complex+for+the+Treatment+of+Influenza&doi=10.1517%2F17460441.2015.1019859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza</span></div><div class="casAuthors">Monod, Alexandre; Swale, Christopher; Tarus, Bogdan; Tissot, Alice; Delmas, Bernard; Ruigrok, Rob WH; Crepin, Thibaut; Slama-Schwok, Anny</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-371</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Influenza viruses are a threat to human health.  There are presently only two methods for treating influenza: vaccines, which require yearly updates, and two classes of antivirals that suffer with the problem of resistance by current human influenza viruses; this is esp. the case with amantadine and rimantadine.  Consequently, there is an urgent need for the development of new antivirals with new mechanisms of action.  Areas covered: In this review, the authors focus on viral protein domains, their assocd. activity and their inhibition by small mols. defined by a structure-based design with a special emphasis on the ribonucleoprotein complex and its inhibitors.  Several new classes of antiviral candidates targeting viral replication through individual domains of the polymerase and the nucleoprotein (NP) have been developed through structure-based design.  Expert opinion: To date, the antivirals targeting neuraminidase are by far the most developed and potent.  Antiviral candidates targeting the NP and polymerase domains are in the pipeline but their pharmacokinetics needs further studies.  The recently published structures of the polymerase expand the possibilities for development of new antivirals.  Combination therapies targeting conserved viral targets and new cellular proteins or exploiting drug promiscuity hold promises to fight against the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpk0IEQbgSgrVg90H21EOLACvtfcHk0ljexZU-it1DIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFehsbk%253D&md5=85ffba64d1b9fe1ef78d7967126cf32d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1019859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1019859%26sid%3Dliteratum%253Aachs%26aulast%3DMonod%26aufirst%3DA.%26aulast%3DSwale%26aufirst%3DC.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DTissot%26aufirst%3DA.%26aulast%3DDelmas%26aufirst%3DB.%26aulast%3DRuigrok%26aufirst%3DR.%2BW.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DSlama-Schwok%26aufirst%3DA.%26atitle%3DLearning%2520from%2520Structure-Based%2520Drug%2520Design%2520and%2520New%2520Antivirals%2520Targeting%2520the%2520Ribonucleoprotein%2520Complex%2520for%2520the%2520Treatment%2520of%2520Influenza%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D345%26epage%3D371%26doi%3D10.1517%2F17460441.2015.1019859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, M.</span></span> <span> </span><span class="NLM_article-title">Determination of Influenza Virus Proteins Required for Genome Replication</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">5669</span>– <span class="NLM_lpage">5673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=2214032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1Ors7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1990&pages=5669-5673&author=T.+S.+Huangauthor=P.+Paleseauthor=M.+Krystal&title=Determination+of+Influenza+Virus+Proteins+Required+for+Genome+Replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of influenza virus proteins required for genome replication</span></div><div class="casAuthors">Huang, Tao Sheng; Palese, Peter; Krystal, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5669-73</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">An artificial vaccinia virus vector-driven replication system for influenza virus RNA has been developed.  In this system, a synthetic NS-like gene is replicated and expressed by influenza virus proteins supplied through infection with vaccinia virus recombinant vectors.  The min. subset of influenza virus proteins needed for specific replication and expression of the viral ribonucleoprotein was found to be the 3 polymerase proteins (PB1, PB2, and PA) and the nucleoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprv1Xro8SMHrVg90H21EOLACvtfcHk0ljexZU-it1DIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1Ors7w%253D&md5=d18b5ecb9e8ebccf1c8ac589a8cffb86</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.%2BS.%26aulast%3DPalese%26aufirst%3DP.%26aulast%3DKrystal%26aufirst%3DM.%26atitle%3DDetermination%2520of%2520Influenza%2520Virus%2520Proteins%2520Required%2520for%2520Genome%2520Replication%26jtitle%3DJ.%2520Virol.%26date%3D1990%26volume%3D64%26spage%3D5669%26epage%3D5673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, E.</span></span> <span> </span><span class="NLM_article-title">The RNA Polymerase of Influenza a Virus: Mechanisms of Viral Transcription and Replication</span>. <i>Acta. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.4149/av_2013_02_113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.4149%2Fav_2013_02_113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=23600869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2qt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=113-122&author=E.+Fodor&title=The+RNA+Polymerase+of+Influenza+a+Virus%3A+Mechanisms+of+Viral+Transcription+and+Replication&doi=10.4149%2Fav_2013_02_113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The RNA polymerase of influenza A virus: mechanisms of viral transcription and replication</span></div><div class="casAuthors">Fodor, E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Virologica (English Edition)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-122</span>CODEN:
                <span class="NLM_cas:coden">AVIRA2</span>;
        ISSN:<span class="NLM_cas:issn">0001-723X</span>.
    
            (<span class="NLM_cas:orgname">AEP - Academic Electronic Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The influenza A virus RNA genome segments are packaged in ribonucleoprotein complexes contg. RNA polymerase and nucleoprotein.  The ribonucleoprotein is involved in the transcription of viral genes and replication of the viral RNA genome in the nucleus of the infected cells, and represents the minimal transcriptional and replicative machinery of an influenza virus.  During transcription, the viral RNA polymerase synthesizes capped and polyadenylated mRNA using 5' capped RNA primers.  During replication, the viral RNA polymerase generates a complementary RNA (cRNA) replication intermediate, a full-length complement of the vRNA that serves as a template for the synthesis of new copies of vRNA.  The nucleoprotein is also an essential component of the viral transcriptional machinery.  The mol. determinants of the transcriptional and replicative activities of the viral RNA polymerase are not fully understood, but recent data suggest that transcription is performed by a cis-acting RNA polymerase, forming part of the ribonucleoprotein complex, while replication might be carried out by a trans-acting RNA polymerase.  Viral as well as cellular factors are known to be involved in the regulation of the activities of the RNA polymerase, e.g. the viral nuclear export protein has been shown to regulate the accumulation of viral transcription and replication products.  The viral transcriptional machinery represents an attractive target for the development of antiviral drugs and lead compds. targeting nucleoprotein and the PA endonuclease domain of the RNA polymerase have already been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQG6QtdUwhmLVg90H21EOLACvtfcHk0ljexZU-it1DIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2qt7%252FO&md5=e1d4ebcf3efd8dc9b0621fb8ba9abccd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4149%2Fav_2013_02_113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4149%252Fav_2013_02_113%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DE.%26atitle%3DThe%2520RNA%2520Polymerase%2520of%2520Influenza%2520a%2520Virus%253A%2520Mechanisms%2520of%2520Viral%2520Transcription%2520and%2520Replication%26jtitle%3DActa.%2520Virol.%26date%3D2013%26volume%3D57%26spage%3D113%26epage%3D122%26doi%3D10.4149%2Fav_2013_02_113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span> <span> </span><span class="NLM_article-title">PA Subunit of RNA Polymerase as a Promising Target for Anti-Influenza Virus Agents</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2007.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1016%2Fj.antiviral.2007.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=18258312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2008&pages=194-201&author=M.+Nakazawaauthor=S.+E.+Kadowakiauthor=I.+Watanabeauthor=Y.+Kadowakiauthor=M.+Takeiauthor=H.+Fukuda&title=PA+Subunit+of+RNA+Polymerase+as+a+Promising+Target+for+Anti-Influenza+Virus+Agents&doi=10.1016%2Fj.antiviral.2007.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">PA subunit of RNA polymerase as a promising target for anti-influenza virus agents</span></div><div class="casAuthors">Nakazawa, Misako; Kadowaki, Shin-etsu; Watanabe, Izumi; Kadowaki, Youko; Takei, Masaya; Fukuda, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RNA polymerase of influenza virus is a specific enzyme necessary for the viral replication.  A siRNA against the RNA polymerase and the RNA polymerase inhibitor L-742,001 reduced accumulation of viral RNAs in the infected cells.  L-742,001 strongly inhibited virus re-growth after removal of the agent from the culture, whereas the neuraminidase inhibitor zanamivir did not.  L-742,001-resistant mutants showed a Thr-20 to Ala substitution in the PA subunit of RNA polymerase.  The drug-resistant virus showed a slight redn. in the susceptibility to L-742,001 in both the plaque assay (threefold redn.) and enzyme assay (two- to three-fold redn.).  The resistance levels were lower than those of zanamivir-resistant mutants in the plaque assay.  Against zanamivir-resistant mutants, L-742,001 retained the same antiviral activity as against the wild-type strain.  These results indicate that L-742,001 is most likely to act at the PA subunit, and possesses a unique profile.  It is suggested that PA subunit of RNA polymerase is a promising target for anti-influenza virus agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDCcfRlSa-tLVg90H21EOLACvtfcHk0liiTOpxV5jfwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFClu74%253D&md5=ce368bc359cb1ad171052dd00ca69e7a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2007.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2007.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DNakazawa%26aufirst%3DM.%26aulast%3DKadowaki%26aufirst%3DS.%2BE.%26aulast%3DWatanabe%26aufirst%3DI.%26aulast%3DKadowaki%26aufirst%3DY.%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DH.%26atitle%3DPA%2520Subunit%2520of%2520RNA%2520Polymerase%2520as%2520a%2520Promising%2520Target%2520for%2520Anti-Influenza%2520Virus%2520Agents%26jtitle%3DAntiviral%2520Res.%26date%3D2008%26volume%3D78%26spage%3D194%26epage%3D201%26doi%3D10.1016%2Fj.antiviral.2007.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruigrok, R. W. H.</span></span> <span> </span><span class="NLM_article-title">The Cap-Snatching Endonuclease of Influenza Virus Polymerase Resides in the PA Subunit</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1038/nature07745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fnature07745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=19194459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=914-918&author=A.+Diasauthor=D.+Bouvierauthor=T.+Crepinauthor=A.+A.+McCarthyauthor=D.+J.+Hartauthor=F.+Baudinauthor=S.+Cusackauthor=R.+W.+H.+Ruigrok&title=The+Cap-Snatching+Endonuclease+of+Influenza+Virus+Polymerase+Resides+in+the+PA+Subunit&doi=10.1038%2Fnature07745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit</span></div><div class="casAuthors">Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7240</span>),
    <span class="NLM_cas:pages">914-918</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The influenza virus polymerase, a heterotrimer composed of three subunits, PA, PB1 and PB2, is responsible for replication and transcription of the eight sep. segments of the viral RNA genome in the nuclei of infected cells.  The polymerase synthesizes viral mRNAs using short capped primers derived from cellular transcripts by a unique 'cap-snatching' mechanism.  The PB2 subunit binds the 5' cap of host pre-mRNAs, which are subsequently cleaved after 10-13 nucleotides by the viral endonuclease, hitherto thought to reside in the PB2 (ref. 5) or PB1 subunits.  Here we describe biochem. and structural studies showing that the amino-terminal 209 residues of the PA subunit contain the endonuclease active site.  We show that this domain has intrinsic RNA and DNA endonuclease activity that is strongly activated by manganese ions, matching observations reported for the endonuclease activity of the intact trimeric polymerase.  Furthermore, this activity is inhibited by 2,4-dioxo-4-phenylbutanoic acid, a known inhibitor of the influenza endonuclease.  The crystal structure of the domain reveals a structural core closely resembling resolvases and type II restriction endonucleases.  The active site is comprised of one histidine and a cluster of three acidic residues, conserved in all influenza viruses, which bind two manganese ions in a configuration similar to other two-metal-dependent endonucleases.  Two active site residues have previously been shown to specifically eliminate the polymerase endonuclease activity when mutated.  These results will facilitate the optimization of endonuclease inhibitors as potential new anti-influenza drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBhrxJf4V9TrVg90H21EOLACvtfcHk0liiTOpxV5jfwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCrt7o%253D&md5=d9ed34cef54fa4166a8a5dbdfe125582</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature07745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07745%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DD.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DMcCarthy%26aufirst%3DA.%2BA.%26aulast%3DHart%26aufirst%3DD.%2BJ.%26aulast%3DBaudin%26aufirst%3DF.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DRuigrok%26aufirst%3DR.%2BW.%2BH.%26atitle%3DThe%2520Cap-Snatching%2520Endonuclease%2520of%2520Influenza%2520Virus%2520Polymerase%2520Resides%2520in%2520the%2520PA%2520Subunit%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D914%26epage%3D918%26doi%3D10.1038%2Fnature07745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selnick, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolanski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span> <span> </span><span class="NLM_article-title">Antiinfluenza Virus Activities of 4-Substituted 2,4-Dioxobutanoic Acid Inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1304</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1128/AAC.40.5.1304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1128%2FAAC.40.5.1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=8723491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADyaK28XislCltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1304-1307&author=J.+C.+Hastingsauthor=H.+Selnickauthor=B.+Wolanskiauthor=J.+E.+Tomassini&title=Antiinfluenza+Virus+Activities+of+4-Substituted+2%2C4-Dioxobutanoic+Acid+Inhibitors&doi=10.1128%2FAAC.40.5.1304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors</span></div><div class="casAuthors">Hastings, J. C.; Selnick, H.; Wolanski, B.; Tomassini, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1304-1307</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We previously identified a series of compds. which specifically inhibited the transcription of influenza A and B viruses (J. Tomassini, H. Selnick, M. E. Davies, M. E. Armstrong, J. Baldwin, M. Bourgeois, J. Hastings, D. Hazuda, J. Lewis, W. McClements, G. Ponticello, E. Radzilowski, G. Smith, A. Tebben, A. Wolfe, Antimicrob. Agents Chemother. 38:2827-2837, 1994).  The compds., 4-substituted 2,4-dioxobutanoic acids, selectively targeted the cap-dependent endonuclease activity of the transcriptase complex.  Addnl., several of these compds. effectively inhibited the replication of influenza virus but not other viruses in cell culture assays.  Here, we report on the anti-influenza virus activities of other potent derivs. of the series evaluated in both in vitro and in vivo infectivity assays.  These compds. inhibited the replication of influenza virus in yield redn. assays, with 50% inhibitory concns. ranging from 0.18 to 0.71 μM.  These 50% inhibitory concns. were similar to those obsd. for inhibition of in vitro transcription (0.32 to 0.54 μM).  One selected compd. also elicited a dose-dependent inhibition of influenza virus replication in mice following an upper respiratory tract challenge.  These studies demonstrate the antiviral efficacy of this inhibitor class and thereby establish the utility of influenza virus endonuclease as a chemotherapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLR1ODjylLS7Vg90H21EOLACvtfcHk0lg8KhoKXzZEIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCltb0%253D&md5=e5f0cdd27a936e6fbb496db3906454ce</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.5.1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.5.1304%26sid%3Dliteratum%253Aachs%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DWolanski%26aufirst%3DB.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26atitle%3DAntiinfluenza%2520Virus%2520Activities%2520of%25204-Substituted%25202%252C4-Dioxobutanoic%2520Acid%2520Inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D1304%26epage%3D1307%26doi%3D10.1128%2FAAC.40.5.1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojena, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghoobar, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkacz, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, M. A.</span></span> <span> </span><span class="NLM_article-title">A Novel Antiviral Agent Which Inhibits the Endonuclease of Influenza Viruses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1128/AAC.40.5.1189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1128%2FAAC.40.5.1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=8723464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADyaK28XislCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1189-1193&author=J.+E.+Tomassiniauthor=M.+E.+Daviesauthor=J.+C.+Hastingsauthor=R.+Linghamauthor=M.+Mojenaauthor=S.+L.+Raghoobarauthor=S.+B.+Singhauthor=J.+S.+Tkaczauthor=M.+A.+Goetz&title=A+Novel+Antiviral+Agent+Which+Inhibits+the+Endonuclease+of+Influenza+Viruses&doi=10.1128%2FAAC.40.5.1189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antiviral agent which inhibits the endonuclease of influenza viruses</span></div><div class="casAuthors">Tomassini, J. E.; Davies, M. E.; Hastings, J. C.; Lingham, R.; Mojena, M.; Raghoobar, S. L.; Singh, S. B.; Tkacz, J. S.; Goetz, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1189-1193</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A novel anti-influenza virus compd., flutimide, was identified in exts. of a recently identified fungal species, Delitschia confertaspora.  The compd., a substituted 2,6-diketopiperazine, selectively inhibited the cap-dependent transcriptase of influenza A and B viruses and had no effect on the activities of other polymerases.  Similar to the 4-substituted 2,4-dioxobutanoic acids, a series of transcriptase inhibitors which we described previously, this inhibitor, which is a natural product, affected neither the initiation nor the elongation of influenza virus mRNA synthesis, but it specifically targeted the cap-dependent endonuclease of the transcriptase.  Addnl., the compd. was inhibitory to the replication of influenza A and B viruses in cell culture.  The selective antiviral properties of this compd. further demonstrate the utility of influenza virus endonuclease as a target of antiviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6jvhH_e_KbVg90H21EOLACvtfcHk0lg1We9jVRQCFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCltrY%253D&md5=b753cbf26527d43fe507bc6fbf895c34</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.5.1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.5.1189%26sid%3Dliteratum%253Aachs%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DDavies%26aufirst%3DM.%2BE.%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DLingham%26aufirst%3DR.%26aulast%3DMojena%26aufirst%3DM.%26aulast%3DRaghoobar%26aufirst%3DS.%2BL.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DTkacz%26aufirst%3DJ.%2BS.%26aulast%3DGoetz%26aufirst%3DM.%2BA.%26atitle%3DA%2520Novel%2520Antiviral%2520Agent%2520Which%2520Inhibits%2520the%2520Endonuclease%2520of%2520Influenza%2520Viruses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D1189%26epage%3D1193%26doi%3D10.1128%2FAAC.40.5.1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Natural Flutimide and Analogous Fully Substituted Pyrazine-2,6-diones, Endonuclease Inhibitors of Influenza Virus</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">5504</span>– <span class="NLM_lpage">5516</span>, <span class="refDoi"> DOI: 10.1021/jo015665d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo015665d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFSjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=5504-5516&author=S.+B.+Singhauthor=J.+E.+Tomassini&title=Synthesis+of+Natural+Flutimide+and+Analogous+Fully+Substituted+Pyrazine-2%2C6-diones%2C+Endonuclease+Inhibitors+of+Influenza+Virus&doi=10.1021%2Fjo015665d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Natural Flutimide and Analogous Fully Substituted Pyrazine-2,6-diones, Endonuclease Inhibitors of Influenza Virus</span></div><div class="casAuthors">Singh, Sheo B.; Tomassini, Joanne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5504-5516</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Flutimide, (Z)-5-(2-methylpropyl)-3-(2-methylpropylidene)-1-hydroxy-3H-pyrazine-2,6-dione, is a fungal metabolite isolated from a new species of Delitschia cofertaspora.  Flutimide has been shown to selectively inhibit cap-dependent endonuclease activity of influenza virus A.  The inhibition of this activity is a target for the potential development of a therapeutic agent to treat influenza infections.  A convergent total synthesis of flutimide starting from L-leucine has been described.  The synthetic methodol. has been extended to include the synthesis of specifically designed arom. analogs of flutimide, some of which exhibited greater than 7-fold improvement in activity.  The most potent compds. were those with p-fluorobenzylidene or p-methoxybenzylidene substitutions at C-5 of 3H-pyrazine-2,6-dione and showed IC50 values of 0.9 and 0.8 μM, resp.  The details of the rationale for the synthetic design, syntheses, and biol. activities of these analogs are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH8hVy0f6unLVg90H21EOLACvtfcHk0lg1We9jVRQCFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFSjs7s%253D&md5=23e9caf8b4f96317cc612a1d96f7b293</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo015665d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo015665d%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%2520of%2520Natural%2520Flutimide%2520and%2520Analogous%2520Fully%2520Substituted%2520Pyrazine-2%252C6-diones%252C%2520Endonuclease%2520Inhibitors%2520of%2520Influenza%2520Virus%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D5504%26epage%3D5516%26doi%3D10.1021%2Fjo015665d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaro, R. E.</span></span> <span> </span><span class="NLM_article-title">Computation-Guided Discovery of Influenza Endonuclease Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1021/ml4003474</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003474" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=61-64&author=E.+Chenauthor=R.+V.+Swiftauthor=N.+Aldersonauthor=V.+A.+Feherauthor=G.+S.+Fengauthor=R.+E.+Amaro&title=Computation-Guided+Discovery+of+Influenza+Endonuclease+Inhibitors&doi=10.1021%2Fml4003474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Computation-Guided Discovery of Influenza Endonuclease Inhibitors</span></div><div class="casAuthors">Chen, Eric; Swift, Robert V.; Alderson, Nazilla; Feher, Victoria A.; Feng, Gen-Sheng; Amaro, Rommie E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Influenza is a global human health threat, and there is an immediate need for new antiviral therapies to circumvent the limitations of vaccination and current small mol. therapies.  During viral transcription, influenza incorporates the 5'-end of the host cell's mRNA in a process that requires the influenza endonuclease.  On the basis of recently published endonuclease crystd. structures, a three-dimensional pharmacophore was developed and used to virtually screen 450,000 compds. for influenza endonuclease inhibitors.  Of 264 compds. tested in a FRET-based endonuclease-inhibition assay, 16 inhibitors (IC50 < 50 μM) that span 5 mol. classes novel to this endonuclease were found (6.1% hit rate).  To det. cytotoxicity and antiviral activity, subsequent cellular assays were performed.  Two compds. suppress viral replication with negligible cell toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwIzni3OsTLLVg90H21EOLACvtfcHk0lhROIespEIoPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrvL&md5=a51ca3b00cd4bd1c039c5acd9d7fcc6e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml4003474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003474%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DE.%26aulast%3DSwift%26aufirst%3DR.%2BV.%26aulast%3DAlderson%26aufirst%3DN.%26aulast%3DFeher%26aufirst%3DV.%2BA.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26aulast%3DAmaro%26aufirst%3DR.%2BE.%26atitle%3DComputation-Guided%2520Discovery%2520of%2520Influenza%2520Endonuclease%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D61%26epage%3D64%26doi%3D10.1021%2Fml4003474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevaert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallocchio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessì, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogolino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span> <span> </span><span class="NLM_article-title">Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00109</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00109" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=866-871&author=N.+Palaauthor=A.+Stevaertauthor=R.+Dallocchioauthor=A.+Dess%C3%ACauthor=D.+Rogolinoauthor=M.+Carcelliauthor=V.+Sannaauthor=M.+Sechiauthor=L.+Naesens&title=Virtual+Screening+and+Biological+Validation+of+Novel+Influenza+Virus+PA+Endonuclease+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors</span></div><div class="casAuthors">Pala, Nicolino; Stevaert, Annelies; Dallocchio, Roberto; Dessi, Alessandro; Rogolino, Dominga; Carcelli, Mauro; Sanna, Vanna; Sechi, Mario; Naesens, Lieve</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">866-871</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The influenza virus RNA-dependent RNA polymerase complex (RdRp), a heterotrimeric protein complex responsible for viral RNA transcription and replication, represents a primary target for antiviral drug development.  One particularly attractive approach is interference with the endonucleolytic "cap-snatching" reaction by the RdRp subunit PA, more precisely by inhibiting its metal-dependent catalytic activity which resides in the N-terminal part of PA (PA-Nter).  Almost all PA inhibitors (PAIs) thus far discovered bear pharmacophoric fragments with chelating motifs able to bind the bivalent metal ions in the catalytic core of PA-Nter.  More recently, the availability of crystallog. structures of PA-Nter has enabled rational design of original PAIs with improved binding properties and antiviral potency.  We here present a coupled pharmacophore/docking virtual screening approach that allowed us to identify PAIs with interesting inhibitory activity in a PA-Nter enzymic assay.  Moreover, antiviral activity in the low micromolar range was obsd. in cell-based influenza virus assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKH888RsSFzrVg90H21EOLACvtfcHk0lhROIespEIoPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bJ&md5=81f9b315013d32ad71fbc7f6c8ce2e62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00109%26sid%3Dliteratum%253Aachs%26aulast%3DPala%26aufirst%3DN.%26aulast%3DStevaert%26aufirst%3DA.%26aulast%3DDallocchio%26aufirst%3DR.%26aulast%3DDess%25C3%25AC%26aufirst%3DA.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DSanna%26aufirst%3DV.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNaesens%26aufirst%3DL.%26atitle%3DVirtual%2520Screening%2520and%2520Biological%2520Validation%2520of%2520Novel%2520Influenza%2520Virus%2520PA%2520Endonuclease%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D866%26epage%3D871%26doi%3D10.1021%2Facsmedchemlett.5b00109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagong, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxyquinolin-2(1H)-ones as Inhibitors of Influenza A Endonuclease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/ml4001112</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4001112" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=547-550&author=H.+Y.+Sagongauthor=A.+Parhiauthor=J.+D.+Baumanauthor=D.+Patelauthor=R.+S.+Vijayanauthor=K.+Dasauthor=E.+Arnoldauthor=E.+J.+LaVoie&title=3-Hydroxyquinolin-2%281H%29-ones+as+Inhibitors+of+Influenza+A+Endonuclease&doi=10.1021%2Fml4001112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease</span></div><div class="casAuthors">Sagong, Hye Yeon; Parhi, Ajit; Bauman, Joseph D.; Patel, Disha; Vijayan, R. S. K.; Das, Kalyan; Arnold, Eddy; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">547-550</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several 3-hydroxyquinolin-2(1H)-ones derivs. were synthesized and evaluated as inhibitors of 2009 pandemic H1N1 influenza A endonuclease.  All five of the monobrominated 3-hydroxyquinolin(1H)-2-ones derivs. were synthesized.  Suzuki-coupling of p-fluorophenylboronic acid with each of these brominated derivs. provided the resp. p-fluorophenyl 3-hydroxyquinolin(1H)-2-ones.  In addn. to 3-hydroxyquinolin-2(1H)-one, its 4-Me, 4-Ph, 4-methyl-7-(p-fluorophenyl), and 4-phenyl-7-(p-fluorophenyl) derivs. were also synthesized.  Comparative studies on their relative activity revealed that both 6- and 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one are among the more potent inhibitors of H1N1 influenza A endonuclease.  An X-ray crystal structure of 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one complexed to the influenza endonuclease revealed that this mol. chelates to two metal ions at the active site of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ-tEcijXjBLVg90H21EOLACvtfcHk0lihJiCiZjTOXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOku7c%253D&md5=ad7492ffd519d11c1cf7c13a68878e25</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml4001112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001112%26sid%3Dliteratum%253Aachs%26aulast%3DSagong%26aufirst%3DH.%2BY.%26aulast%3DParhi%26aufirst%3DA.%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DVijayan%26aufirst%3DR.%2BS.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3D3-Hydroxyquinolin-2%25281H%2529-ones%2520as%2520Inhibitors%2520of%2520Influenza%2520A%2520Endonuclease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D547%26epage%3D550%26doi%3D10.1021%2Fml4001112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Credille, C.
V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Identification of Influenza Endonuclease Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6444</span>– <span class="NLM_lpage">6454</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00628</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00628" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6444-6454&author=C.%0AV.+Credilleauthor=Y.+Chenauthor=S.+M.+Cohen&title=Fragment-Based+Identification+of+Influenza+Endonuclease+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Identification of Influenza Endonuclease Inhibitors</span></div><div class="casAuthors">Credille, Cy V.; Chen, Yao; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6444-6454</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The influenza virus is responsible for millions of cases of severe illness annually.  Yearly variance in the effectiveness of vaccination, coupled with emerging drug resistance, necessitates the development of new drugs to treat influenza infections.  One attractive target is the RNA-dependent RNA polymerase PA subunit.  Herein we report the development of inhibitors of influenza PA endonuclease derived from lead compds. identified from a metal-binding pharmacophore (MBP) library screen.  Pyromeconic acid and derivs. thereof were found to be potent inhibitors of endonuclease.  Guided by modeling and previously reported structural data, several sublibraries of mols. were elaborated from the MBP hits.  Structure-activity relationships were established, and more potent mols. were designed and synthesized using fragment growth and fragment merging strategies.  This approach ultimately resulted in the development of a lead compd. with an IC50 value of 14 nM, which displayed an EC50 value of 2.1 μM against H1N1 influenza virus in MDCK cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO_XnFpireJrVg90H21EOLACvtfcHk0lihJiCiZjTOXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mtL8%253D&md5=a872083d373a846467c7f2eb5439bed4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00628%26sid%3Dliteratum%253Aachs%26aulast%3DCredille%26aufirst%3DC.%2BV.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DFragment-Based%2520Identification%2520of%2520Influenza%2520Endonuclease%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6444%26epage%3D6454%26doi%3D10.1021%2Facs.jmedchem.6b00628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikamiyama-Iwata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi-Kageyama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikamiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel 5-Hydroxy-4-Pyridone-3-Carboxy Acids as Potent Inhibitors of Influenza Cap-Dependent Endonuclease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4739</span>– <span class="NLM_lpage">4742</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1016%2Fj.bmcl.2016.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=27568084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVanur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4739-4742&author=M.+Miyagawaauthor=T.+Akiyamaauthor=M.+Mikamiyama-Iwataauthor=K.+Hattoriauthor=N.+Kuriharaauthor=Y.+Taodaauthor=C.+Takahashi-Kageyamaauthor=N.+Kuroseauthor=H.+Mikamiyamaauthor=N.+Suzukiauthor=K.+Takayaauthor=K.+Tomitaauthor=K.+Matsuoauthor=K.+Morimotoauthor=R.+Yoshidaauthor=T.+Shishidoauthor=T.+Yoshinagaauthor=A.+Satoauthor=M.+Kawai&title=Discovery+of+Novel+5-Hydroxy-4-Pyridone-3-Carboxy+Acids+as+Potent+Inhibitors+of+Influenza+Cap-Dependent+Endonuclease&doi=10.1016%2Fj.bmcl.2016.08.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease</span></div><div class="casAuthors">Miyagawa, Masayoshi; Akiyama, Toshiyuki; Mikamiyama-Iwata, Minako; Hattori, Kazunari; Kurihara, Naoko; Taoda, Yoshiyuki; Takahashi-Kageyama, Chika; Kurose, Noriyuki; Mikamiyama, Hidenori; Suzuki, Naoyuki; Takaya, Kenji; Tomita, Kenji; Matsuo, Kenji; Morimoto, Kenji; Yoshida, Ryu; Shishido, Takao; Yoshinaga, Tomokazu; Sato, Akihiko; Kawai, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4739-4742</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of a novel series of influenza Cap-dependent EndoNuclease (CEN) inhibitors based on the 4-pyridone-carboxylic acid (PYXA) scaffold, which were found from our chelate library.  Our SAR research revealed the lipophilic domain to be the key to CEN inhibition.  In particular, the position between the chelate and the lipophilic domain in the derivs. was essential for enhancing the potency.  Our study, based on virtual modeling, led to the identification of 2y as a potent CEN inhibitor with an IC50 of 5.12 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPeep0KpriR7Vg90H21EOLACvtfcHk0lihJiCiZjTOXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVanur%252FK&md5=8a235ed5f4b2419920bd7eb1ff42495f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DMiyagawa%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DKurihara%26aufirst%3DN.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DTakahashi-Kageyama%26aufirst%3DC.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DMikamiyama%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DTakaya%26aufirst%3DK.%26aulast%3DTomita%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DK.%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DShishido%26aufirst%3DT.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DKawai%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Novel%25205-Hydroxy-4-Pyridone-3-Carboxy%2520Acids%2520as%2520Potent%2520Inhibitors%2520of%2520Influenza%2520Cap-Dependent%2520Endonuclease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4739%26epage%3D4742%26doi%3D10.1016%2Fj.bmcl.2016.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span> <span> </span><span class="NLM_article-title">A Novel Small-Molecule Inhibitor of Influenza A Virus Acts by Suppressing PA Endonuclease Activity of The Viral Polymerase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22880</span>, <span class="refDoi"> DOI: 10.1038/srep22880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fsrep22880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=26956222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVaiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22880&author=S.+Yuanauthor=H.+Chuauthor=K.+Singhauthor=H.+Zhaoauthor=K.+Zhangauthor=R.+Y.+Kaoauthor=B.+Chowauthor=J.+Zhouauthor=B.+J.+Zheng&title=A+Novel+Small-Molecule+Inhibitor+of+Influenza+A+Virus+Acts+by+Suppressing+PA+Endonuclease+Activity+of+The+Viral+Polymerase&doi=10.1038%2Fsrep22880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase</span></div><div class="casAuthors">Yuan, Shuofeng; Chu, Hin; Singh, Kailash; Zhao, Hanjun; Zhang, Ke; Kao, Richard Y. T.; Chow, Billy K. C.; Zhou, Jie; Zheng, Bo-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22880</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The RNA-dependent RNA polymerase of influenza A virus comprises conserved and independently-folded subdomains with defined functionalities.  The N-terminal domain of the PA subunit (PAN) harbors the endonuclease function so that it can serve as a desired target for drug discovery.  To identify a class of anti-influenza inhibitors that impedes PAN endonuclease activity, a screening approach that integrated the fluorescence resonance energy transfer based endonuclease inhibitory assay with the DNA gel-based endonuclease inhibitory assay was conducted, followed by the evaluation of antiviral efficacies and potential cytotoxicity of the primary hits in vitro and in vivo.  A small-mol. compd. ANA-0 was identified as a potent inhibitor against the replication of multiple subtypes of influenza A virus, including H1N1, H3N2, H5N1, H7N7, H7N9 and H9N2, in cell cultures.  Combinational treatment of zanamivir and ANA-0 exerted synergistic anti-influenza effect in vitro.  Intranasal administration of ANA-0 protected mice from lethal challenge and reduced lung viral loads in H1N1 virus infected BALB/c mice.  In summary, ANA-0 shows potential to be developed to novel anti-influenza agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT2A6zhAoZlrVg90H21EOLACvtfcHk0lgbc3tljOV8-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVaiurg%253D&md5=8f90189ba7de66c8c33935daf7fb71cf</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsrep22880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22880%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DKao%26aufirst%3DR.%2BY.%26aulast%3DChow%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26atitle%3DA%2520Novel%2520Small-Molecule%2520Inhibitor%2520of%2520Influenza%2520A%2520Virus%2520Acts%2520by%2520Suppressing%2520PA%2520Endonuclease%2520Activity%2520of%2520The%2520Viral%2520Polymerase%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22880%26doi%3D10.1038%2Fsrep22880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujishita, T.</span>; <span class="NLM_string-name">Mikamiyama, M.</span>; <span class="NLM_string-name">Kawai, M.</span>, <span class="NLM_string-name">Akiyama, T.</span></span> <span> </span><span class="NLM_article-title">Substituted 3-Hydroxy-4-Pyridone Derivative</span>. <span class="NLM_patent">WO2010110231A</span>, Sep 30, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Fujishita&author=M.+Mikamiyama&author=M.+Kawai&author=T.+Akiyama&title=Substituted+3-Hydroxy-4-Pyridone+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFujishita%26aufirst%3DT.%26atitle%3DSubstituted%25203-Hydroxy-4-Pyridone%2520Derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>Calculated
LogP values were obtained using the GALAS calculation algorithm; Advanced
Chemistry Development (ACD/Labs) Software, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Calculated%0ALogP+values+were+obtained+using+the+GALAS+calculation+algorithm%3B+Advanced%0AChemistry+Development+%28ACD%2FLabs%29+Software%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byrn, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bral, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledeboer, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijnbrand, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifsonc, S. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit Antimicrob</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1582</span>, <span class="refDoi"> DOI: 10.1128/AAC.04623-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1128%2FAAC.04623-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=25547360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFaisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1569-1582&author=A.+R.+Byrnauthor=M.+S.+Jonesauthor=B.+H.+Bennettauthor=C.+Bralauthor=P.+M.+Clarkauthor=D.+M.+Jacobsauthor=D.+A.+Kwongauthor=W.+M.+Ledeboerauthor=R.+J.+Leemanauthor=F.+C.+McNeilauthor=A.+M.+Murckoauthor=A.+Nezamiauthor=E.+Perolaauthor=R.+Rijnbrandauthor=K.+Saxenaauthor=W.+A.+Tsaiauthor=Y.+Zhouauthor=S.+P.+Charifsonc&title=Preclinical+Activity+of+VX-787%2C+a+First-in-Class%2C+Orally+Bioavailable+Inhibitor+of+the+Influenza+Virus+Polymerase+PB2+Subunit+Antimicrob&doi=10.1128%2FAAC.04623-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit</span></div><div class="casAuthors">Byrn, Randal A.; Jones, Steven M.; Bennett, Hamilton B.; Bral, Chris; Clark, Michael P.; Jacobs, Marc D.; Kwong, Ann D.; Ledeboer, Mark W.; Leeman, Joshua R.; McNeil, Colleen F.; Murcko, Mark A.; Nezami, Azin; Perola, Emanuele; Rijnbrand, Rene; Saxena, Kumkum; Tsai, Alice W.; Zhou, Yi; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1569-1582/1-1569-1582/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">VX-787 is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex.  Viral genetics and X-ray crystallog. studies provide support for the idea that VX-787 occupies the 7-Me GTP (m7GTP) cap-binding site of PB2.  VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissocn. const.) of 24 nM as detd. by isothermal titrn. calorimetry (ITC).  The cell-based EC50 (the concn. of compd. that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay, with a similar EC50 in a viral RNA replication assay.  VX-787 is active against a diverse panel of influenza A virus strains, including H1N1pdm09 and H5N1 strains, as well as strains with reduced susceptibility to neuraminidase inhibitors (NAIs).  VX-787 was highly efficacious in both prophylaxis and treatment models of mouse influenza and was superior to the neuraminidase inhibitor, oseltamivir, including in delayed-start-to-treat expts., with 100% survival at up to 96 h postinfection and partial survival in groups where the initiation of therapy was delayed up to 120 h postinfection.  At different doses, VX-787 showed a 1-log to >5-log redn. in viral load (relative to vehicle controls) in mouse lungs.  Overall, these favorable findings validate the PB2 subunit of the viral polymerase as a drug target for influenza therapy and support the continued development of VX-787 as a novel antiviral agent for the treatment of influenza infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAxHkSMjovJrVg90H21EOLACvtfcHk0ljzHwCmKXLAaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFaisb8%253D&md5=97b242b9882563529da51aeaf71fd59a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.04623-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04623-14%26sid%3Dliteratum%253Aachs%26aulast%3DByrn%26aufirst%3DA.%2BR.%26aulast%3DJones%26aufirst%3DM.%2BS.%26aulast%3DBennett%26aufirst%3DB.%2BH.%26aulast%3DBral%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DP.%2BM.%26aulast%3DJacobs%26aufirst%3DD.%2BM.%26aulast%3DKwong%26aufirst%3DD.%2BA.%26aulast%3DLedeboer%26aufirst%3DW.%2BM.%26aulast%3DLeeman%26aufirst%3DR.%2BJ.%26aulast%3DMcNeil%26aufirst%3DF.%2BC.%26aulast%3DMurcko%26aufirst%3DA.%2BM.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DRijnbrand%26aufirst%3DR.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DTsai%26aufirst%3DW.%2BA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCharifsonc%26aufirst%3DS.%2BP.%26atitle%3DPreclinical%2520Activity%2520of%2520VX-787%252C%2520a%2520First-in-Class%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520the%2520Influenza%2520Virus%2520Polymerase%2520PB2%2520Subunit%2520Antimicrob%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D1569%26epage%3D1582%26doi%3D10.1128%2FAAC.04623-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yong-Jin Wu, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Geminal Diheteroatomic Motifs: Some Applications of Acetals, Ketals, and Their Sulfur and Nitrogen Homologues in Medicinal Chemistry and Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9786-9874. <a href="https://doi.org/10.1021/acs.jmedchem.1c00790" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00790%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeminal%252BDiheteroatomic%252BMotifs%25253A%252BSome%252BApplications%252Bof%252BAcetals%25252C%252BKetals%25252C%252Band%252BTheir%252BSulfur%252Band%252BNitrogen%252BHomologues%252Bin%252BMedicinal%252BChemistry%252Band%252BDrug%252BDesign%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30042021%26date%3D02072021%26volume%3D64%26issue%3D14%26spage%3D9786%26epage%3D9874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Meiyan  Fan</span>, <span class="hlFld-ContribAuthor ">Zhiyun  Peng</span>, <span class="hlFld-ContribAuthor ">Guangcheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113546. <a href="https://doi.org/10.1016/j.ejmech.2021.113546" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113546%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bhydroxypyranone%252Band%252Bhydroxypyridinone%252Bas%252Bprivileged%252Bscaffolds%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DHe%26aufirst%3DMin%26date%3D2021%26volume%3D221%26spage%3D113546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiyuki  Taoda</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Miyagawa</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Akiyama</span>, <span class="hlFld-ContribAuthor ">Kenji  Tomita</span>, <span class="hlFld-ContribAuthor ">Yasushi  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Ryu  Yoshida</span>, <span class="hlFld-ContribAuthor ">Takeshi  Noshi</span>, <span class="hlFld-ContribAuthor ">Takao  Shishido</span>, <span class="hlFld-ContribAuthor ">Makoto  Kawai</span>. </span><span class="cited-content_cbyCitation_article-title">Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (22)
                                     , 127547. <a href="https://doi.org/10.1016/j.bmcl.2020.127547" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127547%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDihydrodibenzothiepine%25253A%252BPromising%252Bhydrophobic%252Bpharmacophore%252Bin%252Bthe%252Binfluenza%252Bcap-dependent%252Bendonuclease%252Binhibitor%26aulast%3DTaoda%26aufirst%3DYoshiyuki%26date%3D2020%26volume%3D30%26issue%3D22%26spage%3D127547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitrii L.  Obydennov</span>, <span class="hlFld-ContribAuthor ">Elena V.  Chernyshova</span>, <span class="hlFld-ContribAuthor ">Vyacheslav Ya.  Sosnovskikh</span>. </span><span class="cited-content_cbyCitation_article-title">Acyclic Enaminodiones in the Synthesis of Heterocyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2020,</strong> <em>56 </em>
                                    (10)
                                     , 1241-1253. <a href="https://doi.org/10.1007/s10593-020-02807-0" title="DOI URL">https://doi.org/10.1007/s10593-020-02807-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-020-02807-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-020-02807-0%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAcyclic%252BEnaminodiones%252Bin%252Bthe%252BSynthesis%252Bof%252BHeterocyclic%252BCompounds%26aulast%3DObydennov%26aufirst%3DDmitrii%2BL.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D10%26spage%3D1241%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Lei</span>, <span class="hlFld-ContribAuthor ">Jia  Xu</span>, <span class="hlFld-ContribAuthor ">Dian-Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Shao</span>, <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhi-Gang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A concise and unexpected one-pot methodology for the synthesis of pyrazinone-fused pyridones. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (18)
                                     , 2657-2663. <a href="https://doi.org/10.1039/D0QO00590H" title="DOI URL">https://doi.org/10.1039/D0QO00590H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00590H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00590H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bconcise%252Band%252Bunexpected%252Bone-pot%252Bmethodology%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrazinone-fused%252Bpyridones%26aulast%3DLei%26aufirst%3DJie%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D18%26spage%3D2657%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yixian  Liao</span>, <span class="hlFld-ContribAuthor ">Yilu  Ye</span>, <span class="hlFld-ContribAuthor ">Sumei  Li</span>, <span class="hlFld-ContribAuthor ">Yilian  Zhuang</span>, <span class="hlFld-ContribAuthor ">Liye  Chen</span>, <span class="hlFld-ContribAuthor ">Jianxin  Chen</span>, <span class="hlFld-ContribAuthor ">Zining  Cui</span>, <span class="hlFld-ContribAuthor ">Lijian  Huo</span>, <span class="hlFld-ContribAuthor ">Shuwen  Liu</span>, <span class="hlFld-ContribAuthor ">Gaopeng  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112048. <a href="https://doi.org/10.1016/j.ejmech.2020.112048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BSARs%252Bof%252Bdopamine%252Bderivatives%252Bas%252Bpotential%252Binhibitors%252Bof%252Binfluenza%252Bvirus%252BPAN%252Bendonuclease%26aulast%3DLiao%26aufirst%3DYixian%26date%3D2020%26volume%3D189%26spage%3D112048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported potent CEN inhibitors. Results of compound <b>1a</b> tested in our conditions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Screening hit compound <b>2a</b>, and  chemical structure of the CAB scaffold and each substituent positions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2b</b>–<b>q</b> and <b>2t</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) cinnamoyl chloride, LHMDS, THF, −78 °C; (ii) RuCl<sub>3</sub>, NaIO<sub>4</sub>, conc. H<sub>2</sub>SO<sub>4</sub>, MeCN, rt; (iii) conc. H<sub>2</sub>SO<sub>4</sub>, amidosulfuric acid, sodium sulfite, MeCN, rt; (iv) (1) WSC-HCl, HOBt, DMF, rt; (2) 2-methoxyethanamine, rt; (v) amino-alcohol, xylene, 120 °C; (vi) PPh<sub>3</sub>, DEAD, THF, rt; (vii) <i>N</i>-Boc hydrazine, AcOH, toluene, reflux; (viii) (1) TFA, DCM, rt; (2) formaldehyde, EtOH, microwave, 100 °C; (ix) R-Br, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt; (x) TFA, rt; (xi) 2N NaOH aq., EtOH, rt; (xii) (1) ethyl chloroformate, TEA, DMF, rt; (2) amine, DMAP, rt; (xiii) MeMgBr, THF, −50 °C; (xiv) m-CPBA, DCM, rt; (xv) EtOH, reflux; (xvi) MeI, NaH, DMF, rt; (xvii) (1) ethyl chloroformate, TEA, DMF, rt; (2) NaN<sub>3</sub>, rt; (3) MeOH, 50 °C; (xviii) 2N NaOH aq., EtOH, 60 °C; (xix) microwave, Ph<sub>2</sub>O, 245 °C; (xx) NBS, DCM, reflux; (xxi) CuCl, DMSO, 120 °C; (xxii) hexamethyldistannane, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, reflux; BH means benzhydryl.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2r</b>, <b>2s</b>, and <b>2u</b>–<b>w</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) amine, toluene, reflux; (ii) (1) 4 N HCl EtOAc, rt; (2) NaHCO<sub>3</sub> aq., rt; (iii) 2N NaOH aq., THF–MeOH, rt; (iv) microwave, Ph<sub>2</sub>O, 240 °C; (v) R-Br, Cs<sub>2</sub>CO<sub>3</sub>, rt; (vi) TFA, rt; (vii) 28% NH<sub>3</sub> aq., rt; (viii) (1) WSC-HCl, HOBt, DMF, rt, (2) amine, rt; (ix) <i>O</i>-(2,4-dinitrophenyl)hydroxylamine, K<sub>2</sub>CO<sub>3</sub>, DMF, rt; (x) (1) paraformaldehyde, AcOH, toluene, 100 °C, then concentration, (2) bromodiphenylmethane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, (xi) TFA, rt.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Conceivable chelate modes of the CEN active site with CAB-C analogue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking simulation of <b>2i</b> (green) binding to the active site of CEN. Two metals and lipophilic sites are shown in light blue and yellow, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/medium/jm9b00861_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vivo activity of <b>2v</b> in mouse influenza B model when administered immediately after infection: survival curve of female BALB/C mice (5 mice/group) inoculated with influenza viruses B/Maryland/1/59 (100 TCID<sub>50</sub>/mouse) by intranasal instillation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00861/20190905/images/large/jm9b00861_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00861&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, J K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, F. G</span></span> <span> </span><span class="NLM_article-title">Antiviral Combinations for Severe Influenza</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1259</span>– <span class="NLM_lpage">1270</span>, <span class="refDoi"> DOI: 10.1016/S1473-3099(14)70821-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1016%2FS1473-3099%2814%2970821-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=25213733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFerur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1259-1270&author=J.+Dunningauthor=J+K.+Baillieauthor=B.+Caoauthor=F.+G+Hayden&title=Antiviral+Combinations+for+Severe+Influenza&doi=10.1016%2FS1473-3099%2814%2970821-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral combinations for severe influenza</span></div><div class="casAuthors">Dunning, Jake; Baillie, J. Kenneth; Cao, Bin; Hayden, Frederick G.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1259-1270</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Observational data suggest that the treatment of influenza infection with neuraminidase inhibitors decreases progression to more severe illness, esp. when treatment is started soon after symptom onset.  However, even early treatment might fail to prevent complications in some patients, particularly those infected with novel viruses such as the 2009 pandemic influenza A H1N1, avian influenza A H5N1 virus subtype, or the avian influenza A H7N9 virus subtype.  Furthermore, treatment with one antiviral drug might promote the development of antiviral resistance, esp. in immunocompromised hosts and critically ill patients.  An obvious strategy to optimize antiviral therapy is to combine drugs with different modes of action.  Because host immune responses to infection might also contribute to illness pathogenesis, improved outcomes might be gained from the combination of antiviral therapy with drugs that modulate the immune response in an infected individual.  We review available data from preclin. and clin. studies of combination antiviral therapy and of combined antiviral-immunomodulator therapy for influenza.  Early-stage data draw attention to several promising antiviral combinations with therapeutic potential in severe infections, but there remains a need to substantiate clin. benefit.  Combination therapies with favorable exptl. data need to be tested in carefully designed aclin. trials to assess their efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKnDnW6zLM6bVg90H21EOLACvtfcHk0lg77o5B-_qLIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFerur3O&md5=cf91cd12316255bf46c75a652abbcf02</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2814%2970821-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252814%252970821-7%26sid%3Dliteratum%253Aachs%26aulast%3DDunning%26aufirst%3DJ.%26aulast%3DBaillie%26aufirst%3DJ%2BK.%26aulast%3DCao%26aufirst%3DB.%26aulast%3DHayden%26aufirst%3DF.%2BG%26atitle%3DAntiviral%2520Combinations%2520for%2520Severe%2520Influenza%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D1259%26epage%3D1270%26doi%3D10.1016%2FS1473-3099%2814%2970821-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mills, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipsitch, M.</span></span> <span> </span><span class="NLM_article-title">Transmissibility of 1918 Pandemic Influenza</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>432</i></span>,  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1038/nature03063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fnature03063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=15602562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=904-906&author=C.+E.+Millsauthor=J.+M.+Robinsauthor=M.+Lipsitch&title=Transmissibility+of+1918+Pandemic+Influenza&doi=10.1038%2Fnature03063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Transmissibility of 1918 pandemic influenza</span></div><div class="casAuthors">Mills, Christina E.; Robins, James M.; Lipsitch, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7019</span>),
    <span class="NLM_cas:pages">904-906</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The 1918 influenza pandemic killed 20-40 million people worldwide, and is seen as a worst-case scenario for pandemic planning.  Like other pandemic influenza strains, the 1918 A/H1N1 strain spread extremely rapidly.  A measure of transmissibility and of the stringency of control measures required to stop an epidemic is the reproductive no., which is the no. of secondary cases produced by each primary case.  Here we obtained an est. of the reproductive no. for 1918 influenza by fitting a deterministic SEIR (susceptible-exposed-infectious-recovered) model to pneumonia and influenza death epidemic curves from 45 US cities: the median value is less than three.  The estd. proportion of the population with A/H1N1 immunity before Sept. 1918 implies a median basic reproductive no. of less than four.  These results strongly suggest that the reproductive no. for 1918 pandemic influenza is not large relative to many other infectious diseases.  In theory, a similar novel influenza subtype could be controlled.  But because influenza is frequently transmitted before a specific diagnosis is possible and there is a dearth of global antiviral and vaccine stores, aggressive transmission reducing measures will probably be required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmKijrUKQb-rVg90H21EOLACvtfcHk0ljn80m0uqmaAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOht7rK&md5=3944ac7552c031753731d18ffa453882</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature03063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03063%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DC.%2BE.%26aulast%3DRobins%26aufirst%3DJ.%2BM.%26aulast%3DLipsitch%26aufirst%3DM.%26atitle%3DTransmissibility%2520of%25201918%2520Pandemic%2520Influenza%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D904%26epage%3D906%26doi%3D10.1038%2Fnature03063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span> </span><span class="NLM_article-title">Adjusted Vaccine Effectiveness Estimates
for Influenza Seasons from
2005 to 2015</span>; <a href="http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm" class="extLink">http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm</a> (accessed Sep 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Adjusted+Vaccine+Effectiveness+Estimates%0Afor+Influenza+Seasons+from%0A2005+to+2015%3B+http%3A%2F%2Fwww.cdc.gov%2Fflu%2Fprofessionals%2Fvaccination%2Feffectiveness-studies.htm+%28accessed+Sep+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAdjusted%2520Vaccine%2520Effectiveness%2520Estimates%250Afor%2520Influenza%2520Seasons%2520from%250A2005%2520to%25202015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moscona, A.</span></span> <span> </span><span class="NLM_article-title">Neuraminidase Inhibitors for Influenza</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1373</span>, <span class="refDoi"> DOI: 10.1056/NEJMra050740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1056%2FNEJMra050740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=16192481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGmtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=1363-1373&author=A.+Moscona&title=Neuraminidase+Inhibitors+for+Influenza&doi=10.1056%2FNEJMra050740"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neuraminidase inhibitors for influenza</span></div><div class="casAuthors">Moscona, Anne</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1363-1373</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The article discusses neuraminidase inhibitors for influenza virus, in particular zanamivir and oseltamivir.  It covers the development, pharmacokinetics, clin. trials, safety, resistance, and strategies for treatment of various neuraminidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWTdUZ73EM37Vg90H21EOLACvtfcHk0ljn80m0uqmaAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGmtL3L&md5=a8252ccbcc0a796e9206cfb4b3a4d29a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra050740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra050740%26sid%3Dliteratum%253Aachs%26aulast%3DMoscona%26aufirst%3DA.%26atitle%3DNeuraminidase%2520Inhibitors%2520for%2520Influenza%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D1363%26epage%3D1373%26doi%3D10.1056%2FNEJMra050740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiver, G.</span></span> <span> </span><span class="NLM_article-title">The Treatment of Influenza with Antiviral Drugs</span>. <i>Can. Med. Assoc. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=12515786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FgvFCmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2003&pages=49-57&author=G.+Stiver&title=The+Treatment+of+Influenza+with+Antiviral+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The treatment of influenza with antiviral drugs</span></div><div class="casAuthors">Stiver Grant</div><div class="citationInfo"><span class="NLM_cas:title">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>
        ISSN:<span class="NLM_cas:issn">0820-3946</span>.
    </div><div class="casAbstract">Influenza vaccination with current inactivated vaccines homologous to the prevalent wild-type virus can reduce influenza illness in 75%-80% of healthy adults.  Vaccine is recommended for all individuals with chronic underlying diseases and for those aged 65 years or older.  Although influenza vaccination is still advocated for patients with blunted immunity, protection rates are not as high, running at 40% for frail institutionalized elderly people.  The influenza antiviral agents amantadine or rimantadine, zanamivir and oseltamivir can modify the severity of illness and reduce the duration of illness by about 1.5-2.5 days.  Amantadine inhibits only influenza A.  Resistant virus may emerge in up to 33% of amantadine-treated patients in the first 5 days of treatment and be transmitted to susceptible close contacts.  Side effects are usually mild in short courses of treatment.  The neuraminidase inhibitor drugs zanamivir and oseltamivir act on both influenza A and B.  Treatment is most effective when given within 30-36 hours after the onset of illness, and the earlier the better.  Influenza should be treated with antiviral drugs in unvaccinated and vaccinated high-risk patients, as well as immunosuppressed patients with influenza-like illness, in periods of confirmed influenza prevalence.  These drugs may be of great value in the event of a major viral antigenic shift that causes pandemic influenza, if an adequate supply can be sustained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8Urfbou99qTEwO064Z95rfW6udTcc2eYb5q261ZycfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FgvFCmtQ%253D%253D&md5=8343e074c01f0ffdcfeed864852cff50</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStiver%26aufirst%3DG.%26atitle%3DThe%2520Treatment%2520of%2520Influenza%2520with%2520Antiviral%2520Drugs%26jtitle%3DCan.%2520Med.%2520Assoc.%2520J.%26date%3D2003%26volume%3D168%26spage%3D49%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Administration,
U. S. Food and Drug Tamiflu Pediatric Adverse
Events: Questions and Answers</span>; <a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107840.htm" class="extLink">http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107840.htm</a> (accessed Sep 18, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Administration%2C%0AU.+S.+Food+and+Drug+Tamiflu+Pediatric+Adverse%0AEvents%3A+Questions+and+Answers%3B+http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDrugSafety%2FPostmarketDrugSafetyInformationforPatientsandProviders%2Fucm107840.htm+%28accessed+Sep+18%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmolke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyva-Grado, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thangavel, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margine, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krammer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solorzano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sastre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, N. M.</span></span> <span> </span><span class="NLM_article-title">Influenza A(H7N9) Virus Gains Neuraminidase Inhibitor Resistance Without Loss of in Vivo Virulence or Transmissibility</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2854</span>, <span class="refDoi"> DOI: 10.1038/ncomms3854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fncomms3854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=24326875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A280%3ADC%252BC2c3lsVyitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=2854&author=R.+Haiauthor=M.+Schmolkeauthor=V.+H.+Leyva-Gradoauthor=R.+R.+Thangavelauthor=I.+Margineauthor=E.+L.+Jaffeauthor=F.+Krammerauthor=A.+Solorzanoauthor=A.+Garcia-Sastreauthor=P.+Paleseauthor=N.+M.+Bouvier&title=Influenza+A%28H7N9%29+Virus+Gains+Neuraminidase+Inhibitor+Resistance+Without+Loss+of+in+Vivo+Virulence+or+Transmissibility&doi=10.1038%2Fncomms3854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility</span></div><div class="casAuthors">Hai Rong; Schmolke Mirco; Leyva-Grado Victor H; Thangavel Rajagowthamee R; Margine Irina; Jaffe Eric L; Krammer Florian; Solorzano Alicia; Garcia-Sastre Adolfo; Palese Peter; Bouvier Nicole M</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2854</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Without baseline human immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for controlling viral replication in severe infections.  An amino acid change in the viral neuraminidase associated with drug resistance, NA-R292K (N2 numbering), has been found in some H7N9 clinical isolates.  Here we assess the impact of the NA-R292K substitution on antiviral sensitivity and viral replication, pathogenicity and transmissibility of H7N9 viruses.  Our data indicate that an H7N9 isolate encoding the NA-R292K substitution is highly resistant to oseltamivir and peramivir and partially resistant to zanamivir.  Furthermore, H7N9 reassortants with and without the resistance mutation demonstrate comparable viral replication in primary human respiratory cells, virulence in mice and transmissibility in guinea pigs.  Thus, in stark contrast to oseltamivir-resistant seasonal influenza A(H3N2) viruses, H7N9 virus replication and pathogenicity in these models are not substantially altered by the acquisition of high-level oseltamivir resistance due to the NA-R292K mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQAaLrTIVfN4IHWj6b1v8uTfW6udTcc2eYh7qpXTvUIlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3lsVyitA%253D%253D&md5=09537186462d536d4cc65fa967b00f40</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncomms3854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms3854%26sid%3Dliteratum%253Aachs%26aulast%3DHai%26aufirst%3DR.%26aulast%3DSchmolke%26aufirst%3DM.%26aulast%3DLeyva-Grado%26aufirst%3DV.%2BH.%26aulast%3DThangavel%26aufirst%3DR.%2BR.%26aulast%3DMargine%26aufirst%3DI.%26aulast%3DJaffe%26aufirst%3DE.%2BL.%26aulast%3DKrammer%26aufirst%3DF.%26aulast%3DSolorzano%26aufirst%3DA.%26aulast%3DGarcia-Sastre%26aufirst%3DA.%26aulast%3DPalese%26aufirst%3DP.%26aulast%3DBouvier%26aufirst%3DN.%2BM.%26atitle%3DInfluenza%2520A%2528H7N9%2529%2520Virus%2520Gains%2520Neuraminidase%2520Inhibitor%2520Resistance%2520Without%2520Loss%2520of%2520in%2520Vivo%2520Virulence%2520or%2520Transmissibility%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D2854%26doi%3D10.1038%2Fncomms3854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorlund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thabane, L.</span></span> <span> </span><span class="NLM_article-title">Systematic Review of Influenza Resistance to the Neuraminidase Inhibitors</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">134</span>, <span class="refDoi"> DOI: 10.1186/1471-2334-11-134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1186%2F1471-2334-11-134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=21592407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1Knu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=134&author=K.+Thorlundauthor=T.+Awadauthor=G.+Boivinauthor=L.+Thabane&title=Systematic+Review+of+Influenza+Resistance+to+the+Neuraminidase+Inhibitors&doi=10.1186%2F1471-2334-11-134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic review of influenza resistance to the neuraminidase inhibitors</span></div><div class="casAuthors">Thorlund, Kristian; Awad, Tahany; Boivin, Guy; Thabane, Lehana</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Background: Antivirals play a crit. role in the prevention and the management of influenza.  One class of antivirals, neuraminidase inhibitors (NAIs), is effective against all human influenza viruses.  Currently there are two NAI drugs which are licensed worldwide: oseltamivir (Tamiflu) and zanamivir (Relenza); and two drugs which have received recent approval in Japan: peramivir and laninamivir.  Until recently, the prevalence of antiviral resistance has been relatively low.  However, almost all seasonal H1N1 strains that circulated in 2008-09 were resistant to oseltamivir whereas about 1% of tested 2009 pandemic H1N1 viruses were found to be resistant to oseltamivir.  To date, no studies have demonstrated widespread resistance to zanamivir.  It seems likely that the literature on antiviral resistance assocd. with oseltamivir as well as zanamivir is now sufficiently comprehensive to warrant a systematic review.  The primary objectives were to systematically review the literature to det. the incidence of resistance to oseltamivir, zanamivir, and peramivir in different population groups as well as assess the clin. consequences of antiviral resistance.  Methods: We searched MEDLINE and EMBASE without language restrictions in Sept. 2010 to identify studies reporting incidence of resistance to oseltamivir, zanamivir, and peramivir.  We used forest plots and meta-anal. of incidence of antiviral resistance assocd. with the three NAIs.  Subgroup analyses were done across a no. of population groups.  Meta-anal. was also performed to evaluate assocns. between antiviral resistance and clin. complications and symptoms.  Results: We identified 19 studies reporting incidence of antiviral resistance.  Meta-anal. of 15 studies yielded a pooled incidence rate for oseltamivir resistance of 2.6% (95%CI 0.7% to 5.5%).  The incidence rate for all five zanamivir resistance studies was 0%.  Only one study measured incidence of antiviral resistance among subjects given peramivir and was reported to be 0%.  Subgroup analyses detected higher incidence rates among influenza A patients, esp. for H1N1 subtype influenza.  Considerable heterogeneity between studies precluded definite inferences about subgroup results for immunocompromised patients, in-patients, and children.  A meta-anal. of 4 studies reporting assocn. between oseltamivir-resistance and pneumonia yielded a statistically significant risk ratio of 4.2 (95% CI 1.3 to 13.1, p = 0.02).  Oseltamivir resistance was not statistically significantly assocd. with other clin. complications and symptoms.  Conclusion: Our results demonstrate that a substantial no. of patients may become oseltamivir resistant as a result of oseltamivir use, and that oseltamivir resistance may be significantly assocd. with pneumonia.  In contrast, zanamivir resistance has been rarely reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRRg_pLOlP3rVg90H21EOLACvtfcHk0lgHkVvwjbUt6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1Knu78%253D&md5=19171a1f09a59032ff68426138cfa851</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2F1471-2334-11-134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2334-11-134%26sid%3Dliteratum%253Aachs%26aulast%3DThorlund%26aufirst%3DK.%26aulast%3DAwad%26aufirst%3DT.%26aulast%3DBoivin%26aufirst%3DG.%26aulast%3DThabane%26aufirst%3DL.%26atitle%3DSystematic%2520Review%2520of%2520Influenza%2520Resistance%2520to%2520the%2520Neuraminidase%2520Inhibitors%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2011%26volume%3D11%26spage%3D134%26doi%3D10.1186%2F1471-2334-11-134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le, Q. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Someya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngyen, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawaoka, Y.</span></span> <span> </span><span class="NLM_article-title">Avian Flu: Isolation of Drug-Resistant H5N1 Virus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>437</i></span>,  <span class="NLM_fpage">1108</span>, <span class="refDoi"> DOI: 10.1038/4371108a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2F4371108a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=16228009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFaht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=1108&author=Q.+M.+Leauthor=M.+Kisoauthor=K.+Someyaauthor=Y.+T.+Sakaiauthor=T.+H.+Nguyenauthor=K.+H.+L.+Nguyenauthor=N.+D.+Phamauthor=H.+H.+Ngyenauthor=S.+Yamadaauthor=Y.+Muramotoauthor=T.+Horimotoauthor=A.+Takadaauthor=H.+Gotoauthor=T.+Suzukiauthor=Y.+Suzukiauthor=Y.+Kawaoka&title=Avian+Flu%3A+Isolation+of+Drug-Resistant+H5N1+Virus&doi=10.1038%2F4371108a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Avian flu: Isolation of drug-resistant H5N1 virus</span></div><div class="casAuthors">Le, Q. Mai; Kiso, Maki; Someya, Kazuhiko; Sakai, Yuko T.; Nguyen, T. Hien; Nguyen, Khan H. L.; Pham, N. Dinh; Ngyen, Ha H.; Yamada, Shinya; Muramoto, Yukiko; Horimoto, Taisuke; Takada, Ayato; Goto, Hideo; Suzuki, Takashi; Suzuki, Yasuo; Kawaoka, Yoshihiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">7062</span>),
    <span class="NLM_cas:pages">1108</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An H5N1 influenza A virus was isolated on 27 Feb 2005 from a 14-yr-old Vietnamese girl.  Direct sequencing of the virus indicated that some of the population had a histidine-to-tyrosine substitution at position 274 in its neuraminidase protein, a mutation that confers resistance to oseltamivir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmQSejiypu7Vg90H21EOLACvtfcHk0liV9PUorHC4Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFaht7fF&md5=4bf9a5f6771def1987c73c2183e6ff3a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F4371108a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F4371108a%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DQ.%2BM.%26aulast%3DKiso%26aufirst%3DM.%26aulast%3DSomeya%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DY.%2BT.%26aulast%3DNguyen%26aufirst%3DT.%2BH.%26aulast%3DNguyen%26aufirst%3DK.%2BH.%2BL.%26aulast%3DPham%26aufirst%3DN.%2BD.%26aulast%3DNgyen%26aufirst%3DH.%2BH.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DMuramoto%26aufirst%3DY.%26aulast%3DHorimoto%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DA.%26aulast%3DGoto%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DKawaoka%26aufirst%3DY.%26atitle%3DAvian%2520Flu%253A%2520Isolation%2520of%2520Drug-Resistant%2520H5N1%2520Virus%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D1108%26doi%3D10.1038%2F4371108a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monod, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tissot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delmas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruigrok, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slama-Schwok, A.</span></span> <span> </span><span class="NLM_article-title">Learning from Structure-Based Drug Design and New Antivirals Targeting the Ribonucleoprotein Complex for the Treatment of Influenza</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1517/17460441.2015.1019859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1517%2F17460441.2015.1019859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=25792362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltFehsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=345-371&author=A.+Monodauthor=C.+Swaleauthor=B.+Tarusauthor=A.+Tissotauthor=B.+Delmasauthor=R.+W.+Ruigrokauthor=T.+Crepinauthor=A.+Slama-Schwok&title=Learning+from+Structure-Based+Drug+Design+and+New+Antivirals+Targeting+the+Ribonucleoprotein+Complex+for+the+Treatment+of+Influenza&doi=10.1517%2F17460441.2015.1019859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza</span></div><div class="casAuthors">Monod, Alexandre; Swale, Christopher; Tarus, Bogdan; Tissot, Alice; Delmas, Bernard; Ruigrok, Rob WH; Crepin, Thibaut; Slama-Schwok, Anny</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-371</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Influenza viruses are a threat to human health.  There are presently only two methods for treating influenza: vaccines, which require yearly updates, and two classes of antivirals that suffer with the problem of resistance by current human influenza viruses; this is esp. the case with amantadine and rimantadine.  Consequently, there is an urgent need for the development of new antivirals with new mechanisms of action.  Areas covered: In this review, the authors focus on viral protein domains, their assocd. activity and their inhibition by small mols. defined by a structure-based design with a special emphasis on the ribonucleoprotein complex and its inhibitors.  Several new classes of antiviral candidates targeting viral replication through individual domains of the polymerase and the nucleoprotein (NP) have been developed through structure-based design.  Expert opinion: To date, the antivirals targeting neuraminidase are by far the most developed and potent.  Antiviral candidates targeting the NP and polymerase domains are in the pipeline but their pharmacokinetics needs further studies.  The recently published structures of the polymerase expand the possibilities for development of new antivirals.  Combination therapies targeting conserved viral targets and new cellular proteins or exploiting drug promiscuity hold promises to fight against the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpk0IEQbgSgrVg90H21EOLACvtfcHk0liV9PUorHC4Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltFehsbk%253D&md5=85ffba64d1b9fe1ef78d7967126cf32d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F17460441.2015.1019859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2015.1019859%26sid%3Dliteratum%253Aachs%26aulast%3DMonod%26aufirst%3DA.%26aulast%3DSwale%26aufirst%3DC.%26aulast%3DTarus%26aufirst%3DB.%26aulast%3DTissot%26aufirst%3DA.%26aulast%3DDelmas%26aufirst%3DB.%26aulast%3DRuigrok%26aufirst%3DR.%2BW.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DSlama-Schwok%26aufirst%3DA.%26atitle%3DLearning%2520from%2520Structure-Based%2520Drug%2520Design%2520and%2520New%2520Antivirals%2520Targeting%2520the%2520Ribonucleoprotein%2520Complex%2520for%2520the%2520Treatment%2520of%2520Influenza%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2015%26volume%3D10%26spage%3D345%26epage%3D371%26doi%3D10.1517%2F17460441.2015.1019859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palese, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, M.</span></span> <span> </span><span class="NLM_article-title">Determination of Influenza Virus Proteins Required for Genome Replication</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">5669</span>– <span class="NLM_lpage">5673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=2214032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADyaK3cXmt1Ors7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1990&pages=5669-5673&author=T.+S.+Huangauthor=P.+Paleseauthor=M.+Krystal&title=Determination+of+Influenza+Virus+Proteins+Required+for+Genome+Replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of influenza virus proteins required for genome replication</span></div><div class="casAuthors">Huang, Tao Sheng; Palese, Peter; Krystal, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5669-73</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">An artificial vaccinia virus vector-driven replication system for influenza virus RNA has been developed.  In this system, a synthetic NS-like gene is replicated and expressed by influenza virus proteins supplied through infection with vaccinia virus recombinant vectors.  The min. subset of influenza virus proteins needed for specific replication and expression of the viral ribonucleoprotein was found to be the 3 polymerase proteins (PB1, PB2, and PA) and the nucleoprotein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprv1Xro8SMHrVg90H21EOLACvtfcHk0lgXnjXgg8mdyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmt1Ors7w%253D&md5=d18b5ecb9e8ebccf1c8ac589a8cffb86</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.%2BS.%26aulast%3DPalese%26aufirst%3DP.%26aulast%3DKrystal%26aufirst%3DM.%26atitle%3DDetermination%2520of%2520Influenza%2520Virus%2520Proteins%2520Required%2520for%2520Genome%2520Replication%26jtitle%3DJ.%2520Virol.%26date%3D1990%26volume%3D64%26spage%3D5669%26epage%3D5673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, E.</span></span> <span> </span><span class="NLM_article-title">The RNA Polymerase of Influenza a Virus: Mechanisms of Viral Transcription and Replication</span>. <i>Acta. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.4149/av_2013_02_113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.4149%2Fav_2013_02_113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=23600869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2qt7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=113-122&author=E.+Fodor&title=The+RNA+Polymerase+of+Influenza+a+Virus%3A+Mechanisms+of+Viral+Transcription+and+Replication&doi=10.4149%2Fav_2013_02_113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The RNA polymerase of influenza A virus: mechanisms of viral transcription and replication</span></div><div class="casAuthors">Fodor, E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Virologica (English Edition)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-122</span>CODEN:
                <span class="NLM_cas:coden">AVIRA2</span>;
        ISSN:<span class="NLM_cas:issn">0001-723X</span>.
    
            (<span class="NLM_cas:orgname">AEP - Academic Electronic Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The influenza A virus RNA genome segments are packaged in ribonucleoprotein complexes contg. RNA polymerase and nucleoprotein.  The ribonucleoprotein is involved in the transcription of viral genes and replication of the viral RNA genome in the nucleus of the infected cells, and represents the minimal transcriptional and replicative machinery of an influenza virus.  During transcription, the viral RNA polymerase synthesizes capped and polyadenylated mRNA using 5' capped RNA primers.  During replication, the viral RNA polymerase generates a complementary RNA (cRNA) replication intermediate, a full-length complement of the vRNA that serves as a template for the synthesis of new copies of vRNA.  The nucleoprotein is also an essential component of the viral transcriptional machinery.  The mol. determinants of the transcriptional and replicative activities of the viral RNA polymerase are not fully understood, but recent data suggest that transcription is performed by a cis-acting RNA polymerase, forming part of the ribonucleoprotein complex, while replication might be carried out by a trans-acting RNA polymerase.  Viral as well as cellular factors are known to be involved in the regulation of the activities of the RNA polymerase, e.g. the viral nuclear export protein has been shown to regulate the accumulation of viral transcription and replication products.  The viral transcriptional machinery represents an attractive target for the development of antiviral drugs and lead compds. targeting nucleoprotein and the PA endonuclease domain of the RNA polymerase have already been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQG6QtdUwhmLVg90H21EOLACvtfcHk0lgXnjXgg8mdyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2qt7%252FO&md5=e1d4ebcf3efd8dc9b0621fb8ba9abccd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4149%2Fav_2013_02_113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4149%252Fav_2013_02_113%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DE.%26atitle%3DThe%2520RNA%2520Polymerase%2520of%2520Influenza%2520a%2520Virus%253A%2520Mechanisms%2520of%2520Viral%2520Transcription%2520and%2520Replication%26jtitle%3DActa.%2520Virol.%26date%3D2013%26volume%3D57%26spage%3D113%26epage%3D122%26doi%3D10.4149%2Fav_2013_02_113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span> <span> </span><span class="NLM_article-title">PA Subunit of RNA Polymerase as a Promising Target for Anti-Influenza Virus Agents</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2007.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1016%2Fj.antiviral.2007.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=18258312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2008&pages=194-201&author=M.+Nakazawaauthor=S.+E.+Kadowakiauthor=I.+Watanabeauthor=Y.+Kadowakiauthor=M.+Takeiauthor=H.+Fukuda&title=PA+Subunit+of+RNA+Polymerase+as+a+Promising+Target+for+Anti-Influenza+Virus+Agents&doi=10.1016%2Fj.antiviral.2007.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">PA subunit of RNA polymerase as a promising target for anti-influenza virus agents</span></div><div class="casAuthors">Nakazawa, Misako; Kadowaki, Shin-etsu; Watanabe, Izumi; Kadowaki, Youko; Takei, Masaya; Fukuda, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-201</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RNA polymerase of influenza virus is a specific enzyme necessary for the viral replication.  A siRNA against the RNA polymerase and the RNA polymerase inhibitor L-742,001 reduced accumulation of viral RNAs in the infected cells.  L-742,001 strongly inhibited virus re-growth after removal of the agent from the culture, whereas the neuraminidase inhibitor zanamivir did not.  L-742,001-resistant mutants showed a Thr-20 to Ala substitution in the PA subunit of RNA polymerase.  The drug-resistant virus showed a slight redn. in the susceptibility to L-742,001 in both the plaque assay (threefold redn.) and enzyme assay (two- to three-fold redn.).  The resistance levels were lower than those of zanamivir-resistant mutants in the plaque assay.  Against zanamivir-resistant mutants, L-742,001 retained the same antiviral activity as against the wild-type strain.  These results indicate that L-742,001 is most likely to act at the PA subunit, and possesses a unique profile.  It is suggested that PA subunit of RNA polymerase is a promising target for anti-influenza virus agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDCcfRlSa-tLVg90H21EOLACvtfcHk0ljXO0M9XvsIpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFClu74%253D&md5=ce368bc359cb1ad171052dd00ca69e7a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2007.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2007.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DNakazawa%26aufirst%3DM.%26aulast%3DKadowaki%26aufirst%3DS.%2BE.%26aulast%3DWatanabe%26aufirst%3DI.%26aulast%3DKadowaki%26aufirst%3DY.%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DH.%26atitle%3DPA%2520Subunit%2520of%2520RNA%2520Polymerase%2520as%2520a%2520Promising%2520Target%2520for%2520Anti-Influenza%2520Virus%2520Agents%26jtitle%3DAntiviral%2520Res.%26date%3D2008%26volume%3D78%26spage%3D194%26epage%3D201%26doi%3D10.1016%2Fj.antiviral.2007.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dias, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruigrok, R. W. H.</span></span> <span> </span><span class="NLM_article-title">The Cap-Snatching Endonuclease of Influenza Virus Polymerase Resides in the PA Subunit</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">914</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1038/nature07745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fnature07745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=19194459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=914-918&author=A.+Diasauthor=D.+Bouvierauthor=T.+Crepinauthor=A.+A.+McCarthyauthor=D.+J.+Hartauthor=F.+Baudinauthor=S.+Cusackauthor=R.+W.+H.+Ruigrok&title=The+Cap-Snatching+Endonuclease+of+Influenza+Virus+Polymerase+Resides+in+the+PA+Subunit&doi=10.1038%2Fnature07745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit</span></div><div class="casAuthors">Dias, Alexandre; Bouvier, Denis; Crepin, Thibaut; McCarthy, Andrew A.; Hart, Darren J.; Baudin, Florence; Cusack, Stephen; Ruigrok, Rob W. H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7240</span>),
    <span class="NLM_cas:pages">914-918</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The influenza virus polymerase, a heterotrimer composed of three subunits, PA, PB1 and PB2, is responsible for replication and transcription of the eight sep. segments of the viral RNA genome in the nuclei of infected cells.  The polymerase synthesizes viral mRNAs using short capped primers derived from cellular transcripts by a unique 'cap-snatching' mechanism.  The PB2 subunit binds the 5' cap of host pre-mRNAs, which are subsequently cleaved after 10-13 nucleotides by the viral endonuclease, hitherto thought to reside in the PB2 (ref. 5) or PB1 subunits.  Here we describe biochem. and structural studies showing that the amino-terminal 209 residues of the PA subunit contain the endonuclease active site.  We show that this domain has intrinsic RNA and DNA endonuclease activity that is strongly activated by manganese ions, matching observations reported for the endonuclease activity of the intact trimeric polymerase.  Furthermore, this activity is inhibited by 2,4-dioxo-4-phenylbutanoic acid, a known inhibitor of the influenza endonuclease.  The crystal structure of the domain reveals a structural core closely resembling resolvases and type II restriction endonucleases.  The active site is comprised of one histidine and a cluster of three acidic residues, conserved in all influenza viruses, which bind two manganese ions in a configuration similar to other two-metal-dependent endonucleases.  Two active site residues have previously been shown to specifically eliminate the polymerase endonuclease activity when mutated.  These results will facilitate the optimization of endonuclease inhibitors as potential new anti-influenza drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBhrxJf4V9TrVg90H21EOLACvtfcHk0ljXO0M9XvsIpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCrt7o%253D&md5=d9ed34cef54fa4166a8a5dbdfe125582</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnature07745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07745%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DD.%26aulast%3DCrepin%26aufirst%3DT.%26aulast%3DMcCarthy%26aufirst%3DA.%2BA.%26aulast%3DHart%26aufirst%3DD.%2BJ.%26aulast%3DBaudin%26aufirst%3DF.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DRuigrok%26aufirst%3DR.%2BW.%2BH.%26atitle%3DThe%2520Cap-Snatching%2520Endonuclease%2520of%2520Influenza%2520Virus%2520Polymerase%2520Resides%2520in%2520the%2520PA%2520Subunit%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D914%26epage%3D918%26doi%3D10.1038%2Fnature07745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selnick, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolanski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span> <span> </span><span class="NLM_article-title">Antiinfluenza Virus Activities of 4-Substituted 2,4-Dioxobutanoic Acid Inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1304</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1128/AAC.40.5.1304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1128%2FAAC.40.5.1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=8723491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADyaK28XislCltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1304-1307&author=J.+C.+Hastingsauthor=H.+Selnickauthor=B.+Wolanskiauthor=J.+E.+Tomassini&title=Antiinfluenza+Virus+Activities+of+4-Substituted+2%2C4-Dioxobutanoic+Acid+Inhibitors&doi=10.1128%2FAAC.40.5.1304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors</span></div><div class="casAuthors">Hastings, J. C.; Selnick, H.; Wolanski, B.; Tomassini, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1304-1307</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We previously identified a series of compds. which specifically inhibited the transcription of influenza A and B viruses (J. Tomassini, H. Selnick, M. E. Davies, M. E. Armstrong, J. Baldwin, M. Bourgeois, J. Hastings, D. Hazuda, J. Lewis, W. McClements, G. Ponticello, E. Radzilowski, G. Smith, A. Tebben, A. Wolfe, Antimicrob. Agents Chemother. 38:2827-2837, 1994).  The compds., 4-substituted 2,4-dioxobutanoic acids, selectively targeted the cap-dependent endonuclease activity of the transcriptase complex.  Addnl., several of these compds. effectively inhibited the replication of influenza virus but not other viruses in cell culture assays.  Here, we report on the anti-influenza virus activities of other potent derivs. of the series evaluated in both in vitro and in vivo infectivity assays.  These compds. inhibited the replication of influenza virus in yield redn. assays, with 50% inhibitory concns. ranging from 0.18 to 0.71 μM.  These 50% inhibitory concns. were similar to those obsd. for inhibition of in vitro transcription (0.32 to 0.54 μM).  One selected compd. also elicited a dose-dependent inhibition of influenza virus replication in mice following an upper respiratory tract challenge.  These studies demonstrate the antiviral efficacy of this inhibitor class and thereby establish the utility of influenza virus endonuclease as a chemotherapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLR1ODjylLS7Vg90H21EOLACvtfcHk0ljXO0M9XvsIpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCltb0%253D&md5=e5f0cdd27a936e6fbb496db3906454ce</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.5.1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.5.1304%26sid%3Dliteratum%253Aachs%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DWolanski%26aufirst%3DB.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26atitle%3DAntiinfluenza%2520Virus%2520Activities%2520of%25204-Substituted%25202%252C4-Dioxobutanoic%2520Acid%2520Inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D1304%26epage%3D1307%26doi%3D10.1128%2FAAC.40.5.1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mojena, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raghoobar, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkacz, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, M. A.</span></span> <span> </span><span class="NLM_article-title">A Novel Antiviral Agent Which Inhibits the Endonuclease of Influenza Viruses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1128/AAC.40.5.1189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1128%2FAAC.40.5.1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=8723464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADyaK28XislCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1189-1193&author=J.+E.+Tomassiniauthor=M.+E.+Daviesauthor=J.+C.+Hastingsauthor=R.+Linghamauthor=M.+Mojenaauthor=S.+L.+Raghoobarauthor=S.+B.+Singhauthor=J.+S.+Tkaczauthor=M.+A.+Goetz&title=A+Novel+Antiviral+Agent+Which+Inhibits+the+Endonuclease+of+Influenza+Viruses&doi=10.1128%2FAAC.40.5.1189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A novel antiviral agent which inhibits the endonuclease of influenza viruses</span></div><div class="casAuthors">Tomassini, J. E.; Davies, M. E.; Hastings, J. C.; Lingham, R.; Mojena, M.; Raghoobar, S. L.; Singh, S. B.; Tkacz, J. S.; Goetz, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1189-1193</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A novel anti-influenza virus compd., flutimide, was identified in exts. of a recently identified fungal species, Delitschia confertaspora.  The compd., a substituted 2,6-diketopiperazine, selectively inhibited the cap-dependent transcriptase of influenza A and B viruses and had no effect on the activities of other polymerases.  Similar to the 4-substituted 2,4-dioxobutanoic acids, a series of transcriptase inhibitors which we described previously, this inhibitor, which is a natural product, affected neither the initiation nor the elongation of influenza virus mRNA synthesis, but it specifically targeted the cap-dependent endonuclease of the transcriptase.  Addnl., the compd. was inhibitory to the replication of influenza A and B viruses in cell culture.  The selective antiviral properties of this compd. further demonstrate the utility of influenza virus endonuclease as a target of antiviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6jvhH_e_KbVg90H21EOLACvtfcHk0ljWCwVrx4milQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCltrY%253D&md5=b753cbf26527d43fe507bc6fbf895c34</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.5.1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.5.1189%26sid%3Dliteratum%253Aachs%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DDavies%26aufirst%3DM.%2BE.%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DLingham%26aufirst%3DR.%26aulast%3DMojena%26aufirst%3DM.%26aulast%3DRaghoobar%26aufirst%3DS.%2BL.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DTkacz%26aufirst%3DJ.%2BS.%26aulast%3DGoetz%26aufirst%3DM.%2BA.%26atitle%3DA%2520Novel%2520Antiviral%2520Agent%2520Which%2520Inhibits%2520the%2520Endonuclease%2520of%2520Influenza%2520Viruses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26spage%3D1189%26epage%3D1193%26doi%3D10.1128%2FAAC.40.5.1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomassini, J. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Natural Flutimide and Analogous Fully Substituted Pyrazine-2,6-diones, Endonuclease Inhibitors of Influenza Virus</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">5504</span>– <span class="NLM_lpage">5516</span>, <span class="refDoi"> DOI: 10.1021/jo015665d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo015665d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvFSjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=5504-5516&author=S.+B.+Singhauthor=J.+E.+Tomassini&title=Synthesis+of+Natural+Flutimide+and+Analogous+Fully+Substituted+Pyrazine-2%2C6-diones%2C+Endonuclease+Inhibitors+of+Influenza+Virus&doi=10.1021%2Fjo015665d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Natural Flutimide and Analogous Fully Substituted Pyrazine-2,6-diones, Endonuclease Inhibitors of Influenza Virus</span></div><div class="casAuthors">Singh, Sheo B.; Tomassini, Joanne E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5504-5516</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Flutimide, (Z)-5-(2-methylpropyl)-3-(2-methylpropylidene)-1-hydroxy-3H-pyrazine-2,6-dione, is a fungal metabolite isolated from a new species of Delitschia cofertaspora.  Flutimide has been shown to selectively inhibit cap-dependent endonuclease activity of influenza virus A.  The inhibition of this activity is a target for the potential development of a therapeutic agent to treat influenza infections.  A convergent total synthesis of flutimide starting from L-leucine has been described.  The synthetic methodol. has been extended to include the synthesis of specifically designed arom. analogs of flutimide, some of which exhibited greater than 7-fold improvement in activity.  The most potent compds. were those with p-fluorobenzylidene or p-methoxybenzylidene substitutions at C-5 of 3H-pyrazine-2,6-dione and showed IC50 values of 0.9 and 0.8 μM, resp.  The details of the rationale for the synthetic design, syntheses, and biol. activities of these analogs are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH8hVy0f6unLVg90H21EOLACvtfcHk0ljWCwVrx4milQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvFSjs7s%253D&md5=23e9caf8b4f96317cc612a1d96f7b293</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo015665d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo015665d%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%2520of%2520Natural%2520Flutimide%2520and%2520Analogous%2520Fully%2520Substituted%2520Pyrazine-2%252C6-diones%252C%2520Endonuclease%2520Inhibitors%2520of%2520Influenza%2520Virus%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D5504%26epage%3D5516%26doi%3D10.1021%2Fjo015665d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feher, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaro, R. E.</span></span> <span> </span><span class="NLM_article-title">Computation-Guided Discovery of Influenza Endonuclease Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1021/ml4003474</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003474" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=61-64&author=E.+Chenauthor=R.+V.+Swiftauthor=N.+Aldersonauthor=V.+A.+Feherauthor=G.+S.+Fengauthor=R.+E.+Amaro&title=Computation-Guided+Discovery+of+Influenza+Endonuclease+Inhibitors&doi=10.1021%2Fml4003474"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Computation-Guided Discovery of Influenza Endonuclease Inhibitors</span></div><div class="casAuthors">Chen, Eric; Swift, Robert V.; Alderson, Nazilla; Feher, Victoria A.; Feng, Gen-Sheng; Amaro, Rommie E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-64</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Influenza is a global human health threat, and there is an immediate need for new antiviral therapies to circumvent the limitations of vaccination and current small mol. therapies.  During viral transcription, influenza incorporates the 5'-end of the host cell's mRNA in a process that requires the influenza endonuclease.  On the basis of recently published endonuclease crystd. structures, a three-dimensional pharmacophore was developed and used to virtually screen 450,000 compds. for influenza endonuclease inhibitors.  Of 264 compds. tested in a FRET-based endonuclease-inhibition assay, 16 inhibitors (IC50 < 50 μM) that span 5 mol. classes novel to this endonuclease were found (6.1% hit rate).  To det. cytotoxicity and antiviral activity, subsequent cellular assays were performed.  Two compds. suppress viral replication with negligible cell toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwIzni3OsTLLVg90H21EOLACvtfcHk0ljWCwVrx4milQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtrvL&md5=a51ca3b00cd4bd1c039c5acd9d7fcc6e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml4003474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003474%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DE.%26aulast%3DSwift%26aufirst%3DR.%2BV.%26aulast%3DAlderson%26aufirst%3DN.%26aulast%3DFeher%26aufirst%3DV.%2BA.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26aulast%3DAmaro%26aufirst%3DR.%2BE.%26atitle%3DComputation-Guided%2520Discovery%2520of%2520Influenza%2520Endonuclease%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D61%26epage%3D64%26doi%3D10.1021%2Fml4003474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevaert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallocchio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessì, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogolino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanna, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sechi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span> <span> </span><span class="NLM_article-title">Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00109</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00109" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=866-871&author=N.+Palaauthor=A.+Stevaertauthor=R.+Dallocchioauthor=A.+Dess%C3%ACauthor=D.+Rogolinoauthor=M.+Carcelliauthor=V.+Sannaauthor=M.+Sechiauthor=L.+Naesens&title=Virtual+Screening+and+Biological+Validation+of+Novel+Influenza+Virus+PA+Endonuclease+Inhibitors&doi=10.1021%2Facsmedchemlett.5b00109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors</span></div><div class="casAuthors">Pala, Nicolino; Stevaert, Annelies; Dallocchio, Roberto; Dessi, Alessandro; Rogolino, Dominga; Carcelli, Mauro; Sanna, Vanna; Sechi, Mario; Naesens, Lieve</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">866-871</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The influenza virus RNA-dependent RNA polymerase complex (RdRp), a heterotrimeric protein complex responsible for viral RNA transcription and replication, represents a primary target for antiviral drug development.  One particularly attractive approach is interference with the endonucleolytic "cap-snatching" reaction by the RdRp subunit PA, more precisely by inhibiting its metal-dependent catalytic activity which resides in the N-terminal part of PA (PA-Nter).  Almost all PA inhibitors (PAIs) thus far discovered bear pharmacophoric fragments with chelating motifs able to bind the bivalent metal ions in the catalytic core of PA-Nter.  More recently, the availability of crystallog. structures of PA-Nter has enabled rational design of original PAIs with improved binding properties and antiviral potency.  We here present a coupled pharmacophore/docking virtual screening approach that allowed us to identify PAIs with interesting inhibitory activity in a PA-Nter enzymic assay.  Moreover, antiviral activity in the low micromolar range was obsd. in cell-based influenza virus assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKH888RsSFzrVg90H21EOLACvtfcHk0lgptJCbCnyycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bJ&md5=81f9b315013d32ad71fbc7f6c8ce2e62</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00109%26sid%3Dliteratum%253Aachs%26aulast%3DPala%26aufirst%3DN.%26aulast%3DStevaert%26aufirst%3DA.%26aulast%3DDallocchio%26aufirst%3DR.%26aulast%3DDess%25C3%25AC%26aufirst%3DA.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DSanna%26aufirst%3DV.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DNaesens%26aufirst%3DL.%26atitle%3DVirtual%2520Screening%2520and%2520Biological%2520Validation%2520of%2520Novel%2520Influenza%2520Virus%2520PA%2520Endonuclease%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D866%26epage%3D871%26doi%3D10.1021%2Facsmedchemlett.5b00109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagong, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijayan, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVoie, E. J.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxyquinolin-2(1H)-ones as Inhibitors of Influenza A Endonuclease</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1021/ml4001112</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4001112" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=547-550&author=H.+Y.+Sagongauthor=A.+Parhiauthor=J.+D.+Baumanauthor=D.+Patelauthor=R.+S.+Vijayanauthor=K.+Dasauthor=E.+Arnoldauthor=E.+J.+LaVoie&title=3-Hydroxyquinolin-2%281H%29-ones+as+Inhibitors+of+Influenza+A+Endonuclease&doi=10.1021%2Fml4001112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease</span></div><div class="casAuthors">Sagong, Hye Yeon; Parhi, Ajit; Bauman, Joseph D.; Patel, Disha; Vijayan, R. S. K.; Das, Kalyan; Arnold, Eddy; LaVoie, Edmond J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">547-550</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several 3-hydroxyquinolin-2(1H)-ones derivs. were synthesized and evaluated as inhibitors of 2009 pandemic H1N1 influenza A endonuclease.  All five of the monobrominated 3-hydroxyquinolin(1H)-2-ones derivs. were synthesized.  Suzuki-coupling of p-fluorophenylboronic acid with each of these brominated derivs. provided the resp. p-fluorophenyl 3-hydroxyquinolin(1H)-2-ones.  In addn. to 3-hydroxyquinolin-2(1H)-one, its 4-Me, 4-Ph, 4-methyl-7-(p-fluorophenyl), and 4-phenyl-7-(p-fluorophenyl) derivs. were also synthesized.  Comparative studies on their relative activity revealed that both 6- and 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one are among the more potent inhibitors of H1N1 influenza A endonuclease.  An X-ray crystal structure of 7-(p-fluorophenyl)-3-hydroxyquinolin-2(1H)-one complexed to the influenza endonuclease revealed that this mol. chelates to two metal ions at the active site of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ-tEcijXjBLVg90H21EOLACvtfcHk0lgptJCbCnyycw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOku7c%253D&md5=ad7492ffd519d11c1cf7c13a68878e25</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml4001112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001112%26sid%3Dliteratum%253Aachs%26aulast%3DSagong%26aufirst%3DH.%2BY.%26aulast%3DParhi%26aufirst%3DA.%26aulast%3DBauman%26aufirst%3DJ.%2BD.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DVijayan%26aufirst%3DR.%2BS.%26aulast%3DDas%26aufirst%3DK.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26atitle%3D3-Hydroxyquinolin-2%25281H%2529-ones%2520as%2520Inhibitors%2520of%2520Influenza%2520A%2520Endonuclease%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D547%26epage%3D550%26doi%3D10.1021%2Fml4001112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Credille, C.
V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Identification of Influenza Endonuclease Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6444</span>– <span class="NLM_lpage">6454</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00628</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00628" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsF2mtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6444-6454&author=C.%0AV.+Credilleauthor=Y.+Chenauthor=S.+M.+Cohen&title=Fragment-Based+Identification+of+Influenza+Endonuclease+Inhibitors&doi=10.1021%2Facs.jmedchem.6b00628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Identification of Influenza Endonuclease Inhibitors</span></div><div class="casAuthors">Credille, Cy V.; Chen, Yao; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6444-6454</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The influenza virus is responsible for millions of cases of severe illness annually.  Yearly variance in the effectiveness of vaccination, coupled with emerging drug resistance, necessitates the development of new drugs to treat influenza infections.  One attractive target is the RNA-dependent RNA polymerase PA subunit.  Herein we report the development of inhibitors of influenza PA endonuclease derived from lead compds. identified from a metal-binding pharmacophore (MBP) library screen.  Pyromeconic acid and derivs. thereof were found to be potent inhibitors of endonuclease.  Guided by modeling and previously reported structural data, several sublibraries of mols. were elaborated from the MBP hits.  Structure-activity relationships were established, and more potent mols. were designed and synthesized using fragment growth and fragment merging strategies.  This approach ultimately resulted in the development of a lead compd. with an IC50 value of 14 nM, which displayed an EC50 value of 2.1 μM against H1N1 influenza virus in MDCK cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO_XnFpireJrVg90H21EOLACvtfcHk0lhKbkOCBGiNaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsF2mtL8%253D&md5=a872083d373a846467c7f2eb5439bed4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00628%26sid%3Dliteratum%253Aachs%26aulast%3DCredille%26aufirst%3DC.%2BV.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DFragment-Based%2520Identification%2520of%2520Influenza%2520Endonuclease%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6444%26epage%3D6454%26doi%3D10.1021%2Facs.jmedchem.6b00628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikamiyama-Iwata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi-Kageyama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikamiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishido, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshinaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel 5-Hydroxy-4-Pyridone-3-Carboxy Acids as Potent Inhibitors of Influenza Cap-Dependent Endonuclease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4739</span>– <span class="NLM_lpage">4742</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1016%2Fj.bmcl.2016.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=27568084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVanur%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4739-4742&author=M.+Miyagawaauthor=T.+Akiyamaauthor=M.+Mikamiyama-Iwataauthor=K.+Hattoriauthor=N.+Kuriharaauthor=Y.+Taodaauthor=C.+Takahashi-Kageyamaauthor=N.+Kuroseauthor=H.+Mikamiyamaauthor=N.+Suzukiauthor=K.+Takayaauthor=K.+Tomitaauthor=K.+Matsuoauthor=K.+Morimotoauthor=R.+Yoshidaauthor=T.+Shishidoauthor=T.+Yoshinagaauthor=A.+Satoauthor=M.+Kawai&title=Discovery+of+Novel+5-Hydroxy-4-Pyridone-3-Carboxy+Acids+as+Potent+Inhibitors+of+Influenza+Cap-Dependent+Endonuclease&doi=10.1016%2Fj.bmcl.2016.08.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease</span></div><div class="casAuthors">Miyagawa, Masayoshi; Akiyama, Toshiyuki; Mikamiyama-Iwata, Minako; Hattori, Kazunari; Kurihara, Naoko; Taoda, Yoshiyuki; Takahashi-Kageyama, Chika; Kurose, Noriyuki; Mikamiyama, Hidenori; Suzuki, Naoyuki; Takaya, Kenji; Tomita, Kenji; Matsuo, Kenji; Morimoto, Kenji; Yoshida, Ryu; Shishido, Takao; Yoshinaga, Tomokazu; Sato, Akihiko; Kawai, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4739-4742</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We report the discovery of a novel series of influenza Cap-dependent EndoNuclease (CEN) inhibitors based on the 4-pyridone-carboxylic acid (PYXA) scaffold, which were found from our chelate library.  Our SAR research revealed the lipophilic domain to be the key to CEN inhibition.  In particular, the position between the chelate and the lipophilic domain in the derivs. was essential for enhancing the potency.  Our study, based on virtual modeling, led to the identification of 2y as a potent CEN inhibitor with an IC50 of 5.12 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPeep0KpriR7Vg90H21EOLACvtfcHk0linDnQYXOuJgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVanur%252FK&md5=8a235ed5f4b2419920bd7eb1ff42495f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DMiyagawa%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DKurihara%26aufirst%3DN.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DTakahashi-Kageyama%26aufirst%3DC.%26aulast%3DKurose%26aufirst%3DN.%26aulast%3DMikamiyama%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DTakaya%26aufirst%3DK.%26aulast%3DTomita%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DK.%26aulast%3DMorimoto%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DR.%26aulast%3DShishido%26aufirst%3DT.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DKawai%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Novel%25205-Hydroxy-4-Pyridone-3-Carboxy%2520Acids%2520as%2520Potent%2520Inhibitors%2520of%2520Influenza%2520Cap-Dependent%2520Endonuclease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4739%26epage%3D4742%26doi%3D10.1016%2Fj.bmcl.2016.08.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B. J.</span></span> <span> </span><span class="NLM_article-title">A Novel Small-Molecule Inhibitor of Influenza A Virus Acts by Suppressing PA Endonuclease Activity of The Viral Polymerase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">22880</span>, <span class="refDoi"> DOI: 10.1038/srep22880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1038%2Fsrep22880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=26956222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVaiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=22880&author=S.+Yuanauthor=H.+Chuauthor=K.+Singhauthor=H.+Zhaoauthor=K.+Zhangauthor=R.+Y.+Kaoauthor=B.+Chowauthor=J.+Zhouauthor=B.+J.+Zheng&title=A+Novel+Small-Molecule+Inhibitor+of+Influenza+A+Virus+Acts+by+Suppressing+PA+Endonuclease+Activity+of+The+Viral+Polymerase&doi=10.1038%2Fsrep22880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase</span></div><div class="casAuthors">Yuan, Shuofeng; Chu, Hin; Singh, Kailash; Zhao, Hanjun; Zhang, Ke; Kao, Richard Y. T.; Chow, Billy K. C.; Zhou, Jie; Zheng, Bo-Jian</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22880</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The RNA-dependent RNA polymerase of influenza A virus comprises conserved and independently-folded subdomains with defined functionalities.  The N-terminal domain of the PA subunit (PAN) harbors the endonuclease function so that it can serve as a desired target for drug discovery.  To identify a class of anti-influenza inhibitors that impedes PAN endonuclease activity, a screening approach that integrated the fluorescence resonance energy transfer based endonuclease inhibitory assay with the DNA gel-based endonuclease inhibitory assay was conducted, followed by the evaluation of antiviral efficacies and potential cytotoxicity of the primary hits in vitro and in vivo.  A small-mol. compd. ANA-0 was identified as a potent inhibitor against the replication of multiple subtypes of influenza A virus, including H1N1, H3N2, H5N1, H7N7, H7N9 and H9N2, in cell cultures.  Combinational treatment of zanamivir and ANA-0 exerted synergistic anti-influenza effect in vitro.  Intranasal administration of ANA-0 protected mice from lethal challenge and reduced lung viral loads in H1N1 virus infected BALB/c mice.  In summary, ANA-0 shows potential to be developed to novel anti-influenza agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT2A6zhAoZlrVg90H21EOLACvtfcHk0linDnQYXOuJgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVaiurg%253D&md5=8f90189ba7de66c8c33935daf7fb71cf</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsrep22880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep22880%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DChu%26aufirst%3DH.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DKao%26aufirst%3DR.%2BY.%26aulast%3DChow%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DB.%2BJ.%26atitle%3DA%2520Novel%2520Small-Molecule%2520Inhibitor%2520of%2520Influenza%2520A%2520Virus%2520Acts%2520by%2520Suppressing%2520PA%2520Endonuclease%2520Activity%2520of%2520The%2520Viral%2520Polymerase%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D22880%26doi%3D10.1038%2Fsrep22880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujishita, T.</span>; <span class="NLM_string-name">Mikamiyama, M.</span>; <span class="NLM_string-name">Kawai, M.</span>, <span class="NLM_string-name">Akiyama, T.</span></span> <span> </span><span class="NLM_article-title">Substituted 3-Hydroxy-4-Pyridone Derivative</span>. <span class="NLM_patent">WO2010110231A</span>, Sep 30, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Fujishita&author=M.+Mikamiyama&author=M.+Kawai&author=T.+Akiyama&title=Substituted+3-Hydroxy-4-Pyridone+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFujishita%26aufirst%3DT.%26atitle%3DSubstituted%25203-Hydroxy-4-Pyridone%2520Derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>Calculated
LogP values were obtained using the GALAS calculation algorithm; Advanced
Chemistry Development (ACD/Labs) Software, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Calculated%0ALogP+values+were+obtained+using+the+GALAS+calculation+algorithm%3B+Advanced%0AChemistry+Development+%28ACD%2FLabs%29+Software%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Byrn, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bral, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledeboer, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijnbrand, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifsonc, S. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit Antimicrob</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1569</span>– <span class="NLM_lpage">1582</span>, <span class="refDoi"> DOI: 10.1128/AAC.04623-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=10.1128%2FAAC.04623-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=25547360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFaisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2015&pages=1569-1582&author=A.+R.+Byrnauthor=M.+S.+Jonesauthor=B.+H.+Bennettauthor=C.+Bralauthor=P.+M.+Clarkauthor=D.+M.+Jacobsauthor=D.+A.+Kwongauthor=W.+M.+Ledeboerauthor=R.+J.+Leemanauthor=F.+C.+McNeilauthor=A.+M.+Murckoauthor=A.+Nezamiauthor=E.+Perolaauthor=R.+Rijnbrandauthor=K.+Saxenaauthor=W.+A.+Tsaiauthor=Y.+Zhouauthor=S.+P.+Charifsonc&title=Preclinical+Activity+of+VX-787%2C+a+First-in-Class%2C+Orally+Bioavailable+Inhibitor+of+the+Influenza+Virus+Polymerase+PB2+Subunit+Antimicrob&doi=10.1128%2FAAC.04623-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit</span></div><div class="casAuthors">Byrn, Randal A.; Jones, Steven M.; Bennett, Hamilton B.; Bral, Chris; Clark, Michael P.; Jacobs, Marc D.; Kwong, Ann D.; Ledeboer, Mark W.; Leeman, Joshua R.; McNeil, Colleen F.; Murcko, Mark A.; Nezami, Azin; Perola, Emanuele; Rijnbrand, Rene; Saxena, Kumkum; Tsai, Alice W.; Zhou, Yi; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1569-1582/1-1569-1582/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">VX-787 is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex.  Viral genetics and X-ray crystallog. studies provide support for the idea that VX-787 occupies the 7-Me GTP (m7GTP) cap-binding site of PB2.  VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissocn. const.) of 24 nM as detd. by isothermal titrn. calorimetry (ITC).  The cell-based EC50 (the concn. of compd. that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay, with a similar EC50 in a viral RNA replication assay.  VX-787 is active against a diverse panel of influenza A virus strains, including H1N1pdm09 and H5N1 strains, as well as strains with reduced susceptibility to neuraminidase inhibitors (NAIs).  VX-787 was highly efficacious in both prophylaxis and treatment models of mouse influenza and was superior to the neuraminidase inhibitor, oseltamivir, including in delayed-start-to-treat expts., with 100% survival at up to 96 h postinfection and partial survival in groups where the initiation of therapy was delayed up to 120 h postinfection.  At different doses, VX-787 showed a 1-log to >5-log redn. in viral load (relative to vehicle controls) in mouse lungs.  Overall, these favorable findings validate the PB2 subunit of the viral polymerase as a drug target for influenza therapy and support the continued development of VX-787 as a novel antiviral agent for the treatment of influenza infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAxHkSMjovJrVg90H21EOLACvtfcHk0lji4l7bhtU68w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFaisb8%253D&md5=97b242b9882563529da51aeaf71fd59a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.04623-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.04623-14%26sid%3Dliteratum%253Aachs%26aulast%3DByrn%26aufirst%3DA.%2BR.%26aulast%3DJones%26aufirst%3DM.%2BS.%26aulast%3DBennett%26aufirst%3DB.%2BH.%26aulast%3DBral%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DP.%2BM.%26aulast%3DJacobs%26aufirst%3DD.%2BM.%26aulast%3DKwong%26aufirst%3DD.%2BA.%26aulast%3DLedeboer%26aufirst%3DW.%2BM.%26aulast%3DLeeman%26aufirst%3DR.%2BJ.%26aulast%3DMcNeil%26aufirst%3DF.%2BC.%26aulast%3DMurcko%26aufirst%3DA.%2BM.%26aulast%3DNezami%26aufirst%3DA.%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DRijnbrand%26aufirst%3DR.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DTsai%26aufirst%3DW.%2BA.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DCharifsonc%26aufirst%3DS.%2BP.%26atitle%3DPreclinical%2520Activity%2520of%2520VX-787%252C%2520a%2520First-in-Class%252C%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520the%2520Influenza%2520Virus%2520Polymerase%2520PB2%2520Subunit%2520Antimicrob%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2015%26volume%3D59%26spage%3D1569%26epage%3D1582%26doi%3D10.1128%2FAAC.04623-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W69" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2W69','PDB','2W69'); return false;">PDB: 2W69</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i81"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00861">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15333"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00861">10.1021/acs.jmedchem.9b00861</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular modeling with CEN (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Compound purity information; measurement of cap-dependent endonuclease (CEN) inhibitory activity; CPE inhibitory effect confirming assay; docking analysis of compound <b>2i</b>; docking analysis of compound <b>2v</b>; rat PK study; LC/MS/MS analysis; plasma protein binding assay; microsomal stability assay; animal care and use (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_001.pdf">jm9b00861_si_001.pdf (394.54 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_002.pdf">jm9b00861_si_002.pdf (586.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00861/suppl_file/jm9b00861_si_003.csv">jm9b00861_si_003.csv (2.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00861&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-17%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00861%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00861" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999b66fd49d956","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
